10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 _______________________________________________

FORM 10-K

 _______________________________________________

(Mark One)

ý Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the fiscal year ended June 30, 2012

OR

¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to .

Commission File Number: 000-26926

_______________________________________________

ScanSource, Inc.

(Exact name of registrant as specified in its charter)

_______________________________________________ 

South Carolina (State or other jurisdiction of incorporation or organization)	57-0965380 (I.R.S. Employer Identification No.)
6 Logue Court Greenville, South Carolina (Address of principal executive offices)	29615 (Zip Code)

(864) 288-2432

(Registrant’s telephone number, including area code)

 _______________________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Name of Each Exchange on Which Registered
Common Stock, no par value	NASDAQ Global Select Market

Securities registered pursuant to Section 12(g) of the Act:

None.

 _______________________________________________

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    ý  Yes    ¨  No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    ¨  Yes    ý  No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ý  Yes    ¨  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    ý  Yes    ¨  No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ý

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	ý	Accelerated filer	¨
Non-accelerated filer (Do not check if a smaller reporting company)	¨	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    ¨  Yes    ý  No

The aggregate market value of the voting common stock of the Registrant held by non-affiliates of the Registrant at December 31, 2011 was $973,035,756, as computed by reference to the closing price of such stock on such date.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class	Outstanding at August 22, 2012
Common Stock, no par value per share	27,609,840 shares

DOCUMENTS INCORPORATED BY REFERENCE

The registrant has incorporated by referenced into Part III of this report certain portions of its proxy statement for its 2012 Annual Meeting of Shareholders, which is expected to be filed pursuant to Regulation 14A within 120 days after the end of the registrant’s fiscal year ended June 30, 2012.

FORWARD-LOOKING STATEMENTS

The forward-looking statements included in the “Business,” “Risk Factors,” “Legal Proceedings,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Quantitative and Qualitative Disclosures About Market Risk” sections and elsewhere herein, which reflect our best judgment based on factors currently known, involve risks and uncertainties. Words such as “expects,” “anticipates,” “believes,” “intends,” “plans,” “hopes,” and variations of such words and similar expressions are intended to identify such forward-looking statements. Except as may be required by law, we expressly disclaim any obligation to update these forward-looking statements to reflect events or circumstances after the date of this Annual Report on Form 10-K or to reflect the occurrence of unanticipated events. Actual results could differ materially from those anticipated in these forward-looking statements as a result of a number of factors including, but not limited to, the factors discussed in such sections and, in particular, those set forth in the cautionary statements contained in “Risk Factors.” The forward-looking information we have provided in this Annual Report on Form 10-K pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 should be evaluated in the context of these factors.

TABLE OF CONTENTS

		Page
PART I		1
Item 1.	Business	1
Item 1A.	Risk Factors	6
Item 1B.	Unresolved Staff Comments	15
Item 2.	Properties	15
Item 3.	Legal Proceedings	15
Item 4.	Mine Safety Disclosures	15
PART II		16
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	16
Item 6.	Selected Financial Data	17
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	37
Item 8.	Financial Statements and Supplementary Data	38
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	80
Item 9A.	Controls and Procedures	80
Item 9B.	Other Information	80
PART III		81
Item 10.	Directors, Executive Officers and Corporate Governance	81
Item 11.	Executive Compensation	81
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	81
Item 13.	Certain Relationships and Related Transactions, and Director Independence	81
Item 14.	Principal Accountant Fees and Services	81
PART IV		82
Item 15.	Exhibits and Financial Statement Schedules	82
Signatures		84

PART I

ITEM 1.    Business.

ScanSource, Inc., together with its subsidiaries (the “Company”), was incorporated in South Carolina in 1992 and is a leading wholesale distributor of specialty technology products, providing value-added distribution services to resellers. The Company has two geographic distribution segments: the North American distribution segment serving the United States and Canada from our Southaven, Mississippi distribution center and an international segment serving Latin America and Europe from distribution centers located in Florida, Mexico, Brazil and Belgium. The North American distribution segment sells products through four sales units: automated identification and data capture ("AIDC") and point-of-sale ("POS") equipment sold by the (i) ScanSource POS and Barcoding sales unit; voice, data, video and converged communications equipment sold by the (ii) Catalyst Telecom and (iii) ScanSource Communications sales units; and physical security and wireless infrastructure products sold by the (iv) ScanSource Security sales unit. The international distribution segment markets AIDC, POS, communications and security products through its ScanSource Latin America sales unit; AIDC and POS products through its ScanSource Europe sales unit; and communication products through its ScanSource Communications sales unit in Europe. See Note 13 to the Notes to the Consolidated Financial Statements for financial information concerning the Company’s reporting segments and the geographic areas in which the Company operates.

North American Distribution Segment

ScanSource POS and Barcoding Sales Unit

The ScanSource POS and Barcoding sales unit markets AIDC and POS products which interface with computer systems used to automate the collection, processing and communication of information for commercial and industrial applications, including retail sales, distribution, shipping, inventory control, materials handling and warehouse management. The bar code family of products is referred to as automatic identification and data capture because it includes all types of portable data collection terminals, wireless products, bar code label printers and scanners. POS products are those PC-based products that have replaced electronic cash registers in retail and hospitality environments and the peripheral products that attach to them. These peripheral devices include such items as cash drawers, pole displays, signature capture units, display monitors and magnetic strip readers. In addition to these peripheral devices, ScanSource POS and Barcoding also sells products that attach to the POS network in the store, including kiosks, network access points, routers and digital signage displays.

Catalyst Telecom Sales Unit

The Catalyst Telecom sales unit markets voice, data and converged communication systems and is a distributor of Avaya communications solutions, including Avaya Enterprise Solutions, Small and Medium Enterprise (“SME”) and internet protocol (“IP”) products.

ScanSource Communications Sales Unit

ScanSource Communications is a comprehensive value-added distributor of total communications solutions, including video and audio conferencing products; telephony solutions including Voice over IP (“VoIP”); and computer telephony building blocks.

ScanSource Security Sales Unit

The ScanSource Security sales unit focuses on hardware distribution of electronic security equipment. The product offering includes identification, access control, video surveillance, intrusion-related and wireless infrastructure products.

International Distribution Segment

The Company’s international distribution segment markets AIDC, POS and communications products to technology resellers and integrators in the Latin American and European markets. In addition, we distribute specialty security technologies in Latin America. In April 2011, the Company purchased all of the shares of CDC Brasil S.A. (“CDC”), formerly known as CDC Brasil Distribuidora LTDA, a corporation organized under the laws of the Federative Republic of Brazil, in order to expand our reach in the Latin American market. CDC is included with our ScanSource Latin America operating unit.

See Item 1A. “Risk Factors” below for a discussion of certain risks attendant to the Company’s international operations.

1

Products and Markets

The Company currently markets over 100,000 products from approximately 250 hardware and software vendors to over 30,000 reseller customers primarily from its central warehouses in Mississippi, Florida, Mexico, Brazil and Belgium.

AIDC technology incorporates the capabilities for electronic identification and data processing without the need for manual input and consists of a wide range of products that include bar code printers, hand-held and fixed-mount laser scanners, mobile and wireless data collection devices and magnetic stripe readers. As AIDC technology has become more pervasive, applications have evolved from traditional uses such as inventory control, materials handling, distribution, shipping and warehouse management to more advanced applications, such as health care. POS products include those computer-based systems that have replaced electronic cash registers in grocery, retail and hospitality environments. POS product lines include computer-based terminals, monitors, receipt printers, pole displays, cash drawers, keyboards, peripheral equipment and fully integrated processing units. In communications, voice and data products include private branch exchanges (“PBXs”), key systems, and telephone handsets and components used in voice, fax, data, voice recognition, call center management and IP communication applications. Converged communication products combine voice, data, fax and speech technologies to deliver communications solutions that combine computers, telecommunications and the Internet. Converged communications products include telephone and IP network interfaces, VoIP systems, PBX integration products and carrier-class board systems-level products. Video products include video and voice conferencing and network systems. Electronic security products include identification, access control, video surveillance, intrusion-related products and wireless infrastructure products.

See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” below for a discussion of the amount of the Company’s net sales contributed by product categories.

Industry Overview

The distribution channels for specialty technology products generally consist of manufacturers, wholesale distributors such as ScanSource, resellers and end-users. The “sales channel” for specialty technology products typically evolves through a three-stage process: (i) direct sales by manufacturers to end-users; (ii) single-tier distribution in which manufacturers sell to resellers who, in turn, sell directly to end-users; and (iii) two-tier, or wholesale distribution, in which manufacturers sell to wholesale distributors, including ScanSource, who sell only to resellers who, in turn, sell directly to end-users. Currently, the wholesale distribution channel for technology products is served by both broad line and specialty distributors. The broad line distributors are engaged primarily in conventional order fulfillment and typically offer their reseller customers less support and fewer value-added services than do specialty distributors. The specialty distributors that compete with ScanSource are generally smaller, both in terms of size and geographic area covered.

Competition among an expanding number of manufacturers typically causes product prices to decrease and product applications to expand, which has resulted in an increasing number of resellers entering the market in order to support a broader base of potential end-users. As the number of resellers and end-users has grown, competition among manufacturers and within the reseller channel has intensified. Because many specialty technology manufacturers develop products that represent only one part of a total solution, most products eventually are developed to provide interoperability among products from multiple manufacturers. As a result of interoperability, a variety of manufacturers’ products are typically configured together to create a system solution. Therefore, both manufacturers and resellers have become more dependent upon value-added wholesale distributors such as ScanSource for the aggregation of products and reseller support services, as well as the organization and maintenance of an efficient market structure.

In addition, manufacturers that face declining product prices and rising costs of direct sales increasingly rely upon value-added wholesale distributors by outsourcing certain support functions, such as product assortment, delivery, inventory management, technical assistance and marketing. At the same time, shortened product life cycles and the introduction of new products and applications have caused resellers increasingly to rely on wholesale distributors for various inventory management, financing, technical support and related functions. The Company believes that as the reseller market grows and becomes more fragmented, and as specialty technology products continue to transition to open systems, the wholesale distribution channel in which the Company operates will become increasingly more important.

2

Vendors

The Company’s key vendors in its worldwide POS and barcoding sales units include Bematech, Cisco, Datalogic, Datamax-O’Neil, Elo, Epson, Honeywell, IBM, Intermec, Motorola, NCR, Toshiba and Zebra Technologies. The Company’s key vendors in its worldwide communications sales units, including Catalyst Telecom, include Aruba, Avaya, Audiocodes, Dialogic, Extreme Networks, Meru Networks, Plantronics, Polycom and Shoretel. The Company’s key vendors in its security sales units include Alvarion, Arecont, Axis, Bosch, Cisco, Datacard, Exacq Technologies, Fargo, HID, March Networks, Panasonic, Pelco, Ruckus Wireless, Samsung, Sony and Zebra Card.

The Company’s products are typically purchased directly from the manufacturer on a non-exclusive basis. The Company’s agreements with its vendors generally do not restrict the Company from selling similar or comparable products manufactured by competitors. The Company has the flexibility to terminate or curtail sales of one product line in favor of another due to technological change, pricing considerations, product availability, customer demand or vendor distribution policies.

The Company has approximately 250 hardware and software vendors that currently supply its products. Of all of the Company’s vendors, only two, Motorola and Avaya, each constituted more than 10% of the Company’s net sales.

The Company has three non-exclusive distribution agreements with Motorola. One agreement covers sales of Motorola hardware and software products in North and South America, another agreement covers sales of Motorola hardware and software products in Europe, the Middle East and Africa and another agreement covers sales of wireless products in Europe. The Motorola agreements each have a one year term that automatically renews for additional one year terms, and either party may terminate the agreement upon 30 days and 90 days, respectively, notice to the other party.

The Company also has two non-exclusive distribution agreements with Avaya. One agreement covers the distribution of Avaya products in the United States, and the other agreement covers distribution of Avaya products in the United Kingdom and certain portions of continental Europe. In addition, the Avaya agreements provide separate authorizations for the Avaya Enterprise Communications Group (“ECG”) and Avaya Small to Medium Business (“SMB”) product lines. The Avaya agreements each have a one year term that automatically renews for additional one year terms if not terminated by either party upon 180 days or 90 days notice, respectively, to the other party.

In addition to the Motorola and Avaya agreements mentioned above, the Company has written distribution agreements with almost all of its vendors. These agreements are in the form that the Company believes are customarily used by manufacturers and distributors. The Company’s agreements generally provide it with non-exclusive distribution rights and often include territorial restrictions that limit the countries in which the Company can distribute its products. These agreements typically provide the Company with stock rotation and price protection provisions, including with Motorola and Avaya. Stock rotation rights give the Company the ability, subject to certain limitations, to return for credit or exchange a portion of those inventory items purchased from the vendor. Price protection situations occur when a vendor credits the Company for declines in inventory value resulting from the vendor’s price reductions. Along with the Company’s inventory management policies and practices, these provisions are designed to reduce the Company’s risk of loss due to slow-moving inventory, vendor price reductions, product updates or obsolescence.

Some of the Company’s distribution agreements contain minimum purchase requirements that the Company must meet in order to receive preferential prices. The Company participates in various rebate, cash discount and cooperative marketing programs offered by its vendors to support expenses associated with distributing and marketing the vendor’s products. These rebates and purchase discounts are generally influenced by sales volumes and are subject to change.

The Company’s distribution agreements are generally short term, subject to periodic renewal, and provide for termination by either party without cause upon 30 to 120 days notice. The Company’s vendors generally warrant the products the Company distributes and allow returns of defective products, including those returned to the Company by its customers. The Company generally does not independently warrant the products it distributes; however, local laws may in some cases impose warranty obligations on the Company.

The Company’s merchandising department recruits vendors and manages important aspects of its vendor relationships, such as purchasing arrangements, cooperative marketing initiatives, vendor sales force relationships, product training, monitoring of rebate programs and various contract terms and conditions.

3

Customers

The Company’s reseller customers currently include over 30,000 active value-added reseller accounts (“VARs”) located in the United States, Canada, Latin America and Europe. No single customer accounted for more than 6% of the Company’s total net sales for the fiscal year ended June 30, 2012. The Company generally targets two types of reseller customers: specialty technology VARs and networking or PC VARs.

Specialty Technology VARs

These resellers focus on selling specialty technology products as tailored software or integrated hardware solutions for their end-users’ existing applications. They also incorporate specialty technology products into customized technology solutions for their end-users. Primary industries served by these resellers include manufacturing, distribution, health care, pharmaceutical, hospitality, government, convenience, grocery, financial and other retail markets.

Networking or PC VARs

These resellers develop computer solutions and networking for their end-users’ microcomputer needs. They typically have well-established relationships with end-user management information system directors and are seeking additional revenue and profit opportunities in related technology markets, such as AIDC, POS, security or communications.

Sales and Electronic Commerce

The Company’s sales department consists primarily of inside sales representatives located in the United States, Canada, Mexico, Brazil, Belgium, France, Germany, the United Kingdom and the Netherlands. In order to build strong customer relationships, most active resellers are assigned to a sales representative. Each sales representative negotiates pricing directly with their assigned customers. The Company also employs business development representatives who are responsible for developing technical expertise within broad product markets, recruiting customers, creating demand, and reviewing overall product and service requirements of resellers. Each sales representative and business development representative receives comprehensive training with respect to the technical characteristics of each vendor’s products. This training is supplemented by frequent product seminars conducted by vendors’ representatives and bi-weekly meetings among product, marketing and sales managers.

Increasingly, customers rely upon the Company’s electronic ordering and information systems, in addition to its product catalogs and frequent mailings, as sources for product information, including availability and price. Through the Company’s websites, most customers can gain remote access to the Company’s information systems to check real-time product availability, see their customized pricing and place orders. Customers can also follow the status of their orders and obtain United Parcel Service (“UPS”) and Federal Express (“FedEx”) package tracking numbers from this site.

Marketing

The Company provides a range of marketing services, including cooperative advertising with vendors through trade publications and direct mail, product catalogs for each of the North American, European and Latin American markets, periodic newsletters, management of sales leads, trade shows with hardware and software companies and vendors and sales promotions. In addition, the Company organizes and operates its own seminars and teams with top vendors to recruit prospective resellers and introduce new applications for the specialty technology products it distributes. The Company frequently customizes its marketing services for vendors and resellers.

Value-Added Services

In addition to the basic order fulfillment and credit services that conventional wholesale distributors typically provide to resellers, we differentiate ourselves by providing an array of value-added services and business tools that assist resellers to provide more complete solutions and improve customer service. Such services include custom configuration, professional services, technical support, partner marketing, web storefronts, custom packaging, and other specialized services.

4

Operations

Information System

The Company’s information system is a scalable, centralized processing system capable of supporting numerous operational functions including purchasing, receiving, order processing, shipping, inventory management and accounting. Sales representatives rely on the information system for on-line, real-time information on product pricing, inventory availability and reservation, and order status. The Company’s warehouse operations use bar code technology for receiving and shipping, and automated UPS and FedEx systems for freight processing and shipment tracking, each of which is integrated with the Company’s information system. The customer service and technical support departments employ the system for documentation and faster processing of customer product returns. To ensure that adequate inventory levels are maintained, the Company’s buyers depend on the system’s purchasing and receiving functions to track inventory on a continual basis.

Central Warehouse and Shipping

We operate a 600,000 square foot distribution center in Southaven, Mississippi, which is located near the FedEx hub facility in Memphis, Tennessee and serves all of North America. Our European operation utilizes a third party warehouse located in Liege, Belgium that services all of Europe. Our Latin American warehouses are located in Florida, Mexico and Brazil. Our centralized distribution model creates several advantages, including: (i) a reduced amount of “safety stock” inventory which, in turn, reduces the Company’s working capital requirements; (ii) an increased turnover rate through tighter controls over inventory; (iii) maintenance of a consistent order-fill rate; (iv) improved personnel productivity; (v) improved delivery time; (vi) simplified purchasing and tracking; (vii) decreased demand for management personnel; and (viii) flexibility to meet customer needs for systems integration. Our objective is to ship all orders on the same day, using bar code technology to expedite shipments and minimize shipping errors. The Company offers reduced freight rates and flexible delivery options to minimize a reseller’s need for inventory.

Financial Services

Our sales terms are competitive within our specific geographic areas for qualified resellers and facilitate various third-party financing options, including leasing, flooring and other secured financing. We believe this policy reduces the customer’s need to establish multiple credit relationships with a large number of manufacturers.

Competition

The markets in which we operate are highly competitive. Competition is based primarily on factors such as price, product availability, speed and accuracy of delivery, effectiveness of sales and marketing programs, credit availability, ability to tailor specific solutions to customer needs, quality and breadth of product lines and services, and availability of technical and product information.

Our competitors include regional and national wholesale distributors, as well as hardware manufacturers (including most of the Company’s vendors) that sell directly to resellers and to end-users. In addition, our competitors include master resellers that sell to franchisees, third-party dealers and end-users. Certain current and potential competitors have greater financial, technical, marketing and other resources than the Company has and may be able to respond more quickly to new or emerging technologies and changes in customer requirements. Certain smaller, regional competitors, who are specialty two-tier or mixed model master resellers, may also be able to respond more quickly to new or emerging technologies and changes in customer requirements. Competition has increased for our sales units over the last several years as broad-line and other value-added distributors have entered into the specialty technology markets. Such competition could also result in price reductions, reduced margins and/or loss of market share.

In our worldwide POS and barcoding sales units, the Company competes with broad-line distributors, such as Avnet, Ingram Micro and Synnex in all geographic segments. Additionally, the Company also competes against other smaller, more specialized AIDC and POS distributors, such as Azerty, Bluestar, BP Solutions, Interway Do Brasil and Nimax. In our worldwide communications sales units, the Company competes against other broad-line distributors, such as Avnet, Ingram Micro and Tech Data, and more specialized distributors, such as Jenne and Westcon. In our worldwide security sales units, the Company competes against other broad-line distributors, such as Ingram Micro and Tech Data, and more specialized distributors, such as ADI, Anixter and Tri-Northern. As the Company seeks to expand its business into other areas closely related to the Company’s offerings, the Company may encounter increased competition from current competitors and/or from new competitors, some of which may be the Company’s current customers.

5

Employees

As of June 30, 2012, we had approximately 1,500 employees located in North America, Latin America and Europe. There is only one group of employees that belongs to a collective bargaining unit located in Mexico. The Company considers its employee relations to be good.

Service Marks

The Company conducts its business under the trade names and service marks "ScanSource POS and Barcode," "Catalyst Telecom," "ScanSource Communications," "ScanSource Services," "ScanSource Security," "ScanSource Europe," "ScanSource Europe Communications," "ScanSource Latin America," "ScanSource Mexico," and "ScanSource CDC Brasil."

The Company has been issued registrations for the service marks "ScanSource," "Catalyst Telecom," and "NetPoint" in countries in its principal markets. These trade names and service marks do not have value assigned to them and have a designated indefinite life. The Company does not believe that its operations are dependent upon any of its trade names or service marks. The Company also sells products and provides services under various trade names and service marks to which reference is made in this report that are the property of owners other than the Company.

Additional Information

The Company’s principal internet address is www.scansourceinc.com. The information contained on, or that can be accessed through, the Company’s website is not incorporated by reference into this annual report. The Company has included its website address as a factual reference and does not intend it as an active link to its website. The Company provides its annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and all amendments to those reports, free of charge on www.scansourceinc.com, as soon as reasonably practicable after they are electronically filed, or furnished to, the Securities and Exchange Commission (“SEC”).

ITEM 1A. Risk Factors.

The following are certain risk factors that could affect our business, financial position and results of operations. These risks should be considered in connection with evaluating the forward looking statements contained in this Annual Report on Form 10-K because these factors could cause the actual results and conditions to differ materially from those projected in the forward looking statements. There also are other risks that we may not describe, generally because we currently do not perceive them to be material, which could impact us. If any of these risks develops into actual events, our business, financial condition or results of operations could be negatively affected, the market price of our common stock could decline and you may lose all or part of your investment in our common stock. We expressly disclaim any obligation to update or revise any risk factors, whether as a result of new information, future events or otherwise, except as required by law.

Global economic instability – Current world-wide economic conditions and market disruptions may adversely affect our business, pricing strategy and results of operations.

Financial markets throughout the world could experience extreme disruption, including, among other things, severely diminished liquidity and credit availability, rating downgrades of certain investments and declining valuations and pricing volatility of others, volatile energy costs, geopolitical issues and failure and potential failures of major financial institutions. These developments and/or a related general economic downturn may adversely impact our business and financial condition in a number of ways. Currently, we are experiencing weakened demand in our European operations as a result of current economic conditions in the region. Economic slowdowns can lead to reduced information technology spending by end users, which can adversely affect our sales. Economic instability has increased competitive pressure throughout the channels we serve, resulting in pricing pressures that have decreased our margins. This effect may continue in the future. Global economic downturn and instability may also result in changes in vendor terms and conditions, such as rebates, cash discounts and cooperative marketing efforts, which may result in downward pressure on our gross margins. Tightening of credit in financial markets and general economic downturn may adversely affect the ability of our reseller customers, vendors and service providers to obtain financing for significant purchases and operations and to perform their obligations under our agreements with them. This can result in a decrease in or cancellation of orders for our products and services, negatively impact our ability to collect our accounts receivable on a timely basis, result in additional reserves for uncollectible accounts receivable being required and lead to elevated levels of obsolete inventory. Deterioration in financial and credit markets heightens the risk of customer bankruptcies and delays in payments. Significant volatility and fluctuations in the rates of exchange for the U.S. dollar against currencies such as the euro, British pound and the Brazilian real may also negatively impact our customer pricing and operating results.

6

We continue to be unable to predict the duration of the current economic downturn and disruption in financial markets or their effects on our business and results of operations.

International operations – Our international operations expose us to risks that are different from, or possibly greater than, the risks we are exposed to domestically.

We currently have facilities in eight countries outside the United States and sell products in a number of others. A significant portion of our revenue is derived from our international operations. These operations are subject to a variety of risks that are in addition to the risks that we face domestically or are similar risks but with potentially greater exposure. These risks include:

• Changes in international trade laws, such as the North American Free Trade Agreement, affecting our import and export activities, including export license requirements, restrictions on the export of certain technology, and tariff changes;

• Difficulties in collecting accounts receivable and longer collection periods;

• Changes in, or expiration of, various foreign incentives that provide economic benefits to us;

• Changes in labor laws and regulations affecting our ability to hire and retain employees;

• Difficulties in staffing and managing operations in foreign countries;

• Fluctuations of foreign currency, exchange controls and currency devaluations;

• Changes in the interpretation and enforcement of laws (in particular related to items such as duty and taxation);

• Potential political and economic instability and changes in governments;

• Terrorist or military actions that result in destruction or seizure of our assets or suspension or disruption of our operations or those of our customers;

• Potential regulatory changes, including foreign environmental restrictions; and

• Different general economic conditions.

Because we have operations in Brazil, Canada, Mexico and Europe, we are exposed to fluctuations in foreign currency exchange rates. We manage our exposure to fluctuations in the value of currencies using various derivative instruments. However, we may not be able to mitigate all foreign currency related risk. In addition, exchange rate fluctuations may cause our international results to fluctuate significantly when translated into U.S. dollars. Developing economies, such as Brazil, could have sudden and drastic changes in foreign exchange rates compared to others.

In addition, in foreign markets we are more dependent upon third party providers of key services, such as third party freight forwarders and third party warehouses in Europe and Latin America. Adverse changes in any of these third party services could have an adverse effect on our business, financial condition, and results of operations. As we expand our international operations, we expect these risks to increase.

In addition, the value of our equity investment in foreign countries may fluctuate based on changes in foreign currency exchange rates. These fluctuations may result in losses in the event a foreign subsidiary is sold or closed at a time when the foreign currency is weaker than when we initially invested.

7

Brazilian operations – We face special political, economic and regulatory risks by doing business in Brazil, which could materially and adversely affect our financial condition and results of operations.

As a result of our April 2011 acquisition of all of the shares of CDC, we have substantial operations in Brazil and face risks related to that country’s complex tax, labor, trade compliance and consumer protection laws and regulations. We may now have exposure to the complex tax structure in Brazil, where we have noted that several other companies have had issues with Brazilian tax authorities that have impacted earnings. Additionally, developing markets such as Brazil have greater political volatility, greater vulnerability to infrastructure and labor disruptions and are more likely than developed economies to experience market, currency and interest rate fluctuations and may have higher inflation. Any of these factors could adversely affect our financial condition and results of operations. Furthermore, in developing markets it may be common for others to engage in business practices prohibited by laws and regulations applicable to us, such as the Foreign Corrupt Practices Act or similar local anti-bribery laws. These laws generally prohibit companies and their employees, contractors or agents from making improper payments to government officials for the purpose of obtaining or retaining business. Failure to comply with these laws could subject us to civil and criminal penalties that could materially and adversely affect our financial condition and results of operations.

In addition, competition in developing markets such as Brazil is increasing as our competitors grow their global operations. Our success in integrating CDC’s operations is critical to our growth strategy. If we cannot successfully increase our business in Brazil, our product sales, financial condition and results of operations could be materially and adversely affected.

Systems and the transition to a new Enterprise Resource Planning System - Our ability to manage our business and monitor results is highly dependent upon information and communication systems. A failure of these systems or the ERP implementation could disrupt our business.

We are highly dependent upon a variety of internal computer and telecommunication systems to operate our business, including our enterprise resource planning (“ERP”) systems.

In order to continue support of our growth, we are making significant technological upgrades to our information systems. We are in the process of implementing a company-wide, single ERP software system and related processes to perform various functions and improve on the efficiency of our global business. This is a lengthy and expensive process that will result in a diversion of resources from other operations. Continued execution of the project plan, or a divergence from it, may result in cost overruns, project delays or business interruptions. In addition, divergence from our project plan could impact the timing and/or extent of benefits we expect to achieve from the system and process efficiencies.

Any disruptions, delays or deficiencies in the design and/or implementation of the new ERP system, or in the performance of our legacy systems, particularly any disruptions, delays or deficiencies that impact our operations, could adversely affect our ability to effectively run and manage our business and potentially for our customers to access our price and product availability information. Further, as we are dependent upon our ability to gather and promptly transmit accurate information to key decision makers, our business, results of operations and financial condition may be adversely affected if our information systems do not allow us to transmit accurate information, even for a short period of time. Failure to properly or adequately address these issues could impact our ability to perform necessary business operations, which could adversely affect our reputation, competitive position, business, results of operations and financial condition.

In addition, the information systems of companies we acquire may not be sufficient to meet our standards or we may not be able to successfully convert them to provide acceptable information on a timely and cost-effective basis. Furthermore, we must attract and retain qualified people to operate our systems, expand and improve them, integrate new programs effectively with our existing programs, and convert to new systems efficiently when required. Any disruption to our business due to such issues, or an increase in our costs to cover these issues that is greater than what we have anticipated, could have an adverse affect on our financial results and operations.

8

Our customers rely increasingly on our electronic ordering and information systems as a source for product information, including availability and pricing. There can be no assurance that our systems will not fail or experience disruptions, and any significant failure or disruption of these systems could prevent us from making sales, ordering and delivering products and otherwise conducting our business. Many of our customers use our website to check real-time product availability, see their customized pricing and place orders. The Internet and individual websites have experienced a number of disruptions and slowdowns. In addition, some websites have experienced security breakdowns. While our website has not experienced any material disruptions or security breakdowns, any disruptions or breaches in security or a breach that compromises sensitive information could harm our relationship with our vendors, customers and other business partners. Any material disruption of our website or the Internet in general could impair our order processing or prevent our vendors and customers from accessing information and cause us to lose business.

Additional costs, cost overruns and delays with implementation of new ERP system - Significant additional costs, cost overruns and delays in connection with the implementation of our new ERP system may adversely affect our business and results of operations.

The implementation of our new ERP system has and will continue to involve substantial expenditures on system hardware and software, as well as design, development and implementation activities. We have experienced cost overruns and project delays in connection with the implementation process. Until the new ERP system is fully implemented, we expect to incur additional selling, general and administrative expenses and capital expenditures to implement and test the system, and there can be no assurance that other issues relating to the ERP system will not occur or be identified. Our business and results of operations have been and will continue to be adversely affected if we experience operating problems, additional costs, or cost overruns during the ERP implementation process, or if the ERP system and the associated process change significantly.

People - The departure, transition or replacement of key personnel could significantly impact results of our operations. If we cannot continue to hire and retain high quality employees, our business and financial results may be negatively affected.

Our operating results could be adversely affected by increased competition for employees, higher employee turnover, or increased salary and benefit costs. Like most businesses, our employees are important to our success and we are dependent in part on our ability to retain the services of our key management, sales, IT, operational, finance and administrative personnel. We have built our business on a set of core values, and we attempt to hire employees who are committed to these values. We want to hire and retain employees who will fit our culture of providing exceptional service to our vendors and customers. In order to compete and to continue to grow, we must attract, retain, and motivate employees, including those in executive, senior management, sales, marketing, logistics, technical support and other operating positions.

Many of our employees work in small teams to provide specific services to vendors and customers. They are trained to develop their knowledge of vendor products, programs and practices, and customer business needs, as well as to enhance the skills required to provide exceptional service and to manage our business. As they gain experience and develop their knowledge and skills, our employees become highly desired by other businesses. Therefore, to retain our employees, we have to provide a satisfying work environment and competitive compensation and benefits. If our costs to retain our skilled employees increase, then our business and financial results may be negatively affected.

Our continued growth is also dependent, in part, on the skills, experience and efforts of our senior management, including but not limited to, Michael Baur, our Chief Executive Officer. We may not be successful in retaining the members of our senior management team or our other key employees. While we have entered into employment agreements with key executives and have obtained a key person life insurance policy on our CEO's life, the loss of the services of Mr. Baur or any member of our senior management team could also have an adverse effect on our business, financial condition and results of operations. Recent departures, retirement announcements and promotions of senior management has resulted in the transition of many management positions within our company. The process of identifying management successors creates uncertainty and could become a distraction to our senior management and the Board. We may not be successful in attracting qualified candidates to replace key positions when necessary. As a result, the transition process and the identification and recruitment of candidates to fill senior management positions may be disruptive to our business or operations.

Vendor relationships – Terminations of a distribution or services agreement or a significant change in supplier terms, authorizations, or lack of product availability, or conditions of sale could negatively affect our operating margins, revenue or the level of capital required to fund our operations.

9

A significant percentage of our net sales relates to products sold to us by relatively few vendors. As a result of such concentration risk, terminations of supply or services agreements or a change in terms or conditions of sale from one or more of our vendors could negatively affect our operating margins, revenues or the level of capital required to fund our operations. Our vendors have the ability to make adverse changes in their sales terms and conditions, such as reducing the level of purchase discounts and rebates they make available to us. We have no guaranteed price or delivery agreements with our vendors. In certain product categories, limited price protection or return rights offered by our vendors may have a bearing on the amount of product we may be willing to stock. Our inability to pass through to our reseller customers the impact of these changes, as well as our failure to develop systems to manage ongoing vendor programs, could cause us to record inventory write-downs or other losses and could have significant negative impact on our gross margins.

We receive purchase discounts and rebates from some vendors based on various factors, including goals for quantitative and qualitative sales or purchase volume and customer related metrics. Certain purchase discounts and rebates may affect gross margins. Many purchase discounts from vendors are based on percentage increases in sales of products. Our operating results could be negatively impacted if these rebates or discounts are reduced or eliminated or if our vendors significantly increase the complexity of process and costs for us to receive such rebates.

Our ability to obtain particular products or product lines in the required quantities and our ability to fulfill customer orders on a timely basis is critical to our success. Our manufacturers have experienced product supply shortages from time to time due to the inability of certain suppliers to supply certain products on a timely basis. As a result, we have experienced, and may in the future continue to experience, short-term shortages of specific products. In addition, vendors who currently distribute their products through us may decide to shift to or substantially increase their existing distribution, through other distributors, their own dealer networks, or directly to resellers or end-users. Suppliers have, from time to time, made efforts to reduce the number of distributors with which they do business. This could result in more intense competition as distributors strive to secure distribution rights with these vendors, which could have an adverse effect on our operating results. If vendors are not able to provide us with an adequate supply of products to fulfill our customer orders on a timely basis or we cannot otherwise obtain particular products or a product line or vendors substantially increase their existing distribution through other distributors, their own dealer networks, or directly to resellers, our reputation, sales and profitability may suffer.

Customer relationships – We operate in a highly competitive environment and good customer relations are critical to our success. There can be no assurance that we will be able to retain and expand our customer relationships or acquire new customers.

Meeting our customers’ needs quickly and fairly is critical to our business success. Our transactions with our customers are generally performed on a purchase order basis rather than under long term supply agreements. Our customers generally do not have an obligation to purchase from us. Therefore, our customers can readily switch their distributors. From time to time, we experience shortages in availability of some products from vendors, and this impacts our customers’ decisions regarding whether to make purchases from us. Anything that negatively impacts our customer relations also can negatively impact our operating results. Accordingly, our sales can vary as a result of fluctuations in pricing, product availability, and general competitive and economic conditions.

Credit exposure – We have credit exposure to our reseller customers. Any adverse trends in their businesses could cause us to suffer credit losses.

We have credit exposure to our reseller customers and negative trends in their businesses could increase our credit risk. As is customary in our industry, we extend credit to our reseller customers, and most of our sales are on open accounts. We may be unable to collect on receivables if our reseller customers experience decreases in demand for their products and services, do not manage their businesses adequately, or otherwise become less able to pay due to adverse economic conditions. As we grow and compete for business, our typical payment terms tend to be longer, and therefore may increase our credit risk.

While we evaluate our resellers’ qualifications for credit and monitor our extensions of credit, these efforts cannot prevent all credit losses, and credit losses in excess of historical levels would negatively impact our performance. In addition, for financial reporting purposes we estimate future credit losses and establish an appropriate reserve. To the extent that our credit losses exceed those reserves, our financial performance will be negatively impacted. There is no guarantee that our operating expenses will not increase as a result of the recognition of bad debt expense from our reseller customers.

Centralized functions – We have centralized a number of functions to provide efficient support to our business. As a result, a loss or reduction of use of one of our locations could have an adverse effect on our business operations and financial results.

10

In order to be as efficient as possible, we centralize a number of critical functions. For instance, we currently distribute products in North America from a single warehouse near Memphis, Tennessee (with corresponding arrangements for our Latin American and European markets). Similarly, we utilize a single information system based in Greenville, South Carolina for our North American and European operations, while our Latin American operations have separate systems. While we have backup systems and business continuity plans, any significant or lengthy interruption of our ability to provide these centralized functions could significantly impair our ability to continue normal business operations. In addition, the centralization of these functions increases our exposure to local risks, such as the availability of qualified employees and the lessening of competition for critical services, such as freight and communications.

Although we have business interruption insurance, not all losses are covered, and an uninsured loss from electrical or telephone failure, fire or other casualty, or other disruption could have an adverse effect on our business, financial condition, and results of operations. In addition, there are limits on all of our insurance coverage, and it is possible that losses might exceed that coverage.

Inventory – The value of our inventory may be adversely affected by market and other factors.

Our business, like that of other distributors, is subject to the risk that the value of our inventory will be adversely affected by price reductions by manufacturers or by technological changes affecting the usefulness or desirability of our products. Under the terms of most of our vendor agreements and the policy of most manufacturers of specialty technology products, we have some price protection and stock rotation opportunities with respect to slow-moving or obsolete inventory items. However, these protections are limited in scope and do not protect against all declines in inventory value, excess inventory, or product obsolescence, and in some instances we may not be able to fulfill all necessary conditions or successfully manage such price protection or stock rotation opportunities. In addition, these industry practices are sometimes not reflected in vendor agreements and their application in a particular situation is dependent upon negotiations between our vendors and us. As a result, from time-to-time we are required to write down the value of excess and obsolete inventory, and should any of these write-downs occur at a significant level, they could have an adverse effect on our business, financial condition, and results of operations.

Should we experience an economic downturn, it is possible that prices may decline due to an oversupply of product, and therefore, there may be a greater risk of declines in inventory value. In addition, our vendors may become insolvent and unable to fulfill their product obligations to us. Significant declines in inventory value in excess of established inventory reserves or dramatic changes in prevailing technologies could have an adverse effect on our business, financial condition, and results of operations.

Narrow profit margins – Our narrow margins significantly impact our operating results.

Our industry is highly competitive and characterized by narrow gross and operating margins. As a result, we have significant price competition that results in narrow gross profit and operating profit margins. Because these margins are narrow, fluctuations in sales can have a significant impact on our overall operating results.

Competition – We experience intense competition in all of our markets. Such competition could result in reduced margins and loss of our market share.

The markets that we operate in are highly competitive. We compete on the basis of price, product availability, speed and accuracy of delivery, effectiveness of sales and marketing programs, credit availability, ability to tailor solutions to the needs of our customers, quality and breadth of product line and services, and availability of technical and product information. Our competitors include regional and national wholesale distributors as well as hardware manufacturers (including most of our vendors) that sell directly to resellers and to end users. In addition, we compete with master resellers that sell to franchisees, third party dealers and end-users. Certain of our current and potential competitors have greater financial, technical, marketing and other resources than we have and may be able to respond more quickly to new or emerging technologies and changes in customer requirements. Certain smaller, regional competitors, who are specialty two-tier or mixed model master resellers, may also be able to respond more quickly to new or emerging technologies and changes in customer requirements. Competition has increased for our sales units as broad line and other value-added distributors have entered into the specialty technology markets. Such competition could result in price reductions, reduced margins and loss of our market share. As a result of intense price competition in our industry, our gross margins and our operating profit margins have historically been narrow, and we expect them to be narrow in the future. To remain competitive we may be forced to offer more credit or extended payment terms to our customers. This could result in an increase in our need for capital, increase our financing costs, increase our bad debt expenses and have a negative impact on our financial results.

11

Growth strategies – If we fail to effectively manage and implement our organic growth strategies, we may experience a negative effect on our business and financial results.

A significant component of our growth strategy has been to add new vendors and products, and we expect to be able to enter new product markets in the future. Expansion of our existing product markets and entry into new product markets divert the use of our resources and systems, require additional resources that might not be available (or available on acceptable terms), result in new or more intense competition, may require longer implementation times or greater start-up expenditures than anticipated, and may otherwise fail to achieve the desired results in a timely fashion, if at all. In addition, while we have been very successful in adding new vendors in the past, we already represent most of the significant vendors in our primary areas of focus, and there is regular consolidation among our vendors. As a result, there may be fewer expansion opportunities of this nature in the future. If we are unable to increase our sales and earnings by expanding our product offerings in a cost effective manner, then our revenues may not grow.

Our ability to successfully manage our growth will require continued enhancement of our operational, managerial, and financial resources and controls. Our failure to effectively manage our growth could have an adverse effect on our business, financial condition, and results of operations. Additionally, our growth may increase our working capital requirements and as a result, we may require additional equity or debt financing. Such financing may not be available on terms that are favorable to us, if at all.

Acquisitions – Our growth strategy includes potential acquisitions of companies that complement or expand our existing business. Acquisitions involve a number of risks and uncertainties.

We have and expect to continue to acquire companies that complement or expand our business in the United States or internationally. Acquisitions may involve significant risks and uncertainties including distraction of management’s attention away from normal business operations; sufficient revenue generation to offset liabilities assumed and expenses associated with the acquisition; difficulty in the integration of acquired businesses, including new employees, business systems and technology; inability to adapt to challenges of new markets, including geographies, products and services, or to attract new sources of profitable business from expansion of products or services; exposure to new regulations; and issues not discovered in our due diligence process. Our operations may be adversely impacted by an acquisition that (i) is not suited for us, (ii) is improperly executed, or (iii) substantially increases our debt. Any of these factors could adversely affect our operating results or financial condition.

Liquidity and capital resources – Market factors may increase the cost and availability of capital. Additional capital may not be available to us on acceptable terms to fund our working capital needs and growth.

Our business requires significant levels of capital to finance accounts receivable and product inventory that is not financed by trade creditors. We have an increased demand for capital when our business is expanding, including through acquisitions. Changes in payment terms with either suppliers or customers could increase our capital requirements. We have historically relied upon cash generated from operations, borrowings under our revolving credit facility, secured and unsecured borrowings, and, to a lesser extent, borrowings under a subsidiary’s line of credit to satisfy our capital needs and to finance growth. While we believe that our existing sources of liquidity will provide sufficient resources to meet our current working capital and cash requirements, if we require an increase in capital to meet our future business needs, such capital may not be available to us on terms acceptable to us, or at all. Changes in how lenders rate our credit worthiness, as well as macroeconomic factors such as the current economic downturn and global economic instability may restrict our ability to raise capital in adequate amounts or on terms acceptable to us, and the failure to do so could harm our ability to operate our business.

In addition, our cash and cash equivalents are deposited with various financial institutions located in the various countries in which we operate. We endeavor to monitor these financial institutions regularly for credit quality; however, we are exposed to risk of loss on such funds or we may experience significant disruptions in our liquidity needs if one or more of these financial institutions were to suffer bankruptcy or similar restructuring.

Terrorist or military operations–Future terrorist or military operations could result in a disruption of our operation or loss of assets in certain markets.

Future terrorist or military actions, in the United States or abroad, could result in destruction or seizure of assets or suspension or disruption of our operations. Additionally, such actions could affect the operations of our suppliers or customers, resulting in loss of access to products, potential losses on supplier programs, loss of business, higher losses on receivables or inventory, and/or other disruptions in our business, which could negatively affect our operating results. We do not carry broad insurance covering such terrorist or military actions, and even if we were to seek such coverage, the cost would likely be prohibitive.

12

Laws and regulations – Changes in tax laws, and other laws and regulations may adversely impact us.

We are subject to a wide range of local, state and federal laws and regulations both in the United States and in the other countries in which we operate. While we plan our operations based upon existing and anticipated laws and regulations, we cannot anticipate every change and can have only little, if any, impact on others. We are particularly susceptible to changes in income and other tax laws, laws regulating international trade, and accounting and securities disclosure laws and regulations. To a lesser degree, changes in environmental regulation, including electronic waste recovery legislation, may impact us. In each case, a change in the laws or regulations that we are required to comply with could have an adverse impact on our business operations or financial results.

Cyber security risk – Our reputation and business may be harmed from cyber security risk and we may be subject to legal claims if there is loss, disclosure or misappropriation of or access to our customers' or our business partners' or our own information or other breaches of our information security.

We make extensive use of online services and centralized data processing, including through third party service providers. The secure maintenance and transmission of customer information is a critical element of our operations. Our information technology and other systems that maintain and transmit customer or employee information or those of service providers or business partners may be compromised by a malicious third party penetration of our network security, or that of a third party service provider or business partner, or impacted by advertent or inadvertent actions or inactions by our employees, or those of a third party service provider or business partner. As a result, our customers' information may be lost, disclosed, accessed or taken without our customers' consent.

In addition, our third party service providers and other business partners process and maintain proprietary business information and data related to our business-to-business customers, suppliers and other business partners. Our information technology and other systems that maintain and transmit this information, or those of service providers or business partners, may also be compromised by a malicious third party penetration of our network security or that of a third party service provider or business partner, or impacted by advertent or inadvertent actions or inactions by our employees or those of a third party service provider or business partner. As a result, our business information, customer, supplier, and other business partner data may be lost, disclosed, accessed or taken without their consent.

Any such loss, disclosure or misappropriation of, or access to, customers' or business partners' information or other breach of our information security can result in legal claims or legal proceedings, including regulatory investigations and actions, may have a serious impact on our reputation and may adversely affect our businesses, operating results and financial condition. Furthermore, the loss, disclosure or misappropriation of our business information may adversely affect our businesses, operating results and financial condition.

Third party logistics and warehousing providers – We use third party logistics and warehousing providers in certain parts of the world that may expose us to risks or liabilities based on their execution that may adversely affect our business operations or financial results.

In Europe and Brazil, we use third parties to provide warehousing and logistics services in order to provide cost effective operations and scale in certain regions. The failure or inability of one or more of these third-parties to deliver products from suppliers to us or products from us to our customers could disrupt our business and harm our reputation and operating results. We work closely with our third party logistics and warehousing providers to anticipate issues, and also review public information regarding their financial health. Additionally, deterioration of the financial condition of our logistical and warehousing providers could have an adverse impact on our logistical processes. Poor financial condition of these providers could result in delayed responsiveness or delivery failure, which would ultimately affect our responsiveness to our customers. However, issues may not be identified timely, which may lead to lack of or poor execution, loss or litigation.

13

Third-party freight carriers – We are dependent on third-parties for the delivery of a majority of our products. Changes in shipping terms or the failure or inability of our third-party shippers to perform could have an adverse impact on our business and results of operations.

We are dependent upon major shipping companies, including FedEx and UPS, for the shipment of our products to and from our centralized warehouses. Changes in shipping terms, or the inability of these third-party shippers to perform effectively (whether as a result of mechanical failure, casualty loss, labor stoppage, or any other reason), could have an adverse effect on our business, financial condition, and results of operations. From time to time, we have experienced significant increases in shipping costs due to increases in fuel costs. Additionally, deterioration of the financial condition of our carriers could have an adverse impact on our logistical processes and shipping costs. Poor financial condition of our freight carriers could result in delayed responsiveness in their service lead times, which would ultimately affect our responsiveness to our customers. Additionally, if our carriers were to increase our shipping costs, it may adversely affect our financial results if we are unable to pass on these higher costs to our customers.

Fair value measurement of contingent consideration, goodwill and other intangible assets – Changes in the fair value of the assets and liabilities measured at fair value could have a significant effect on our reported earnings.

The acquisition of CDC was structured having an upfront payment with five annual cash installments based upon the financial performance of CDC for the twelve month periods ended on June 30, 2011 through June 30, 2015. In accordance with ASC 805, Business Combinations, a liability for the contingent consideration driven by an earn-out must be recorded at the on-set of the purchase and must be revalued at every reporting period. Changes in the fair value of the liability are recorded as an adjustment to operating income. These changes can occur due to changes in estimated future financial results, the probabilities of achieving these results and the discount rate reflective of our creditworthiness and market risk premium associated with the Brazilian market. Both gains and losses can occur due to changes in these fair value estimates, thus increasing volatility of our earnings.

On at least an annual basis, we are required to assess our goodwill and other intangible assets for impairment. This includes continuously monitoring events and circumstances that could trigger an impairment test outside of our annual impairment testing date on June 30 of each year. Testing goodwill and other intangibles for impairment requires the use of significant estimates and other inputs outside of our control. If the carrying of goodwill in any of our goodwill reporting units or other intangible assets is determined to exceed their respective fair values, we may be required to record significant impairment charges that would adversely affect our operating results.

Accounting rules – Changes in accounting rules or standards could have a significant adverse affect on our reported earnings.

Our financial statements are prepared in accordance with U.S. generally accepted accounting principles. These principles are subject to interpretations by various governing bodies including the Financial Accounting Standards Board, the Public Company Accounting Oversight Board, the SEC and the American Institute of Certified Public Accountants. These governing bodies create and interpret appropriate accounting standards. Future periodic assessments required by current or new accounting standards may result in additional non-cash charges and/or changes in presentation or disclosure. A change from current accounting standards could have a significant adverse effect on our financial position or results of operations.

Quarterly fluctuations – Our net sales and operating results are dependent on a number of factors. Our net sales may fluctuate from quarter to quarter, and these fluctuations may cause volatility in our stock price.

Our net sales and operating results may fluctuate quarterly as a result of changes in demand for our products and services, the introduction of new technology, actions by our competitors, changes in vendors’ prices or price protection policies, changes in vendors’ business practices or strategies, changes in freight rates, the timing or the addition of operating expenses to support our growth, the timing of major marketing or other service projects, product supply shortages, changes in product mix, and the general economic factors referenced above. In addition, a substantial portion of our net sales in each quarter results from orders booked in that quarter, which are difficult to accurately forecast in advance. As a result, our performance in one period may vary significantly from our performance in the preceding quarter, and may differ significantly from our forecast of performance from quarter to quarter. The impact of these variances may cause volatility in our stock price.

14

Litigation – We routinely are involved in litigation that can be costly and lead to adverse results.

In the ordinary course of our business, we are involved in a wide range of disputes, some of which result in litigation. In addition, as a public company with a large shareholder base, we are susceptible to class-action and other litigation resulting from disclosures that we make and our other activities. Litigation is expensive to bring and defend, and the outcome of litigation can be adverse and significant. Not all adverse outcomes can be anticipated, and applicable accounting rules do not always require or permit the establishment of a reserve until a final result has occurred or becomes probable and estimable. In some instances we are insured for the potential losses; in other instances we are not. An uninsured adverse outcome in significant litigation could have an adverse effect on our business, financial condition and results of operations.

ITEM 1B.    Unresolved Staff Comments.

Not applicable.

ITEM 2. Properties.

The Company owns a 70,000 square foot building in Greenville, South Carolina, which is the site of its principal executive and sales offices, and a 103,000 square foot building on adjacent property, of which approximately 40,000 feet is subleased to unrelated third parties.

North American Distribution Facilities

In February 2008, the Company completed the process of relocating its North American distribution operations from Memphis, Tennessee to its current location in Southaven, Mississippi, allowing for substantially expanded warehousing capacity. The Southaven facility accommodates approximately 600,000 square feet with an optional 147,000 square feet of available expansion space. A subsidiary of the Company entered into a ten-year lease associated with this facility, with options to extend the lease for two consecutive five-year periods.

The Company or its subsidiaries also have offices, each of approximately 12,000 square feet or less, in leased facilities in Norcross, Georgia; Williamsville, New York; Tempe, Arizona; Lenexa, Kansas; Eagan, Minnesota; and Toronto, Canada.

International Distribution Facilities

The Company or its subsidiaries lease 29,000 square feet of office and distribution center space in Miami, Florida, 25,000 square feet of office and distribution center space in Mexico City, Mexico, 17,000 square feet of office space in Cologne, Germany and 21,000 square feet of office space in Brussels, Belgium. The Company utilizes the logistical services of a third party warehouse in Liège, Belgium and . During fiscal 2012, we have consolidated the European warehouse operations in Liège and transferred our inventory from Cologne to the third party warehouse in Liège. In April 2011, the Company acquired CDC, which leases approximately 24,000 square feet of office and distribution center space in São José dos Pinhais, Brazil, leases 20,000 square feet of office and distribution center space in Barueri, Brazil, and utilizes the logistical services of a third party warehouse in Jaboatão dos Guararapes, Brazil.

The Company or its subsidiaries have additional sales offices, each of approximately 10,000 square feet or less, in leased facilities in Bad Homburg, Germany; Hull, England; Crawley, England; Egham, England; Olivet, France; Eindhoven, Netherlands, Curitiba, Brazil; Blumenau, Brazil; and Fortaleza, Brazil.

Management believes the Company’s office and warehouse facilities are adequate to support its operations at their current levels and for the foreseeable future.

ITEM 3. Legal Proceedings.

The Company and its subsidiaries are, from time to time, parties to lawsuits arising out of operations. Although there can be no assurance, based upon information known to the Company, the Company believes that any liability resulting from an adverse determination of such lawsuits would not have a material adverse effect on the Company’s financial condition or results of operations.

ITEM 4. Mine Safety Disclosures.

Not applicable.

15

PART II

ITEM 5. Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

The Company’s common stock is quoted on the NASDAQ Global Select Market under the symbol “SCSC.” The Company has never paid or declared a cash dividend since inception, and the Board of Directors does not intend to institute a cash dividend policy in the foreseeable future. Under the terms of the Company’s revolving credit facility, the payment of cash dividends is prohibited. As of August 20, 2012, there were approximately 560 holders of record of our common stock. The following table sets forth, for the periods indicated, the high and low sales prices of the Company’s common stock on the NASDAQ Global Select Market.

	High		Low
Fiscal Year 2012
First quarter	$	40.00	$	27.20
Second quarter	38.05		28.53
Third quarter	39.74		34.46
Fourth quarter	38.06		28.03
Fiscal Year 2011
First quarter	$	29.90	$	23.59
Second quarter	33.42		26.89
Third quarter	39.93		30.31
Fourth quarter	38.12		31.82

Stock Performance Chart

The following stock performance graph compares cumulative total shareholder return on the Company’s common stock over a five-year period with the Nasdaq Market Index and with the Standard Industrial Classification (“SIC”) Code Index (SIC Code 5045 – Wholesale Computers and Peripheral Equipment and Software) for the same period. Total shareholder return represents stock price changes and assumes the reinvestment of dividends. The graph assumes the investment of $100 on June 30, 2007.

16

	2007		2008		2009		2010		2011		2012
ScanSource, Inc.	$	100	$	84	$	77	$	78	$	117	$	96
NASDAQ Composite	$	100	$	85	$	73	$	83	$	110	$	115
SIC Code 5045 – Computers & Peripheral Equipment	$	100	$	84	$	80	$	73	$	93	$	81

ITEM 6. Selected Financial Data.

The selected financial data below should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the Consolidated Financial Statements and related notes thereto included elsewhere in this Annual Report on Form 10-K. The following statement of income data and balance sheet data were derived from the Company’s Consolidated Financial Statements.

FIVE YEAR FINANCIAL SUMMARY

	Fiscal Year Ended June 30,
	2012			2011			2010			2009			2008(1)
	(in thousands, except per share data)
Statement of income data:
Net sales	$	3,015,296		$	2,666,531		$	2,114,979		$	1,847,969		$	2,175,485
Cost of goods sold	2,713,272			2,392,224			1,896,052			1,639,121			1,947,867
Gross profit	302,024			274,307			218,927			208,848			227,618
Selling, general and administrative expenses	188,388			161,326			143,151			134,730			133,653
Change in fair value of contingent consideration	120			(128		)	—			—			—
Operating income	113,516			113,109			75,776			74,118			93,965
Interest expense, net	(1,247		)	511			85			771			3,959
Other (income) expense, net	3,552			712			(50		)	(2,307		)	(212		)
Income before income taxes and minority interest	111,211			111,886			75,741			75,654			90,218
Provision for income taxes	36,923			38,363			26,929			27,966			34,586
Net income	74,288			73,523			48,812			47,688			55,632
Net income per common share, basic	$	2.72		$	2.74		$	1.83		$	1.80		$	2.13
Weighted-average shares outstanding, basic	27,362			26,872			26,605			26,445			26,098
Net income per common share, diluted	$	2.68		$	2.70		$	1.82		$	1.79		$	2.10
Weighted-average shares outstanding, diluted	27,751			27,246			26,869			26,588			26,445

17

	As of June 30,
	2012		2011		2010		2009		2008
	(in thousands)
Balance sheet data:
Working capital	$	533,529	$	532,167	$	436,953	$	399,647	$	368,636
Total assets	1,201,806		1,182,188		859,750		748,631		772,206
Total long-term debt (including short-term borrowings)	9,697		60,106		30,429		30,429		56,623
Total shareholders’ equity	$	652,311	$	587,394	$	486,851	$	445,446	$	395,753

(1) Included in the statement of income for the fiscal year ended June 30, 2008 are $1.0 million of direct costs associated with the special committee review of the Company’s stock option practices. See Note 1A to the Notes to Consolidated Financial Statements included in Part II, Item 8 of the Company’s amended Annual Report on Form 10-K/A for the fiscal year ended June 30, 2006.

18

ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Certain statements within this Annual Report on Form 10-K, including this Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”), are not historical facts and contain “forward-looking statements” as described in the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties and actual results could differ materially from those projected. Factors that could cause actual results to differ materially include the following: our ability to manage our business when general economic conditions are poor; our ability to manage the potential adverse effects of operating in foreign jurisdictions; our dependence upon information systems and the ability to transition to a new ERP system without business disruption; our dependence on vendors, product supply, and availability; our ability to retain key employees, particularly senior management; our ability to retain and expand our existing and new customer relationships; our ability to manage and limit our credit exposure due to the deterioration in the financial condition of our customers; our ability to centralize certain functions to provide efficient support to our business; our ability to remain profitable in the face of narrow margins; our ability to manage and negotiate successful pricing and stock rotation opportunities associated with inventory value decreases; our ability to compete in new and existing markets that are highly competitive; our ability to integrate acquisitions and effectively manage and implement our growth strategies; our inability to obtain required capital at acceptable terms to fund our working capital and growth strategies; our ability to manage disruptions or loss of certain assets from terrorist or military operations; our ability to anticipate adverse changes in tax laws, accounting rules, and other laws and regulations; our ability to manage volatility in earnings resulting from U.S. GAAP requirements to revalue our earnout obligation to the sellers of CDC; our inability to eliminate potential volatility in our net sales and operating results on a quarterly basis as a result of changes in demand for our products; our dependence on third-party freight carriers; our ability to resolve or settle potentially adverse litigation matters; and our ability to hedge or mitigate the effects of fluctuations in foreign exchange rates. Additional discussion of these and other factors affecting our business and prospects is contained in our periodic filings with the SEC, copies of which can be obtained under the “Investors Relations” tab on our website at www.scansourceinc.com. Please refer to the cautionary statements and important factors discussed in Item 1A. “Risk Factors” in this Annual Report on Form 10-K for further information. This discussion and analysis should be read in conjunction with Item 6. “Selected Financial Data” and the Consolidated Financial Statements and the Notes thereto included elsewhere in this Annual Report on Form 10-K.

Overview

ScanSource, Inc. is a leading wholesale distributor of specialty technology products, providing value-added distribution sales to resellers in the specialty technology markets. The Company distributes more than 100,000 products worldwide. The Company has two geographic distribution segments: the North American distribution segment serving the United States and Canada from the Southaven, Mississippi distribution center and an international segment serving Latin America and Europe from distribution centers located in Florida, Mexico, Brazil and Belgium. Each segment is managed around its geographic customer and vendor bases and is supported by its centralized infrastructure, such as warehousing and back office operations as appropriate. The North American distribution segment markets automatic identification and data capture (“AIDC”) and point-of-sale (“POS”) products through its ScanSource POS and Barcoding sales unit; voice, data and converged communications equipment through its Catalyst Telecom sales unit; video conferencing, telephony and communications products through its ScanSource Communications sales unit; and electronic security products and wireless infrastructure products through its ScanSource Security sales unit. The international distribution segment markets AIDC, POS and Barcode, communications, and security products through its ScanSource Latin America sales unit; POS and AIDC products through its ScanSource Europe sales unit; and communication products through its ScanSource Communications sales unit in Europe.

The Company was incorporated in South Carolina in December 1992 and is headquartered in Greenville, South Carolina. The Company serves North America from a single, centrally-located distribution center located in Southaven, Mississippi, near the FedEx hub. The single warehouse and strong management information system form the cornerstone of the Company’s cost-driven operational strategy. This strategy has been expanded to Latin America and Europe.

The Company distributes products for many of its key vendors in all of its geographic markets; however certain vendors only allow distribution to specific geographies. The Company’s key vendors in its worldwide POS and barcoding sales units include Bematech, Cisco, Datalogic, Datamax-O’Neil, Elo, Epson, Honeywell, IBM, Intermec, Motorola, NCR, Toshiba and Zebra Technologies. The Company’s key vendors in its worldwide communications sales units, including Catalyst Telecom, sales unit include Aruba, Avaya, Audiocodes, Dialogic, Extreme Networks, Meru Networks, Plantronics, Polycom and Shoretel. The Company’s key vendors in its security sales units include Alvarion, Arecont, Axis, Bosch, Cisco, Datacard, Exacq Technologies, Fargo, HID, March Networks, Panasonic, Pelco, Ruckus Wireless, Samsung, Sony and Zebra Card.

19

Our objective is to continue to grow profitable sales in the technologies we distribute. In doing so, our management team faces numerous challenges that require attention and resources. Certain business units and geographies are experiencing increased competition for the products we distribute. This competition may come in the form of pricing, credit terms, service levels, product availability and in some cases, changes from a closed distribution sales model, where resellers must purchase exclusively from one distributor, to an open distribution sales model, where resellers may choose to purchase from multiple distributors. As this competition could affect both our market share and pricing of our products, we may change our strategy in order to effectively compete.

We have continued investing in our international distribution segment, particularly in Europe, by temporarily accepting lower than normal returns in the business in an effort to protect existing market share and gain new customers. In the current year, our results in the international distribution segment were weaker than expected as the markets in Europe and Latin America seemed to contract and competitive pressures intensified. While certain international markets are volatile in the current macroeconomic environment, especially parts of Europe, we are continuing to invest in this business to position the Company favorably against our competitors for the long term.

We are in the process of designing and developing a new Enterprise Resource Planning (“ERP”) system that is intended to be used globally and provide operational efficiencies. We have recently received a project assessment from a third party service provider, which indicates that the project will take longer to implement and exceed our previously disclosed cost estimates.

During the year, we have consolidated the warehousing function of our German communications business into our Belgian operations. This consolidation gives us logistical efficiencies and service level advantages such as greater flexibility and scalability.

We have committed funds to Brazil to provide for a portion of future contingent consideration payments owed to the former shareholders of CDC and are continuously working to add new vendors and grow existing vendors in our various geographies. This is our first full year of results with our most recent acquisition, CDC, Brazil's leading distributor of AIDC and POS solutions. Also, we continue to evaluate strategic acquisitions to enhance our technological and geographic portfolios.

Cost Control/Profitability

Our operating income growth is driven not only by gross profits but by a disciplined control of operating expenses. Our operations feature a scalable information system, streamlined management, and centralized distribution, enabling us to achieve the economies of scale necessary for cost-effective order fulfillment. From inception, we have managed our general and administrative expenses by maintaining strong cost controls. However, in order to continue to grow in our markets, we have invested in new initiatives, including investments in new geographic markets such as Europe and Latin America; increased marketing efforts to recruit resellers; and enhanced employee benefit plans to retain employees.

Evaluating Financial Condition and Operating Performance

We place a significant emphasis on operating income and return on invested capital (“ROIC”) in evaluating and monitoring financial condition and operating performance. We use ROIC, a non-GAAP measure, to assess efficiency at allocating capital under our control to generate returns. We compute ROIC as earnings before interest, taxes, depreciation and amortization ("EBITDA") divided by invested capital. Invested capital is defined as average equity plus daily average funded debt for the period.

The following table summarizes our return on invested capital ratio for the fiscal years ended June 30, 2012, 2011, and 2010, respectively:

	2012		2011		2010
Return on invested capital ratio	17.2	%	20.6	%	16.7	%

20

Management uses ROIC as a performance measurement because we believe this metric best balances the Company’s operating results with asset and liability management, excludes the results of capitalization decisions, is easily computed and understand, and drives changes in shareholder value. The components of this calculation and reconciliation to the Company’s financial statements are shown, as follows:

Reconciliation of EBITDA to Net Income	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Net income	$	74,288	$	73,523	$	48,812
Plus: income taxes	36,923		38,363		26,929
Plus: interest expense	1,639		1,723		1,472
Plus: depreciation & amortization	9,922		6,662		6,064
EBITDA (numerator)	$	122,772	$	120,271	$	83,277

Invested capital calculations	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
Equity – beginning of the year	$	587,394		$	486,851		$	445,446
Equity – end of the year	652,311			587,394			486,851
Average equity	619,853			537,123			466,148
Average funded debt(1)	92,125			46,186			31,800
Invested capital (denominator)	$	711,978		$	583,309		$	497,948
Return on invested capital	17.2		%	20.6		%	16.7		%

(1) Average funded debt is calculated as the daily average amounts outstanding on our short-term and long-term interest-bearing debt.

Our return on invested capital was 17.2% for the year, down from 20.6% in the prior year, but up from 16.7% in fiscal 2010 . The decrease from the prior year is largely due to lower margins arising from mix and competitive pricing pressures and increased headcount and investment in our international segment to sustain market share and existing volumes throughout the current European economic downturn.

21

Results of Operations

The following table sets forth for the periods indicated certain income and expense items as a percentage of net sales:

	Fiscal Year Ended June 30,
	2012		2011		2010
Statement of income data:
Net sales	100.0	%	100.0	%	100.0	%
Cost of goods sold	90.0		89.7		89.6
Gross profit	10.0		10.3		10.4
Selling, general and administrative expenses	6.2		6.0		6.8
Change in fair value of contingent consideration	0.0		0.0		0.0
Operating income	3.8		4.2		3.6
Interest expense (income), net	0.0		0.0		0.0
Other expense (income), net	0.1		0.0		0.0
Income before income taxes and minority interest	3.7		4.2		3.6
Provision for income taxes	1.2		1.4		1.3
Net income	2.5	%	2.8	%	2.3	%

Comparison of Fiscal Years Ended June 30, 2012 and 2011

Net Sales

The Company has two reporting segments, which are based on geographic location. The following table summarizes the Company’s net sales results (net of inter-segment sales) for each of these product categories and reporting segments for the comparable fiscal years ending June 30th:

Product Category

	2012		2011		$ Change		% Change
	(in thousands)
POS, barcoding and security products	$	1,837,307	$	1,615,461	$	221,846	13.7	%
Communications products	1,177,989		1,051,070		126,919		12.1	%
Total net sales	$	3,015,296	$	2,666,531	$	348,765	13.1	%

Geographic Segments

	2012		2011		$ Change		% Change
	(in thousands)
North American distribution segment	$	2,236,459	$	2,022,668	$	213,791	10.6	%
International distribution segment	778,837		643,863		134,974		21.0	%
Total net sales	$	3,015,296	$	2,666,531	$	348,765	13.1	%

Consolidated net sales for the fiscal year ended June 30, 2012 increased 13.1% to $3.0 billion in comparison to prior fiscal year net sales of $2.7 billion. Fiscal year June 30, 2012 net sales include the addition of CDC in Brazil, which we acquired on April 15, 2011.

22

North American Distribution

The North American distribution segment includes sales to technology resellers in the United States and Canada. Sales to technology resellers in Canada accounted for less than 4% of total net sales for both fiscal years presented. During fiscal 2012 net sales for this segment increased by approximately $214 million, or 10.6%, as compared to the prior fiscal year, with increases in all of our sales units. We had particularly strong year-over-year growth rates in our ScanSource Security and ScanSource Communications sales units.

Net sales for the Company’s North American POS, barcoding, and security product categories increased by 7.4% in comparison to the prior fiscal year. We have experienced increased competition in the POS and AIDC channel in North America in response to market share gains in the previous period. ScanSource Security continues to deliver strong double-digit growth over the prior year, primarily from video surveillance and wireless networking products from vendors such as Axis Communications and Ruckus Wireless.

The Company has two North American sales units that sell communications products to our customers – the Catalyst Telecom and ScanSource Communications sales units. The combined sales of these units were 14.1% higher for the fiscal year ended June 30, 2012 versus the prior fiscal year. We have had strong performance with several of our key vendors, including Aruba, Polycom and ShoreTel.

International Distribution

The international distribution segment markets POS, AIDC, communications and security products in Latin America and POS, AIDC and communications products in Europe. Sales for the international segment increased $135 million or 21.0% over the prior year, attributable primarily to the first full year of results in Brazil from the CDC acquisition completed in April 2011. Aside from incremental business in Brazil, revenues in our international segment remained flat over the prior year due to competitive pressures, coupled with the Eurozone economic downturn.

Additionally, our fiscal year sales growth was partially offset by weaker average euro to U.S. dollar and Brazilian real to U.S. dollar exchange rates over the prior year. Changes in foreign exchange had an unfavorable impact of $28.4 million to our international segment's net sales for the year ended June 30, 2012. Excluding the impact of foreign exchange rate fluctuation, the net sales increase was 25.4%.

Gross Profit

The following table summarizes the Company’s gross profit for the fiscal years ended June 30th:

									% of Sales June 30,
	2012		2011		$ Change		% Change		2012		2011
	(in thousands)
North American distribution segment	$	218,709	$	201,831	$	16,878	8.4	%	9.8	%	10.0	%
International distribution segment	83,315		72,476		10,839		15.0	%	10.7	%	11.3	%
Total gross profit	$	302,024	$	274,307	$	27,717	10.1	%	10.0	%	10.3	%

North American Distribution

Gross profit for the North American distribution segment increased $16.9 million, or 8.4%, for the fiscal year ended June 30, 2012. The increase in gross profit was primarily the result of higher sales volume in all of our sales units. However, due to unfavorable vendor programs, partially offset by favorable product mix, we have incurred lower margins, effectively reducing gross profit percentage by 0.2% in North America.

23

International Distribution

Gross profit in our international distribution segment increased $10.8 million, or 15.0%, for the fiscal year ended June 30, 2012. The increase in gross profit is primarily the result of the impact of having a full year of CDC results, partially offset by the decrease in gross profit generated in Europe. Gross profit as a percentage of sales decreased 0.6% from the prior year. This is largely the result of increased inventory reserves in Europe, coupled with changes to certain vendor programs.

Operating Expenses

The following table summarizes the Company’s operating expenses for the periods ended June 30th:

										% of Sales June 30,
	2012		2011			$ Change		% Change		2012		2011
	(in thousands)
Selling, general and administrative expense	$	188,388	$	161,326		$	27,062	16.8	%	6.3	%	6.1	%
Change in fair value of contingent consideration	120		(128		)	248		(193.8	)%	—	%	—	%
Operating expense	$	188,508	$	161,198		$	27,310	16.9	%	6.3	%	6.0	%

For the fiscal year ended June 30, 2012, selling, general and administrative expenses were $188.4 million, a 16.8% increase from the prior year. Operating expenses as a percentage of sales increased to 6.3% for the fiscal year ended June 30, 2012, compared to 6.0% in the prior year. This increase was mainly attributable to a full year of operating results from the acquisition of CDC, higher compensation expense and incremental expenses related to our ERP project that are required to be expensed as incurred.

We have elected to present changes in fair value of the contingent consideration owed to former shareholders of CDC separately from other selling, general and administrative expenses. In the current year, we have recorded a $0.1 million loss, driven by changes to forecasted and actual results, offset by recurring amortization of the unrecognized fair value discount. During fiscal year 2012, quarterly changes in fair value of the contingent consideration ranged from a $1.1 million loss to a $1.1 million gain.

Operating Income

The following table summarizes the Company’s operating income for the fiscal years ended June 30th:

										% of Sales June 30,
	2012		2011		$ Change			% Change		2012		2011
	(in thousands)
North American distribution segment	$	104,044	$	94,932	$	9,112		9.6	%	4.7	%	4.7	%
International distribution segment	9,472		18,177		(8,705		)	(47.9	)%	1.2	%	2.8	%
Total operating income	$	113,516	$	113,109	$	407		0.4	%	3.8	%	4.2	%

North American Distribution

For the North American distribution segment, operating income increased 9.6% or $9.1 million from the prior year. The change is largely the result of higher volume in the current year. Operating income percentage has remained consistent from the prior year.

24

International Distribution

For the international distribution segment, operating income decreased 47.9% or $8.7 million from the prior year. The decrease is attributable to weaker operating results in fiscal year 2012. Operating margin percentage decreased 1.6% from the prior year. In the current year, gross margins are down in Europe because of increased inventory reserves and changes to vendor programs, as mentioned above. Additionally, operating expenses are higher as we continue to invest in international markets. Results from CDC have partially offset the decreased operating income generated in Europe.

Total Other (Income) Expense

The following table summarizes the Company’s total other (income) expense for the fiscal years ended June 30th:

												% of Sales June 30,
	2012			2011			$ Change			% Change		2012		2011
	(in thousands)
Interest expense	$	1,639		$	1,723		$	(84	)	(4.9	)%	0.1	%	0.1	%
Interest income	(2,886		)	(1,212		)	(1,674		)	138.1	%	(0.1	)%	(0.1	)%
Net foreign exchange losses	3,766			965			2,801			290.3	%	0.1	%	—	%
Other, net	(214		)	(253		)	39			(15.4	)%	—	%	—	%
Total other (income) expense	$	2,305		$	1,223		$	1,082		88.5	%	0.1	%	—	%

Interest expense reflects interest paid on borrowings on the Company’s revolving credit facility and long-term debt. Interest expense for the fiscal year ended June 30, 2012 was $1.6 million compared to $1.7 million for the comparative prior year period.

Interest income for the period ended June 30, 2012 increased $1.7 million from the comparative prior year . The Company generates interest income on cash invested in Brazil to fund a portion of future earnout payments and to supplement local working capital needs, in addition to longer-term interest bearing receivables and, to a lesser extent, interest earned on cash and cash equivalent balances.

Net foreign exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign currency exchange contract gains and losses. Foreign exchange gains and losses are generated as the result of fluctuations in the value of the British pound versus the euro, the U.S. dollar versus the euro, the U.S. dollar versus the Brazilian real and other currencies versus U.S. dollar. For fiscal 2012, the majority of losses were associated with exposures between the U.S. dollar and Brazilian real. In September 2011, we incurred a $2.5 million non-recurring loss in conjunction with an unfavorable forward exchange contract to purchase Brazilian reais. In August 2011, the Company decided to pre-fund a portion of the estimated earnout payments associated with the CDC acquisition. This contract was designed to preserve the currency exchange for the few weeks required to transfer the cash to Brazil. From the time that we entered into the contract through settlement, the real devalued from the contractual rate by 11.8%, ultimately resulting in a $2.5 million loss. Further contributing to the fiscal year foreign exchange loss, the Brazilian business incurred significant losses on U.S. dollar denominated exposures in the first quarter that were not hedged at the time. Subsequently, we have been including these exposures in our hedging activities.

Provision for Income Taxes

Income tax expense was $36.9 million and $38.4 million for the fiscal years ended June 30, 2012 and 2011, respectively, reflecting an effective tax rate of 33.2% and 34.3%, respectively. This decrease reflects the benefit of changes in geographic mix to tax jurisdictions with lower corporate income tax rates, the recognition of various tax credits in multiple jurisdictions and the reversal of certain tax reserves. The Company expects the fiscal year 2013 effective tax rate to be more consistent with fiscal year 2011.

25

Net Income

The following table summarizes the Company’s net income for the fiscal year ended June 30th:

									% of Sales June 30,
	2012		2011		$ Change		% Change		2012		2011
	(in thousands)
Net income	$	74,288	$	73,523	$	765	1.0	%	2.5	%	2.8	%

Net income for the fiscal year ended June 30, 2012 was $74.3 million, a $0.8 million or 1.0% increase over the prior fiscal year. The increase in net income is attributable to the changes in operating profit and income tax expense previously discussed.

Comparison of Fiscal Years Ended June 30, 2011 and 2010

Net Sales

The Company has two reporting segments, which are based on geographic location. The following table summarizes the Company’s net sales results (net of inter-segment sales) for each of these product categories and reporting segments for the comparable fiscal years ending June 30th:

Product Category

	2011		2010		$ Change		% Change
	(in thousands)
POS, barcoding and security products	$	1,615,461	$	1,300,525	$	314,936	24.2	%
Communications products	1,051,070		814,454		236,616		29.1	%
Total net sales	$	2,666,531	$	2,114,979	$	551,552	26.1	%

Geographic Segments

	2011		2010		$ Change		% Change
	(in thousands)
North American distribution segment	$	2,022,668	$	1,666,012	$	356,656	21.4	%
International distribution segment	643,863		448,967		194,896		43.4	%
Total net sales	$	2,666,531	$	2,114,979	$	551,552	26.1	%

Consolidated net sales for the fiscal year ended June 30, 2011 increased 26.1% to $2.7 billion in comparison to prior fiscal year net sales of $2.1 billion.

North American Distribution

The North American distribution segment includes sales to technology resellers in the United States and Canada that originate from our centralized distribution facility located in Southaven, Mississippi. Sales to technology resellers in Canada accounted for less than 4% of total net sales for both fiscal years presented. As North American macro-economic conditions improved in fiscal 2011, net sales for this segment increased by approximately $356.7 million, or 21.4%, as compared to the prior fiscal year.

The Company’s North American POS, barcoding, and security product categories saw revenues increase by 17.6% in comparison to the prior fiscal year. During the fiscal year ended June 30, 2011, these product lines experienced stronger demand as economic conditions improved from the 2010 fiscal year. The Company had its strongest percentage growth in its security product lines from the prior year, driven by increased demand and market penetration in its video surveillance and wireless networking lines.

26

The Company has two North American sales units that sell communications products to our customers – the Catalyst Telecom and ScanSource Communications sales units. The combined sales of these units were 25.8% higher for the fiscal year ended June 30, 2011 versus the prior fiscal year. Both of these sales units also experienced strong sales growth due to continued improvement of economic conditions and increased market share and big deals over the prior year.

International Distribution

The international distribution segment includes sales in Latin America and Europe from the ScanSource POS and Barcoding sales unit and in Europe through the ScanSource Communications sales unit. Sales for the overall international segment increased $194.9 million or 43.4% over the prior fiscal year. The year-to-date sales growth was partially offset by a weaker average Euro to U.S. Dollar exchange rate from the prior year. On a constant exchange rate basis, the sales increase was 44.7%. Changes in foreign exchange had an unfavorable impact of $5.7 million on our international distribution net sales for the year ended June 30, 2011. The constant currency increase in sales for both geographies was driven primarily by strong volumes in Europe and Latin America in conjunction with the acquisition of CDC Brasil, S.A and a full twelve months of results from Algol Europe in fiscal 2011.

The addition of CDC generated $29.6 million in net sales in 2011. Excluding CDC’s net sales, international distribution segment net sales increased $165.2 million or 36.8% in fiscal year 2011 from the prior year.

Gross Profit

The following table summarizes the Company’s gross profit for the fiscal years ended June 30th:

									% of Sales June 30,
	2011		2010		$ Change		% Change		2011		2010
	(in thousands)
North American distribution segment	$	201,831	$	167,638	$	34,193	20.4	%	10.0	%	10.1	%
International distribution segment	72,476		51,289		21,187		41.3	%	11.3	%	11.4	%
Total gross profit	$	274,307	$	218,927	$	55,380	25.3	%	10.3	%	10.4	%

North American Distribution

Gross profit for the North American distribution segment increased $34.2 million, or 20.4%, for the fiscal year ended June 30, 2011, as compared to the prior fiscal year. The increase in gross profit was primarily the result of higher sales volume in all of our sales units, as previously discussed. Gross profit as a percentage of sales remained consistent with the prior year, only decreasing 0.1%.

International Distribution

Gross profit in our international distribution segment increased $21.2 million or 41.3% for the fiscal year ended June 30, 2011, from the prior fiscal year. The increase in gross profit was primarily the result of higher sales volume in all of our sales units, as previously discussed. Gross profit as a percentage of sales remained consistent with the prior year, only decreasing 0.1%. Compared to the prior year, we saw slightly lower margins from competitive pricing pressure in the current year, coupled with favorable upfront discounts in Europe from the prior year. The decrease was partially offset by strong margins recognized by the CDC.

27

Operating Expenses

The following table summarizes the Company’s operating expenses for the periods ended June 30th:

									% of Sales June 30,
	2011		2010		$ Change		% Change		2011		2010
	(in thousands)
Operating expenses	$	161,198	$	143,151	$	18,047	12.6	%	6.0	%	6.8	%

For the fiscal year ended June 30, 2011, operating expenses were $161.2 million, a 12.6% increase from the prior year. This increase was mainly attributable to increased recurring expenses from headcount and other variable expenses driven from higher sales, a charge of $2.4 million to fund a supplemental executive retirement plan (“Founder’s SERP” or “SERP”) for our founder and former CEO and $4.0 million of incremental operating expenses from the acquisition of CDC. The increase was partially offset by a $3.1 million legal settlement recovery with a former service provider, which was recorded as a reduction to operating expenses in the second quarter of fiscal 2011.

Operating expenses as a percentage of sales decreased to 6.0% for the fiscal year ended June 30, 2011, compared to 6.8% in the prior year. This decrease was largely the result of scale on higher revenues over a smaller increase of operating expenses.

Operating Income

The following table summarizes the Company’s operating income for the fiscal years ended June 30th:

									% of Sales June 30,
	2011		2010		$ Change		% Change		2011		2010
	(in thousands)
North American distribution	$	94,932	$	64,342	$	30,590	47.5	%	4.7	%	3.9	%
International distribution	18,177		11,434		6,743		59.0	%	2.8	%	2.5	%
Total operating income	$	113,109	$	75,776	$	37,333	49.3	%	4.2	%	3.6	%

Operating income increased 49.3% or $37.3 million for the fiscal year ended June 30, 2011 as compared to the prior fiscal year. This increase was the result of increased gross profit on higher sales volumes experienced in both the North American and International distribution segments, partially offset by increased operating expenses described above.

Total Other (Income) Expense

The following table summarizes the Company’s total other (income) expense for the fiscal years ended June 30th:

											% of Sales June 30,
	2011			2010			$ Change		% Change		2011		2010
	(in thousands)
Interest expense	$	1,723		$	1,472		$	251	17.1	%	0.1	%	0.1	%
Interest income	(1,212		)	(1,387		)	175		(12.6	)%	(0.1	)	(0.1	)%
Net foreign exchange losses	965			239			726		303.8	%	—	%	—	%
Other, net	(253		)	(289		)	36		(12.5	)%	—	%	—	%
Total other (income) expense	$	1,223		$	35		$	1,188	3,394.3	%	—	%	—	%

28

Interest expense reflects interest paid on borrowings on the Company’s revolving credit facility and long-term debt. Interest expense for the fiscal year ended June 30, 2011 was $1.7 million compared to $1.5 million for the comparative prior year period. The increase in interest expense was the result of increased average debt balances between the respective periods.

Interest income for the period ended June 30, 2011 decreased slightly from the comparative prior year period by $0.2 million. The Company generates interest income on longer-term interest bearing receivables, and, to a much lesser extent, interest earned on cash and cash-equivalent balances on hand.

Net foreign exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign currency exchange contract gains and losses. Foreign exchange losses and gains are generated as the result of fluctuations in the value of the Euro versus the British Pound, the U.S. Dollar versus other currencies and most recently between the Brazilian Real and the U.S. Dollar due to the acquisition of CDC. During the fiscal year ended June 30, 2011 and June 30, 2010, the Company generated a net foreign exchange loss due to fluctuations of the U.S. Dollar against the Euro, British Pound, Mexican Peso, Canadian Dollar and Brazilian Real. While the Company utilizes foreign exchange contracts and debt in non-functional currencies to hedge foreign currency exposure, our foreign exchange policy prohibits us from entering into speculative transactions.

Provision for Income Taxes

Income tax expense was $38.4 million and $26.9 million for the fiscal years ended June 30, 2011 and 2010, respectively, reflecting an effective tax rate of 34.3% and 35.6%, respectively. The decrease in the effective tax rate from the prior fiscal year is largely attributable to a favorable mix of income derived from lower tax rate jurisdictions, and reflects the benefit of a full year of changes to the international capital structure executed during fiscal 2010.

Net Income

The following table summarizes the Company’s net income for the fiscal year ended June 30th:

									% of Sales June 30,
	2011		2010		$ Change		% Change		2011		2010
	(in thousands)
Net income	$	73,523	$	48,812	$	24,711	50.6	%	2.8	%	2.3	%

Net income for the fiscal year ended June 30, 2011 was $73.5 million, a $24.7 million or 50.6% increase over the prior fiscal year. The increase in net income is attributable to the changes in operating profit previously discussed.

29

Quarterly Results

The following tables set forth certain unaudited quarterly financial data. The information has been derived from unaudited financial statements that, in the opinion of management, reflect all adjustments.

	Three Months Ended
	Fiscal 2012								Fiscal 2011
	Jun. 30 2012		Mar. 31 2012		Dec. 31 2011		Sept. 30 2011		Jun. 30 2011		Mar. 31 2011		Dec. 31 2010		Sept. 30 2010
	(in thousands, except per share data)
Net sales	$	754,470	$	707,883	$	782,684	$	770,259	$	734,891	$	613,466	$	683,644	$	634,530
Cost of goods sold	680,643		638,615		702,845		691,169		660,520		547,637		613,018		571,049
Gross profit	$	73,827	$	69,268	$	79,839	$	79,090	$	74,371	$	65,829	$	70,626	$	63,481
Net income	$	19,785	$	14,756	$	21,367	$	18,380	$	19,660	$	16,534	$	21,621	$	15,708
Weighted-average shares outstanding, basic	27,579		27,489		27,244		27,138		27,056		26,938		26,786		26,713
Weighted-average shares outstanding, diluted	27,886		27,926		27,674		27,551		27,515		27,413		27,160		26,992
Net income per common share, basic	$	0.72	$	0.54	$	0.78	$	0.68	$	0.73	$	0.61	$	0.81	$	0.59
Net income per common share, diluted	$	0.71	$	0.53	$	0.77	$	0.67	$	0.71	$	0.60	$	0.80	$	0.58

Critical Accounting Policies and Estimates

Management’s discussion and analysis of financial condition and results of operations are based on our consolidated financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP" or "GAAP"). The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis management evaluates its estimates, including those related to the allowance for uncollectible accounts receivable, inventory reserves to reduce inventories to the lower of cost or market, and vendor incentives. Management bases its estimates on historical experience and on various other assumptions that management believes to be reasonable under the circumstances, the results of which form a basis for making judgments about the carrying value of assets and liabilities that are not readily available from other sources. Actual results may differ materially from these estimates under different assumptions or conditions, however, management believes that its estimates, including those for the above-described items, are reasonable and that the actual results will not vary significantly from the estimated amounts. For further discussion of our significant accounting policies, refer to Note 1, Business and Summary of Significant Accounting Policies.

Revenue Recognition

Revenue is recognized once four criteria are met: (1) the Company must have persuasive evidence that an arrangement exists; (2) delivery must occur(this includes the transfer of both title and risk of loss, provided that no significant obligations remain); (3) the price must be fixed and determinable; and (4) collectability must be reasonably assured. The Company allows its customers to return product for exchange or credit subject to certain limitations. A provision for estimated losses on returns is recorded based on historical experience.

30

Service revenue associated with configuration and marketing services is recognized when the work is complete and the four criteria discussed above have been substantially met. We also distribute third-party service contracts, typically for product maintenance and support. Since we act as an agent on behalf of most of these service contracts sold, revenue is recognized net of cost at the time of sale. However, we distribute some self-branded warranty programs and engage a third party (generally the original equipment manufacturer) to cover the fulfillment of any obligations arising from these contracts. These revenues and associated third party costs are amortized over the life of contract and presented in net sales and cost of goods sold, respectively. Other miscellaneous service revenue associated with configuration, marketing, service contracts and other services has approximated 2% or less of consolidated net sales for fiscal years 2012, 2011 and 2010.

During the fiscal years ended June 30, 2012, 2011 and 2010, the Company has not engaged in any sales transactions involving multiple element arrangements. Had any arrangements with multiple deliverables occurred, we would follow the guidance set forth in Accounting Standards Codification ("ASC") 605.

Allowances for Trade and Notes Receivable

The Company maintains an allowance for uncollectible accounts receivable for estimated losses resulting from customers’ failure to make payments on accounts receivable due to the Company. Management determines the estimate of the allowance for uncollectible accounts receivable by considering a number of factors, including: (1) historical experience, (2) aging of the accounts receivable and (3) specific information obtained by the Company on the financial condition and the current creditworthiness of its customers. If the financial condition of the Company’s customers were to deteriorate and reduce the ability of the Company’s customers to make payments on their accounts, the Company may be required to increase its allowance by recording additional bad debt expense. Likewise, should the financial condition of the Company’s customers improve and result in payments or settlements of previously reserved amounts, the Company may be required to record a reduction in bad debt expense to reverse the recorded allowance. A provision for estimated returns and allowances and associated losses is recorded and based on historical experience.

Inventory Reserves

Management determines the inventory reserves required to reduce inventories to the lower of cost or market based principally on the effects of technological changes, quantities of goods on hand, and other factors. An estimate is made of the market value, less cost to dispose, of products whose value is determined to be impaired. If these products are ultimately sold at less than estimated amounts, additional reserves may be required. The estimates used to calculate these reserves are applied consistently. The adjustments are recorded in the period in which the loss of utility of the inventory occurs, which establishes a new cost basis for the inventory. This new cost basis is maintained until such time that the reserved inventory is disposed of, returned to the vendor or sold. To the extent that specifically reserved inventory is sold, cost of goods sold is expensed for the new cost basis of the inventory sold.

Vendor Programs

The Company receives incentives from vendors related to cooperative advertising allowances, volume rebates and other incentive agreements. These incentives are generally under quarterly, semi-annual or annual agreements with the vendors. Some of these incentives are negotiated on an ad hoc basis to support specific programs mutually developed between the Company and the vendor. Vendors generally require that we use their cooperative advertising allowances exclusively for advertising or other marketing programs. Incentives received from vendors for specifically identified incremental cooperative advertising programs are recorded as adjustments to selling, general and administrative expenses. The Financial Accounting Standards Board’s (“FASB”) ASC 605 – Revenue Recognition, addresses accounting by a customer (including a reseller) for certain consideration received from a vendor. This guidance requires that the portion of these vendor funds in excess of our costs be reflected as a reduction of inventory. Such funds are recognized as a reduction of the cost of products sold when the related inventory is sold.

The Company records unrestricted volume rebates received as a reduction of inventory and as a reduction of the cost of goods sold when the related inventory is sold. Amounts received or receivables from vendors that are not yet earned are deferred in the consolidated balance sheets. In addition, the Company may receive early payment discounts from certain vendors. The Company records early payment discounts received as a reduction of inventory and recognizes the discount as a reduction of cost of goods sold when the related inventory is sold. ASC 605 requires management to make certain estimates of the amounts of vendor incentives that will be received. Actual recognition of the vendor consideration may vary from management estimates based on actual results.

31

Share-Based Payments

The Company accounts for share-based compensation using the provisions of ASC 718, Accounting for Stock Compensation, which requires the recognition of the fair value of share-based compensation. Share-based compensation is estimated at the grant date based on the fair value of the awards, in accordance with the provisions of ASC 718. Since this compensation cost is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company has elected to expense grants of awards with graded vesting on a straight-line basis over the requisite service period for each separately vesting portion of the award.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred income taxes reflect tax consequences on future years of differences between the tax bases of assets and liabilities and their financial reporting amounts. Valuation allowances are provided against deferred tax assets in accordance with ASC 740, Accounting for Income Taxes. Federal income taxes are not assessed on the undistributed earnings of foreign subsidiaries because it has been the practice of the Company to reinvest those earnings in the business outside the United States. See Note 11 for further discussion.

Additionally, the Company maintains reserves for uncertain tax provisions in accordance with ASC 740. See Note 11 for more information.

Business Combinations

The Company accounts for business combinations in accordance with ASC Topic 805, Business Combinations. ASC 805 establishes principles and requirements for recognizing the total consideration transferred to and the assets acquired, liabilities assumed and any non-controlling interest in the acquired target in a business combination. ASC 805 also provides guidance for recognizing and measuring goodwill acquired in a business combination and requires the acquirer to disclose information that users may need to evaluate and understand the financial impact of the business combination. See Note 4, Acquisitions for further discussion.

Goodwill

The carrying value of goodwill is reviewed at a reporting unit level at least annually for impairment, or more frequently if impairment indicators exist. Our goodwill reporting units are our North America segment and, in our international segment, various components one level below. The goodwill testing utilizes a two-step impairment analysis, whereby the Company compares the carrying value of each identified reporting unit to its fair value. The fair values of the reporting units are estimated using the net present value of discounted cash flows generated by each reporting unit. Considerable judgment is necessary in estimating future cash flows, discount rates and other factors affecting the estimated fair value of the reporting units, including the operating and macroeconomic factors. Historical financial information, internal plans and projections, and industry information are used in making such estimates.

In the two-step impairment analysis, goodwill is first tested for impairment by comparing the fair value of the reporting unit with the reporting unit's carrying amount to identify any potential impairment. If fair value is determined to be less than carrying value, a second step is used whereby the implied fair value of the reporting unit's goodwill, determined through a hypothetical purchase price allocation, is compared with the carrying amount of the reporting units' goodwill. If the implied fair value of the reporting unit's goodwill is less than its carrying amount, an impairment charge is recorded in current earnings for the difference. We also assess the recoverability of goodwill if facts and circumstances indicate goodwill may be impaired. In our most recent annual test, we estimated the fair value of our reporting units primarily based on the income approach utilizing the discounted cash flow method. The discounted cash flow method required us to estimate future cash flows and discount those amounts to a present value. The key assumptions utilized in determining fair value included:

•Industry weighted-average cost of capital ("WACC"): We utilized a WACC relative to each reporting unit's respective geography and industry as the discount rate for estimated future cash flows. The WACC is intended to represent a rate of return that would be expected by a market place participant in each respective geography.

•Operating income: We utilized historical and expected revenue growth rates, gross margins and operating expense percentages, which varied based on the projections of each reporting unit being evaluated.

32

•Cash flows from working capital changes: We utilized a projected cash flow impact pertaining to expected changes in working capital as each of our goodwill reporting units grow.

While we believe our assumptions are appropriate, they are subject to uncertainty and by nature include judgments and estimates regarding future events, including projected growth rates, margin percentage and operating efficiencies. During fiscal years 2012, 2011 and 2010, no impairment charges related to goodwill were recorded. However, as of the latest annual goodwill impairment test, the estimated fair value of our Brazilian goodwill reporting unit exceeded its carrying value by a smaller margin than the Company's other goodwill reporting units. Our Brazilian operations were only recently acquired, resulting in a carrying value that approximates its fair value.

The carrying value of our Brazilian goodwill asset as of June 30, 2012 was $19.8 million. The estimated fair value of our Brazilian goodwill reporting unit exceeded the carrying value by 7% in the most recent annual impairment test. The increase in sensitivity to our Brazilian goodwill reporting unit is driven largely by the general macroeconomic environment and lower expectations for future results in this unit. Key assumptions used in determining fair value include projected growth and operating margin, working capital requirements and discount rates. While we do not believe that this goodwill reporting unit is impaired at this time, if we are not able to achieve projected operating margins within the expected working capital requirements and/or there are unfavorable changes to the discount rate, a future impairment of goodwill is at least reasonably possible.

Liability for Contingent Consideration

In addition to the initial cash consideration paid to former CDC shareholders, the Company is obligated to make additional earnout payments based on future results through fiscal year 2015 based on a multiple of the subsidiary’s pro forma net income as defined in Exhibit 2.1.(b)(2) of the Share Purchase and Sale Agreement. Future payments are to be paid in Brazilian currency, the real. There are four remaining earnout payments payable in annual installments on August 31, 2012 – 2014 with the final payment on October 31, 2015. In accordance with ASC Topic 805, the Company determines the fair value of this liability for contingent consideration at each reporting date throughout the term of the earnout using a discounted cash flow model following the income approach. Each period the Company will reflect the contingent consideration liability at fair value with changes recorded in the change in fair value of contingent consideration line item on the consolidated income statement. Current and noncurrent portions of the liability are presented in the current portion of contingent consideration and long-term portion of contingent consideration line items on the consolidated balance sheet.

Accounting Standards Recently Issued

See Note 1 in the Notes to Consolidated Financial Statements for the discussion on recent accounting pronouncements.

Liquidity and Capital Resources

Our primary sources of liquidity are cash flow from operations, borrowings under the $300 million revolving credit facility, Industrial Revenue Bond and borrowings under the European subsidiary’s €6 million line of credit. As a distribution company, our business requires significant investment in working capital, particularly accounts receivable and inventory, partially financed through our accounts payable to vendors and revolving lines of credit. Overall, as our sales volumes increase our net investment in working capital typically increases, which in general results in decreased cash flow from operating activities. Conversely, when sales volumes decrease, our net investment in working capital typically decreases, which in general, results in increased cash flow from operating activities.

Cash and cash equivalents totaled $29.2 million at June 30, 2012, compared to $28.7 million at June 30, 2011, of which $18.7 million and $10.9 million was held outside of the United States as of June 30, 2012 and 2011, respectively. There has been a significant increase in cash held outside of the United States due to a $22 million cash transfer to our Brazilian subsidiary to provide for a portion of future earnout payments to the former shareholders of CDC. We transferred the cash in September 2011 to our Brazilian subsidiary in order to mitigate foreign exchange rate risk and supplement our working capital needs in Brazil.

Cash balances are generated and used in many locations throughout the world. Management’s intent is to permanently reinvest these funds in our businesses outside the United States to continue to fund growth in our international operations. Furthermore, our current plans do not require repatriation of funds from our international operations to fund operations in the United States. If these funds were needed in the operations of the United States, we would be required to record and pay significant income taxes upon repatriation of these funds. See Note11, Income Taxes in the notes to the consolidated financial statements for further discussion.

33

In the current year, we generated $60.0 million of cash flows from operating activities as opposed to generating $10.7 million in the prior year. The increase in operating cash flows is largely the result of slower growth in trade receivables due to slower year-over-year growth rate in sales versus the prior year. Working capital has slightly increased to $533.5 million at June 30, 2012 from $532.2 million at June 30, 2011. During this economic downturn, we continue to maintain our commitment to extend reasonable credit terms to our resellers and stock strategic inventory to accommodate anticipated reseller demand for our vendors' products.

The number of days sales in receivables (DSO) was 56 at June 30, 2012, compared to 57 days at June 30, 2011 and March 31, 2012, which are within our typically expected range.

Inventory turnover decreased to 5.6 times during the fourth quarter of the current fiscal year versus 6.1 times in the comparative prior year period. This decrease in turns was largely the function of higher inventory levels built up throughout fiscal 2012, as a result of favorable vendor pricing, longer lead times and anticipation for demand in certain products. Beginning in the third quarter of the current fiscal year, Management initiated a global plan to reduce inventories to levels more consistent with our current volumes and weaker growth in Europe. We have lowered 8% of our inventory since December 31, 2011. We had 7.4 paid-for inventory days as of June 30, 2012 versus 8.3 days at the end of the prior year and 14.8 days at March 31, 2012, which indicates the progress that we have made. We are continuing our efforts to properly size our inventory levels and reduce our carrying costs without risking sales opportunities with our resellers.

We are in the process of designing and developing a new ERP system. We have spent approximately $33.5 million on the project from inception through June 30, 2012. Of the total amount spent, $26.8 million has been in the form of capital expenditures. We have received a project assessment from a third party service provider, which indicates that the project will take longer to implement and exceed previously disclosed cost estimates, which at the high end was $38.5 million. We have revised our projections for the project and believe that total spend could range from $58 million to $72 million and extend past fiscal year 2013. Capital expenditures for fiscal 2013 could range from $9 million to $15 million for a total capital expenditure of up to $41.8 million.

Cash used in investing activities for the twelve months ended June 30, 2012 was $12.8 million, compared to $51.1 million used in the prior year. Current year investing cash flows are primarily attributable to the investment in our new ERP system and building improvements in the United States and Belgium. The prior year included a $36.2 million payment, net of cash acquired, for the acquisition of CDC Brazil. According to the Share Purchase and Sale Agreement, cash payments to the previous shareholders of CDC will be made annually through October 2015. Aside from the prior year CDC acquisition, fiscal year 2011 investing cash outflows were primarily for investment in the new ERP system mentioned above.

On October 11, 2011, we refinanced the $250 million revolving credit facility, due on September 28, 2012. We entered into a five-year, $300 million multi-currency senior secured revolving credit facility pursuant to the terms of an Amended and Restated Credit Agreement (the “New Credit Agreement”) with JPMorgan Chase Bank, N.A., as administrative agent and a syndicate of lenders named therein. The New Credit Agreement allows for the issuance of up to $50 million for letters of credit and has a $150 million accordion feature that allows the Company to increase the availability to $450 million subject to obtaining commitments for the incremental capacity from existing or new lenders. We incurred $1.4 million in debt issuance costs that were capitalized to other assets, including identifiable intangible assets on the consolidated balance sheet, which are being amortized on a straight-line basis through the maturity date of the New Credit Agreement on October 11, 2016.

In the current fiscal year, cash used by financing activities amounted to $42.3 million, in comparison to cash provided of $33.7 million in the prior year. The cash flow decrease is primarily attributable to paying off our $25 million unsecured note payable, all borrowings on the $300 million revolving credit facility and the first earnout payment to the sellers of CDC. These payments were primarily funded by cash flows generated in operations. In the prior year, proceeds from our revolving credit facility were needed to fund working capital growth and the CDC acquisition.

34

At our option, loans denominated in U.S. dollars under the New Credit Agreement, other than swingline loans, bear interest at a rate equal to a spread over the London Interbank Offered Rate (“LIBOR”) or prime rate depending upon the Company's ratio of total debt (excluding accounts payable and accrued liabilities) to EBITDA, measured as of the end of the most recent year or quarter, as applicable, for which financial statements have been delivered to the Lenders (the “Leverage Ratio”). This spread ranges from 1.00% to 2.25% for LIBOR-based loans and 0.00% to 1.25% for prime rate-based loans. Borrowings under the New Credit Agreement are guaranteed by substantially all of the domestic assets of the Company as well as certain foreign subsidiaries determined to be material under the New Credit Agreement and a pledge of up to 65% of capital stock or other equity interest in each Guarantor (as defined in the New Credit Agreement). We were in compliance with all covenants under the credit facility as of June 30, 2012.

As mentioned above, there are no outstanding borrowings on the Company's $300 million revolving credit facility as of June 30, 2012. There was $26.5 million outstanding on the Company’s primary revolving line of credit facility at the end of the prior year.

On a gross basis, we borrowed $1,408.5 million and repaid $1,433.2 million on the $300 million revolving credit facility in fiscal 2012 and additionally paid $1.4 million of debt issuance costs. In the prior year, we borrowed $769.5 million and repaid $743.9 million. The average daily balance on the revolving credit facility was $78.6 million and $14.2 million for the years ended June 30, 2012 and 2011, respectively. There were no standby letters of credits issued and outstanding as of June 30, 2012, leaving $300 million available for additional borrowings.

In addition to our multi-currency $300 million revolving credit facility, we have a €6.0 million subsidiary line of credit utilized by our European operations which bears interest at the 30-day Euro Interbank Offered Rate (“EURIBOR”) plus a spread ranging from 1.25% to 2.00% per annum. As of June 30, 2012, there was $4.3 million outstanding and $3.2 million at June 30, 2011. This facility is secured by the assets of our European operations and is guaranteed by ScanSource, Inc.

On April 15, 2011, the Company, through its wholly-owned subsidiary, ScanSource do Brasil Participações LTDA completed its acquisition of all of the shares of CDC, pursuant to a Share Purchase and Sale Agreement dated April 7, 2011. The purchase price was paid with an initial payment of $36.2 million, net of cash acquired, assumption of working capital payables and debt, and variable annual payments through October 2015 based on CDCs annual financial results. We made our first subsequent earnout payment related to CDC results for the twelve months ended June 30, 2011 in January 2012 in the amount of $2.0 million. As of June 30, 2012, we have $16.7 million recorded for the earnout obligation, of which $5.0 million is classified as current and due August 31, 2012. Future earnout payments will be funded by cash on hand and our existing revolving credit facility.

On January 2, 2008, we entered into a $25 million promissory note with a financial institution. This note payable accrued interest on the unpaid balance at a rate per annum equal to the 30 day LIBOR plus 0.65% and scheduled to mature on September 28, 2012. The entire note was paid during fiscal 2012 using proceeds from our New Credit Agreement.

On August 1, 2007, the Company entered into an agreement with the State of Mississippi in order to provide financing for the acquisition and installation of certain equipment to be utilized at the Company’s Southaven, Mississippi distribution facility, through the issuance of an industrial development revenue bond. The bond matures on September 1, 2032 and accrues interest at the 30-day LIBOR rate plus a spread of 0.85%. The terms of the bond allow for payment of interest only for the first 10 years of the agreement, and then, starting on September 1, 2018 through 2032, principal and interest payments are due until the maturity date or the redemption of the bond. The outstanding balance on this facility was $5.4 million as of June 30, 2012, and the effective interest rate was 1.09%. The Company was in compliance with all covenants associated with this agreement as of June 30, 2012.

The Company believes that its existing sources of liquidity, including cash resources and cash provided by operating activities, supplemented as necessary with funds under the Company’s credit agreements, will provide sufficient resources to meet the Company’s present and future working capital and cash requirements for at least the next twelve months.

Commitments

At June 30, 2012, the Company had contractual obligations in the form of non-cancelable operating leases, debt (including interest payments) and the contingent consideration for the earnout pertaining to the CDC acquisition. See Notes 6 and 12 of notes to the consolidated financial statements. The following table summarizes our future contractual obligations:

35

	Payments Due by Period
	Total		Year 1		Years 2-3		Years 4-5		Greater than 5 Years
	(in thousands)
Contractual Obligations
Principal debt payments	$	9,697	$	4,268	$	—	$	—	$	5,429
Non-cancelable operating leases(1)	19,713		4,671		7,294		5,730		2,018
Contingent consideration(2)	16,653		4,976		7,974		3,703		—
Other(3)	—		—		—		—		—
Total obligations	$	46,063	$	13,915	$	15,268	$	9,433	$	7,447

(1) Amounts to be paid in future periods for real estate taxes, insurance, and other operating expenses applicable to the properties pursuant to the respective operating leases have been excluded from the table above as the amounts payable in future periods are generally not specified in the lease agreements and are dependent upon amounts which are not known at this time. Such amounts were not material in the current fiscal year.

(2) Amounts disclosed regarding future CDC earnout payments are presented at their discounted fair value. Estimated future, undiscounted earnout payments total $23.9 million as of June 30, 2012.

(3) Amounts totaling $11.6 million of deferred compensation which are included in current and other non-current liabilities in our Consolidated Balance Sheet as of June 30, 2012 have been excluded from the table above due to the uncertainty of the timing of the payment of these obligations, which are generally at the discretion of the individual employees or upon death of the former employee, respectively.

As discussed earlier, we are in the process of designing and developing a new ERP system. We have spent approximately $33.5 million on the project from inception through June 30, 2012. Of the total amount spent, $26.8 million has been in the form of capital expenditures. During the current fiscal year, we have revised our projections for the project and believe that total spend could range from $58 million to $72 million and extend past fiscal year 2013. Capital expenditures for fiscal 2013 could range from $9 million to $15 million for a total capital expenditure of up to $41.8 million.

36

ITEM 7A. Quantitative and Qualitative Disclosures about Market Risk.

The Company’s principal exposure to changes in financial market conditions in the normal course of its business is a result of its selective use of bank debt and transacting business in foreign currencies in connection with its foreign operations.

Interest Rate Risk

The Company is exposed to changes in interest rates primarily as a result of its borrowing activities, which include revolving credit facilities with a group of banks used to maintain liquidity and fund the Company’s business operations. The nature and amount of the Company’s debt may vary as a result of future business requirements, market conditions and other factors. A hypothetical 100 basis point increase or decrease in interest rates on borrowings on the Company’s revolving credit facility, variable rate long-term debt and subsidiary line of credit for the fiscal year ended June 30, 2012 would have resulted in a $0.9 million increase or decrease, respectively, in pre-tax income for the period.

The Company evaluates its interest rate risk and may use interest rate swaps to mitigate the risk of interest rate fluctuations associated with the Company's variable rate long-term debt. At June 30, 2012, the Company had $5.4 million in variable rate long-term debt outstanding with no interest rate swaps in place. If used, derivative instruments have the potential to expose the Company to certain market risks including the possibility of (1) the Company’s hedging activities not being as effective as anticipated in reducing the volatility of the Company’s cash flows, (2) the counterparty not performing its obligations under the applicable hedging arrangement, (3) the hedging arrangement being imperfect or ineffective, or (4) the terms of the swap or associated debt may change. The Company seeks to lessen such risks by having established a policy to identify, control, and manage market risks which may arise from changes in interest rates, as well as limiting its counterparties to major financial institutions. The Company's previous interest rate swap expired on September 28, 2011 and was not renewed due to subsequent payment of the interest rate swap's entire underlying $25 million promissory note on October 11, 2011.

Foreign Currency Exchange Rate Risk

The Company is exposed to foreign currency risks that arise from its foreign operations in Canada, Mexico, Brazil and Europe. These risks include transactions denominated in non-functional currencies and intercompany loans with foreign subsidiaries. In the normal course of the business, foreign exchange risk is managed by the use of foreign currency forward contracts to hedge these exposures as well as balance sheet netting of exposures. In addition, exchange rate fluctuations may cause our international results to fluctuate significantly when translated into U.S. dollars. These risks may change over time as business practices evolve and could have a material impact on the Company’s financial results in the future.

The Company’s Board of Directors has approved a foreign exchange hedging policy to reduce foreign currency exposure. The Company’s policy is to utilize financial instruments to reduce risks where internal netting cannot be effectively employed and not to enter into foreign currency derivative instruments for speculative or trading purposes. The Company monitors its risk associated with the volatility of certain foreign currencies against its functional currencies and enters into foreign exchange derivative contracts to minimize short-term currency risks on cash flows. These positions are based upon balance sheet exposures and, in certain foreign currencies, our forecasted purchases and sales. The Company continually evaluates foreign exchange risk and may enter into foreign exchange transactions in accordance with its policy. Actual variances from these forecasted transactions can adversely impact foreign exchange results. Foreign currency gains and losses are included in other expense (income).

The Company has elected not to designate its foreign currency contracts as hedging instruments, and therefore, the instruments are marked-to-market with changes in their values recorded in the consolidated income statement each period. The Company's foreign currencies are primarily British pounds, euros, Mexican pesos, Brazilian real and Canadian dollars. At June 30, 2012, the fair value of the Company’s currency forward contracts outstanding was a net payable of less than $0.1 million. The Company does not utilize financial instruments for trading or other speculative purposes.

37

ITEM 8. Financial Statements and Supplementary Data.

Index to Financial Statements

	Page
Financial Statements
Report of Independent Registered Certified Public Accounting Firm	39
Report of Independent Registered Certified Public Accounting Firm on Internal Control Over Financial Reporting	40
Consolidated Balance Sheets	41
Consolidated Income Statements	42
Consolidated Statements of Shareholders’ Equity	43
Consolidated Statements of Cash Flows	44
Notes to Consolidated Financial Statements	45

All schedules and exhibits not included are not applicable, not required or would contain information which is shown in the financial statements or notes thereto.

38

Report of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders of ScanSource, Inc.

We have audited the accompanying consolidated balance sheets of ScanSource, Inc. and subsidiaries as of June 30, 2012 and 2011, and the related Consolidated Statements of Income, Shareholders’ Equity, and Cash Flows for each of the three years in the period ended June 30, 2012. Our audits also included the financial statement schedule listed in Item 15(a). These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of ScanSource, Inc. and subsidiaries at June 30, 2012 and 2011, and the consolidated results of their operations and their cash flows for each of the three years in the period ended June 30, 2012, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), ScanSource, Inc.’s internal control over financial reporting as of June 30, 2012, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated August 24, 2012 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

Greenville, South Carolina

August 24, 2012

39

Report of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders of ScanSource, Inc.

We have audited ScanSource, Inc. and subsidiaries’ internal control over financial reporting as of June 30, 2012, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). ScanSource, Inc. and subsidiaries’ management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, ScanSource, Inc. and subsidiaries maintained, in all material respects, effective internal control over financial reporting as of June 30, 2012, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of ScanSource, Inc. and subsidiaries as of June 30, 2012 and 2011, and the related consolidated statements of income, shareholders’ equity, and cash flows for each of the three years in the period ended June 30, 2012 of ScanSource, Inc. and subsidiaries and our report dated August 24, 2012 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

Greenville, South Carolina

August 24, 2012

40

ScanSource, Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except for share information)

	June 30, 2012			June 30, 2011
Assets
Current assets:
Cash and cash equivalents	$	29,173		$	28,747
Accounts receivable, less allowance of $27,349 at June 30, 2012 and $26,562 at June 30, 2011	470,808			462,102
Inventories	475,479			467,350
Prepaid expenses and other assets	41,846			35,421
Deferred income taxes	14,624			15,894
Total current assets	1,031,930			1,009,514
Property and equipment, net	48,785			36,819
Goodwill	53,885			59,090
Other assets, including identifiable intangible assets	67,206			76,765
Total assets	$	1,201,806		$	1,182,188
Liabilities and Shareholders’ Equity
Current liabilities:
Short-term borrowings	$	4,268		$	3,164
Current portion of contingent consideration	4,976			2,398
Accounts payable	419,683			406,453
Accrued expenses and other liabilities	67,776			60,157
Income taxes payable	1,698			5,175
Total current liabilities	498,401			477,347
Long-term debt	5,429			30,429
Borrowings under revolving credit facility	—			26,513
Long-term portion of contingent consideration	11,677			21,396
Other long-term liabilities	33,988			39,109
Total liabilities	549,495			594,794
Commitments and contingencies
Shareholders’ equity:
Preferred stock, no par value; 3,000,000 shares authorized, none issued	—			—
Common stock, no par value; 45,000,000 shares authorized, 27,604,840 and 27,109,932 shares issued and outstanding at June 30, 2012 and June 30, 2011, respectively	139,557			123,608
Retained earnings	534,445			460,157
Accumulated other comprehensive (loss) income	(21,691		)	3,629
Total shareholders’ equity	652,311			587,394
Total liabilities and shareholders’ equity	$	1,201,806		$	1,182,188

See accompanying notes to consolidated financial statements

41

ScanSource, Inc. and Subsidiaries

Consolidated Income Statements

Years Ended June 30, 2012, 2011, and 2010

(in thousands, except for per share information)

	2012			2011			2010
Net sales	$	3,015,296		$	2,666,531		$	2,114,979
Cost of goods sold	2,713,272			2,392,224			1,896,052
Gross profit	302,024			274,307			218,927
Selling, general and administrative expenses	188,388			161,326			143,151
Change in fair value of contingent consideration	120			(128		)	—
Operating income	113,516			113,109			75,776
Interest expense	1,639			1,723			1,472
Interest income	(2,886		)	(1,212		)	(1,387		)
Other expense (income), net	3,552			712			(50		)
Income before income taxes	111,211			111,886			75,741
Provision for income taxes	36,923			38,363			26,929
Net income	$	74,288		$	73,523		$	48,812
Per share data:
Net income per common share, basic	$	2.72		$	2.74		$	1.83
Weighted-average shares outstanding, basic	27,362			26,872			26,605
Net income per common share, diluted	$	2.68		$	2.70		$	1.82
Weighted-average shares outstanding, diluted	27,751			27,246			26,869

See accompanying notes to consolidated financial statements

42

ScanSource, Inc. and Subsidiaries

Consolidated Statements of Shareholders’ Equity

Years Ended June 30, 2012, 2011, and 2010

(in thousands, except for share information)

	Common Stock (Shares)	Common Stock (Amount)		Retained Earnings		Accumulated Other Comprehensive Income (Loss)			Total
Balance at June 30, 2009	26,565,870	$	104,461	$	337,822	$	3,163		$	445,446
Comprehensive Income:
Net income	—	—		48,812		—			48,812
Unrealized gain on hedged transaction, net of tax of $85	—	—		—		148			148
Foreign currency translation adjustment	—	—		—		(15,045		)	(15,045		)
Total comprehensive income									33,915
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes	137,168	1,095		—		—			1,095
Share based compensation	—	6,168		—		—			6,168
Tax benefit of deductible compensation arising from exercise or vesting of share based payment arrangements	—	227		—		—			227
Balance at June 30, 2010	26,703,038	$	111,951	$	386,634	$	(11,734	)	$	486,851
Comprehensive Income:
Net income	—	—		73,523		—			73,523
Unrealized gain on hedged transaction, net of tax of $272	—	—		—		468			468
Foreign currency translation adjustment	—	—		—		14,895			14,895
Total comprehensive income									88,886
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes	406,894	6,373		—		—			6,373
Share based compensation	—	5,081		—		—			5,081
Tax benefit of deductible compensation arising from exercise or vesting of share based payment arrangements	—	203		—		—			203
Balance at June 30, 2011	27,109,932	$	123,608	$	460,157	$	3,629		$	587,394
Comprehensive Income:
Net income	—	—		74,288		—			74,288
Unrealized gain on hedged transaction, net of tax of $76	—	—		—		139			139
Foreign currency translation adjustment	—	—		—		(25,459		)	(25,459		)
Total comprehensive income									48,968
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes	494,908	7,642		—		—			7,642
Share based compensation	—	7,004		—		—			7,004
Tax benefit of deductible compensation arising from exercise or vesting of share based payment arrangements	—	1,303		—		—			1,303
Balance at June 30, 2012	27,604,840	$	139,557	$	534,445	$	(21,691	)	$	652,311

See accompanying notes to consolidated financial statements

43

ScanSource, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

Years Ended June 30, 2012, 2011, and 2010

(in thousands)

	2012			2011			2010
Cash flows from operating activities:
Net income	$	74,288		$	73,523		$	48,812
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	9,922			6,662			6,064
Allowance for accounts and notes receivable	7,134			7,488			10,854
Share-based compensation and restricted stock	6,840			4,877			6,065
Deferred income taxes	(6,377		)	(1,431		)	(4,658		)
Excess tax benefits from share-based payment arrangements	(1,720		)	(203		)	(227		)
Change in fair value of contingent consideration	120			(128		)	—
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(36,666		)	(77,305		)	(79,145		)
Inventories	(27,043		)	(79,654		)	(133,492		)
Prepaid expenses and other assets	(4,103		)	(17,392		)	884
Other noncurrent assets	1,166			(10,279		)	(2,660		)
Accounts payable	28,306			78,298			57,977
Accrued expenses and other liabilities	8,371			31,060			6,876
Income taxes payable	(280		)	(4,828		)	4,486
Net cash provided by (used in) operating activities	59,958			10,688			(78,164		)
Cash flows from investing activities:
Capital expenditures	(12,790		)	(14,869		)	(5,606		)
Cash paid for business acquisitions, net of cash acquired	—			(36,228		)	(9,994		)
Net cash provided by (used in) investing activities	(12,790		)	(51,097		)	(15,600		)
Cash flows from financing activities:
Increases (decreases) in short-term borrowings, net	1,345			1,706			—
Borrowings (repayments) on revolving credit, net of expenses	(25,999		)	25,376			—
Borrowings (repayments) on long-term debt	(25,000		)	—			—
Contingent consideration payments	(2,000		)	—			—
Exercise of stock options	7,642			6,372			1,095
Excess tax benefits from share-based payment arrangements	1,720			203			227
Net cash provided by (used in) financing activities	(42,292		)	33,657			1,322
Effect of exchange rate changes on cash and cash equivalents	(4,450		)	894			(617		)
Increase (decrease) in cash and cash equivalents	426			(5,858		)	(93,059		)
Cash and cash equivalents at beginning of period	28,747			34,605			127,664
Cash and cash equivalents at end of period	$	29,173		$	28,747		$	34,605
Supplemental disclosure of cash flow information:
Interest paid during the year	$	1,578		$	1,705		$	1,391
Income taxes paid during the year	$	46,057		$	43,233		$	23,210

See accompanying notes to consolidated financial statements

44

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

June 30, 2012

(1) Business and Summary of Significant Accounting Policies

Business Description

ScanSource, Inc. and its subsidiaries (the “Company”) is a leading wholesale distributor of specialty technology products, providing value-added distribution sales to resellers in the specialty technology markets. The Company has two geographic distribution segments: the North American distribution segment serving the United States and Canada from the Southaven, Mississippi distribution center, and an international segment currently serving Latin America and Europe from distribution centers located in Florida, Mexico and Brazil, and in Belgium, respectively. The North American distribution segment markets automatic identification and data capture (“AIDC”) and point-of-sale (“POS”) products through its ScanSource POS and Barcoding sales unit; voice, data and converged communications equipment through its Catalyst Telecom sales unit; video conferencing, telephony, and communications products through its ScanSource Communications unit; and electronic security products and wireless infrastructure products through its ScanSource Security Distribution unit. The international distribution segment markets AIDC, POS, communications and security products through its ScanSource Latin America sales unit; AIDC and POS products through its ScanSource Europe sales unit; and communication products through its ScanSource Communications sales unit in Europe.

On April 15, 2011, the Company purchased all of the shares of CDC Brasil S.A. (“CDC”), formerly known as CDC Brasil Distribuidora LTDA. CDC, the leading POS and Barcoding distributor in Brazil, is now included under the ScanSource Latin America operating unit.

Consolidation Policy

The consolidated financial statements include the accounts of the Company. All significant inter-company accounts and transactions have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to the allowance for uncollectible accounts receivable and inventory reserves. Management bases its estimates on assumptions that management believes to be reasonable under the circumstances, the results of which form a basis for making judgments about the carrying value of assets and liabilities that are not readily available from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, management believes that its estimates, including those for the above described items, are reasonable and that the actual results will not vary significantly from the estimated amounts.

The following significant accounting policies relate to the more significant judgments and estimates used in the preparation of the Consolidated Financial Statements:

(a) Allowances for Trade and Notes Receivable

The Company maintains an allowance for uncollectible accounts receivable for estimated losses resulting from customers’ failure to make payments on accounts receivable due to the Company.

45

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

Management determines the estimate of the allowance for uncollectible accounts receivable by considering a number of factors, including: (1) historical experience, (2) aging of the accounts receivable and (3) specific information obtained by the Company on the financial condition and the current creditworthiness of its customers. If the financial condition of the Company’s customers were to deteriorate and reduce the ability of the Company’s customers to make payments on their accounts, the Company may be required to increase its allowance by recording additional bad debt expense. Likewise, should the financial condition of the Company’s customers improve and result in payments or settlements of previously reserved amounts, the Company may be required to record a reduction in bad debt expense to reverse the recorded allowance. A provision for estimated returns and allowances and associated losses is recorded and based on historical experience.

(b) Inventory Reserves

Management determines the inventory reserves required to reduce inventories to the lower of cost or market based principally on the effects of technological changes, quantities of goods on hand, and other factors. An estimate is made of the market value, less cost to dispose, of products whose value is determined to be impaired. If these products are ultimately sold at less than estimated amounts, additional reserves may be required. The estimates used to calculate these reserves are applied consistently. The adjustments are recorded in the period in which the loss of utility of the inventory occurs, which establishes a new cost basis for the inventory. This new cost basis is maintained until such time that the reserved inventory is disposed of, returned to the vendor or sold. To the extent that specifically reserved inventory is sold, cost of goods sold is expensed for the new cost basis of the inventory sold.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation in the accompanying consolidated financial statements.

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company maintains some zero-balance, disbursement accounts at various financial institutions in which the Company does not maintain significant depository relationships. Due to the nature of the Company’s banking relationships with these institutions, the Company does not have the right to offset most if not all outstanding checks written from these accounts against cash on hand. Checks released but not yet cleared from these accounts in the amounts of $48.2 million and $73.6 million are classified to accounts payable as of June 30, 2012 and June 30, 2011, respectively.

The Company maintains its cash with various financial institutions globally that are monitored regularly for credit quality. At times, such investments may be in excess of FDIC or other federally insured limits.

Concentration of Credit Risk

The Company sells its products to a large base of value-added resellers throughout North America, Latin America and Europe. The Company performs ongoing credit evaluations of its customers’ financial condition. In certain cases, the Company will accept tangible assets as collateral to increase the trade credit of its customers. No single customer accounted for more than 6% of the Company’s net sales for fiscal 2012, 2011, or 2010.

The Company has established arrangements with certain customers for longer term financing. The Company accounts for these arrangements by recording them at their historical cost less specific allowances at balance sheet dates. Interest income is recognized in the period earned and is recorded as interest income in the Consolidated Income Statement.

46

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

Derivative Financial Instruments

The Company uses derivative instruments to manage certain exposures related to foreign currency as well as changes in interest rates as a result of our borrowing activities. We record all derivative instruments as either assets or liabilities in the balance sheet at fair value. The Company currently does not use derivative financial instruments for trading or speculative purposes.

The Company’s foreign currency exposure results from purchasing and selling internationally in several foreign currencies. In addition, the Company has foreign currency risk related to debt that is denominated in currencies other than the U.S. dollar. The Company may reduce its exposure to fluctuations in foreign exchange rates by creating offsetting positions through the use of derivative financial instruments or multi-currency borrowings. The market risk related to the foreign exchange agreements is offset by changes in the valuation of the underlying items. Derivative financial instruments related to foreign currency exposure are accounted for on an accrual basis with gains or losses on these contracts recorded in income in the period in which their value changes, with the offsetting entry for unsettled positions reflected in either other assets or other liabilities. These contracts are generally for a duration of 90 days or less. The Company has elected not to designate its foreign currency contracts as hedging instruments. They are, therefore, marked-to-market with changes in their fair value recorded in the Consolidated Income Statement each period. The Company's foreign currencies are denominated primarily by British pounds, euros, Mexican pesos, Brazilian real and Canadian dollars.

During the fiscal year ended June 30, 2008, the Company entered into an interest rate swap and designated this instrument as a hedge of the cash flows on certain variable rate debt. The interest rate swap matured on September 28, 2011 of the current fiscal year. To the extent the derivative instrument was effective in offsetting the variability of the hedged cash flows, changes in the fair value of the derivative instrument were not included in current earnings, but were reported as other comprehensive income (loss). There was no ineffective portion to be recorded as an adjustment to earnings. There have been no other interest rate swap agreements executed in fiscal year June 30, 2012.

Investments

The Company has investments that are held in a grantor trust formed by the Company related to the ScanSource, Inc. Nonqualified Deferred Compensation Plan and Founder’s Supplemental Executive Retirement Plan (“SERP”). The Company has classified these investments as trading securities, and they are recorded at fair market value with unrealized gains and losses included in the accompanying Consolidated Income Statements. The Company’s obligations under this deferred compensation plan change in concert with the performance of the investments along with contributions and withdrawals to and from the plan. The fair value of these investments and the corresponding deferred compensation obligation was $11.6 million and $12.9 million as of June 30, 2012 and June 30, 2011, respectively. These investments are classified as either current assets or other non-current assets in the Consolidated Balance Sheets depending on the timing of planned disbursements. The deferred compensation obligation is classified either within current liabilities or other long-term liabilities as well. The amounts of these investments classified as current assets with corresponding current liabilities were $1.2 million and $3.1 million at June 30, 2012 and June 30, 2011, respectively.

Inventories

Inventories (consisting entirely of finished goods) are stated at the lower of cost (first-in, first-out method) or market.

47

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

Vendor Programs

The Company receives incentives from vendors related to cooperative advertising allowances, volume rebates and other incentive agreements. These incentives are generally under quarterly, semi-annual or annual agreements with the vendors. Some of these incentives are negotiated on an ad hoc basis to support specific programs mutually developed between the Company and the vendor. Vendors generally require that we use their cooperative advertising allowances exclusively for advertising or other marketing programs. Incentives received from vendors for specifically identified incremental cooperative advertising programs are recorded as adjustments to selling, general and administrative expenses. The Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 605 – Revenue Recognition, addresses accounting by a customer (including a reseller) for certain consideration received from a vendor. This guidance requires that the portion of these vendor funds in excess of our costs be reflected as a reduction of inventory. Such funds are recognized as a reduction of the cost of products sold when the related inventory is sold.

The Company records unrestricted volume rebates received as a reduction of inventory and as a reduction of the cost of goods sold when the related inventory is sold. Amounts received or receivables from vendors that are not yet earned are deferred in the Consolidated Balance Sheets. In addition, the Company may receive early payment discounts from certain vendors. The Company records early payment discounts received as a reduction of inventory and recognizes the discount as a reduction of cost of goods sold when the related inventory is sold. ASC 605 requires management to make certain estimates of the amounts of vendor incentives that will be received. Actual recognition of the vendor consideration may vary from management estimates based on actual results.

Vendor Concentration

The Company sells products from many suppliers, however, sales from products supplied by Motorola and Avaya each constituted more than 10% of the Company’s net sales for years ended June 30, 2012, 2011 and 2010, respectively.

Product Warranty

The Company’s vendors generally provide a warranty on the products distributed by the Company and allow the Company to return defective products, including those that have been returned to the Company by its customers. In two of our product lines, the Company offers a self-branded warranty program, in which Management has determined that the Company is the primary obligor of these programs. The Company purchases contracts from unrelated third parties, generally the original equipment manufacturers, to fulfill any obligation to service or replace defective product claimed on these warranty programs. As such, the Company has not recorded a provision for estimated service warranty costs. For all other product lines, the Company does not independently provide a warranty on the products it distributes; however, to maintain customer relations, the Company facilitates returns of defective products from the Company’s customers by accepting for exchange, with the Company’s prior approval, most defective products within 30 days of invoicing.

Property and Equipment

Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over estimated useful lives of 3 to 10 years for furniture, equipment and computer software, 40 years for buildings and 15 years for building improvements. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life. Maintenance, repairs and minor renewals are charged to expense as incurred. Additions, major renewals and betterments to property and equipment are capitalized. In fiscal 2010, the Company began the design and development of a new Enterprise Resource Planning System (“ERP”). The compensation costs of employees associated with this process are capitalized to the construction in process asset related to this project.

To the extent that the Company has longstanding, "in-process" projects that have not been implemented for their intended operational use, the Company capitalizes the portion of interest expense incurred during the asset's acquisition period that theoretically could have been avoided in accordance with ASC 835. The amount capitalized is determined by applying the appropriate capitalization rate to the average amount of accumulated expenditures for the asset during the reporting period. The capitalization rate used is based on the rates applicable to borrowings outstanding during the reporting period. Currently, the Company is capitalizing interest expense to its only significant, in-process asset recorded for the new ERP system discussed in the Management, Discussion and Analysis section of this Form 10-K and in Note 3.

48

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

Goodwill

The Company accounts for recorded goodwill in accordance with ASC 350, Goodwill and Other Intangible Assets, which requires that goodwill is reviewed annually for impairment or more frequently if impairment indicators exist.Goodwill testing utilizes a two-step impairment analysis, whereby the Company compares the carrying value of each identified reporting unit to its fair value. The carrying value of goodwill is reviewed at a reporting unit level at least annually for impairment, or more frequently if impairment indicators exist. Our goodwill reporting units are our North America segment and, in our international segment, various components one-level below. The fair values of the reporting units are estimated using the net present value of discounted cash flows generated by each reporting unit. Considerable judgment is necessary in estimating future cash flows, discount rates and other factors affecting the estimated fair value of the reporting units, including the operating and macroeconomic factors. Historical financial information, internal plans and projections, and industry information is used in making such estimates.

In the two-step impairment analysis, goodwill is first tested for impairment by comparing the fair value of the reporting unit with the reporting unit's carrying amount to identify any potential impairment. If fair value is determined to be less than carrying value, a second step is used whereby the implied fair value of the reporting unit's goodwill, determined through a hypothetical purchase price allocation, is compared with the carrying amount of the reporting units' goodwill. If the implied fair value of the reporting unit's goodwill is less than its carrying amount, an impairment charge is recorded in current earnings for the difference. We also assess the recoverability of goodwill if facts and circumstances indicate goodwill may be impaired. In our most recent annual test, we estimated the fair value of our reporting units primarily based on the income approach utilizing the discounted cash flow method. We also utilized fair value estimates derived from the market approach utilizing the public company market multiple method to validate the results of the discounted cash flow method, which required us to make assumptions about the applicability of those multiples to our reporting units. The discounted cash flow method required us to estimate future cash flows and discount those amounts to present value. The key assumptions utilized in determining fair value included:

•Industry weighted-average cost of capital ("WACC"): We utilized a WACC relative to each reporting unit's respective geography and industry as the discount rate for estimated future cash flows. The WACC is intended to represent a rate of return that would be expected by a market place participant in each respective geography.

•Operating income: We utilized historical and expected revenue growth rates, gross margins and operating expense percentages, which varied based on the projections of each reporting unit being evaluated.

•Cash flows from working capital changes: We utilized a projected cash flow impact pertaining to expected changes in working capital as each of our goodwill reporting units grow.

See Note 5 to the consolidated financial statements for more information regarding goodwill.

Intangible Assets

Intangible assets consist of customer relationships, debt issuance costs, trade names, distributor agreements and non-compete agreements. Customer relationships and distributor agreements are amortized using the straight-line method over their estimated useful lives, which range from 5 to 15 years. Debt issuance costs are amortized over the term of the credit facility.

Trade names are amortized over a period ranging from 1 to 2 years. Non-compete agreements are amortized over their contract life. These assets are included in other assets and are shown in detail in Note 5, Goodwill and Other Identifiable Intangible Assets.

49

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

Impairment of Long-Lived Assets

The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset or asset group may not be recoverable. Tests for recoverability of a long-lived asset to be held and used are measured by comparing the carrying amount of the long-lived asset to the sum of the estimated future discounted cash flows expected to be generated by the asset. In estimating the future discounted cash flows we use projections of cash flows directly associated with, and which are expected to arise as a direct result of, the use and eventual disposition of the assets. If it is determined that a long-lived asset is not recoverable, an impairment loss would be calculated equal to the excess of the carrying amount of the long-lived asset over its fair value. The Company did not record any material impairment charges for the fiscal years ended June 30, 2012, 2011 and 2010.

Fair Value of Financial Instruments

The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. The carrying values of financial instruments such as accounts receivable, accounts payable, accrued liabilities, borrowings under the revolving credit facility and subsidiary lines of credit approximate fair value based upon either short maturities or variable interest rates of these instruments. For additional information related to the fair value of derivatives, please see Note 8, Fair Value of Financial Instruments.

Liability for Contingent Consideration

In addition to the initial cash consideration paid to former CDC shareholders, the Company is obligated to make additional earnout payments based on future results through fiscal year 2015 based on a multiple of the subsidiary’s pro forma net income as defined in Exhibit 2.1.(b)(2) of the Share Purchase and Sale Agreement by and among the Company’s Brazilian subsidiary, the former shareholders and CDC, dated April 7, 2011. Future payments are to be paid in Brazilian currency, the real. The Company made its first payment in January 2012 to the former shareholders of $2.0 million. The next payment is anticipated to be made on August 31, 2012 based on the pro forma results of the twelve month period ended June 30, 2012. The remaining earnout payments will become payable in three additional installments on August 31, 2013 and 2014 with the final payment on October 31, 2015. In accordance with ASC Topic 805, the Company determined the fair value of this liability for contingent consideration on the acquisition date using a discounted cash flow model following the income approach. Each period the Company reflects the contingent consideration liability at fair value with changes recorded in the change in fair value of contingent consideration line item in the Consolidated Income Statements.

Contingencies

The Company accrues for contingent obligations, including estimated legal costs, when it is probable that a liability is incurred and the amount is reasonably estimable. As facts concerning contingencies become known, management reassesses its position and makes appropriate adjustments to the financial statements. Estimates that are particularly sensitive to future changes include tax, legal, and other regulatory matters, which are subject to change as events evolve, and as additional information becomes available during the administrative and litigation process.

Revenue Recognition

Revenue is recognized once four criteria are met: (1) the Company must have persuasive evidence that an arrangement exists; (2) delivery must occur (this includes the transfer of both title and risk of loss, provided that no significant obligations remain); (3) the price must be fixed and determinable; and (4) collectability must be reasonably assured. The Company allows its customers to return product for exchange or credit subject to certain limitations. A provision for estimated losses on returns is recorded based on historical experience.

50

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

Service revenue associated with configuration and marketing services is recognized when the work is complete and the four criteria discussed above have been substantially met. The Company also distributes third-party service contracts, typically for product maintenance and support. Since the Company acts as an agent on behalf of most of these service contracts sold, revenue is recognized net of cost at the time of sale. However, the Company distributes some self-branded warranty programs and engages a third party (generally the original equipment manufacturer) to cover the fulfillment of any obligations arising from these contracts. These revenues and associated third party costs are amortized over the life of the contract and presented in net sales and cost of goods sold, respectively. Other service revenue associated with configuration, marketing, service contracts and other services approximates 2% or less of consolidated net sales for fiscal years 2012, 2011 and 2010.

During the fiscal years ended June 30, 2012, 2011 and 2010, the Company has not engaged in any sales transactions involving multiple element arrangements. Had any arrangements with multiple deliverables occurred, the Company would follow the guidance set forth in ASC 605.

Shipping Revenue and Costs

Shipping revenue is included in net sales, and related costs are included in cost of goods sold. Shipping revenue for the years ended June 30, 2012, 2011 and 2010 was $12.2 million, $11.5 million and $10.2 million, respectively.

Advertising Costs

The Company defers advertising-related costs until the advertising is first run in trade or other publications, or in the case of brochures, until the brochures are printed and available for distribution. Advertising costs, included in marketing costs, after vendor reimbursement, were not significant in any of the three fiscal years ended June 30, 2012. Deferred advertising costs at June 30, 2012 and 2011 were also not significant.

Foreign Currency

The currency effects of translating the financial statements of the Company’s foreign entities that operate in their local currency are included in the cumulative currency translation adjustment component of accumulated other comprehensive income or loss. The Company's functional currencies include dollars, euros, British pounds and Brazilian real. The assets and liabilities of these foreign entities are translated into U.S. dollars using the exchange rate at the end of the respective period. Sales, costs and expenses are translated at average exchange rates effective during the respective period. Foreign currency transactional and re-measurement gains and losses are included in other expense (income) in the consolidated income statement. Such amounts are not significant to any of the periods presented.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred income taxes reflect tax consequences on future years of differences between the tax bases of assets and liabilities and their financial reporting amounts. Valuation allowances are provided against deferred tax assets when it is more likely than not that an asset will not be realized in accordance with ASC 740, Accounting for Income Taxes. Federal income taxes are not assessed on the undistributed earnings of foreign subsidiaries because it has been the practice of the Company to reinvest those earnings in the business outside the United States. See Note 11 for further discussion.

Additionally, the Company maintains reserves for uncertain tax provisions in accordance with ASC 740. See Note 11 for more information.

51

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

Share-Based Payments

The Company accounts for share-based compensation using the provisions of ASC 718, Accounting for Stock Compensation, which requires the recognition of the fair value of share-based compensation. Share-based compensation is estimated at the grant date based on the fair value of the awards, in accordance with the provisions of ASC 718. Since this compensation cost is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company has elected to expense grants of awards with graded vesting on a straight-line basis over the requisite service period for each separately vesting portion of the award.

Comprehensive Income

ASC 220, Comprehensive Income, defines comprehensive income as the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The primary components of comprehensive income for the Company include net income, foreign currency translation adjustments arising from the consolidation of the Company’s foreign subsidiaries, and any unrealized gains or losses on effectively hedged transactions, net of tax. Currently, the Company is not engaged in any fair value of cash flow hedges that qualify for comprehensive income treatment.

Business Combinations

The Company accounts for business combinations in accordance with ASC Topic 805, Business Combinations. ASC 805 establishes principles and requirements for recognizing the total consideration transferred to and the assets acquired, liabilities assumed and any non-controlling interest in the acquired target in a business combination. ASC 805 also provides guidance for recognizing and measuring goodwill acquired in a business combination and requires the acquirer to disclose information that users may need to evaluate and understand the financial impact of the business combination. See Note 4 for further discussion.

Recent Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS. The amendments in this update are the result of the work of the FASB and the International Accounting Standards Board (“IASB”) to develop common requirements for measuring fair value and for disclosing information about fair value measurements. The amendment became effective for interim and annual periods beginning after December 15, 2011, which was the interim period ended March 31, 2012 for the Company. This amendment has had no impact on the Company's consolidated financial statements.

In June 2011, the FASB issued ASU 2011-05, Presentation of Comprehensive Income. The objective of this update is to improve the comparability, consistency and transparency of financial reporting and to increase the prominence of items reported in other comprehensive income. The update will become effective for fiscal years, and the interim periods within those years, beginning after December 15, 2011, which will be fiscal 2013 for the Company. The update will eliminate the option to present components of other comprehensive income as part of the statement of changes in stockholders' equity, which is the Company's current practice, and will require companies to present all nonowner changes in stockholders' equity either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The Company is currently determining which method of presentation will be used in future filings.

In September 2011, the FASB issued ASU 2011-08, Testing Goodwill for Impairment. The objective of this update is to simplify how entities, both public and nonpublic, test goodwill for impairment. The amendments in the update permit an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test described in Topic 350. The more likely than not threshold is defined as having a likelihood of more than 50 percent. This amendment is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011, which will be fiscal 2013 for the Company. Early adoption is permitted. The Company is currently assessing the future impact of this ASU on its consolidated financial statements.

52

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

In December 2011, the FASB issued ASU 2011-11, Disclosures about Offsetting Assets and Liabilities. The objective of this update is to converge the differences in U.S. GAAP and IFRS in disclosures regarding offsetting (netting) assets and liabilities in the presentation of financial statements. This amendment will enhance disclosures required by U.S. GAAP by requiring improved information about financial instruments and derivative instruments that are either (1) offset in accordance with either Section 210-20-45 or Section 815-10-45 or (2) subject to an enforceable master netting arrangement or similar agreement. The Company currently does not offset any financial instruments or derivatives and is currently assessing the future impact of this ASU on its consolidated financial statements.

In July 2012, the FASB issued ASU 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment. The objective of this update is to simplify how entities, both public and nonpublic, test indefinite-lived intangible assets other than goodwill. This amendment allows companies to first assess qualitative factors of impairment of all indefinite-lived intangible assets, similar to the provisions in ASU 2011-08. The Company currently does not have any indefinite-lived intangible assets, other than goodwill and is currently assessing the future impact of this ASU on its consolidated financial statements.

(2) Earnings per Share

Basic earnings per share are computed by dividing net income by the weighted-average number of common shares outstanding. Diluted earnings per share are computed by dividing net income by the weighted-average number of common and potential common shares outstanding.

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands, except per share data)
Fiscal Year Ended June 30, 2012:
Net income	$	74,288	$	73,523	$	48,812
Denominator:
Weighted-average shares, basic	27,362		26,872		26,605
Dilutive effect of share-based payments	389		374		264
Weighted-average shares, diluted	27,751		27,246		26,869
Net income per common share, basic	$	2.72	$	2.74	$	1.83
Net income per common share, diluted	$	2.68	$	2.70	$	1.82

For the years ended June 30, 2012, 2011 and 2010, there were 583,000, 947,000 and 1,208,000 weighted average shares, respectively, excluded from the computation of diluted earnings per share because their effect would have been antidilutive.

53

(3) Property and Equipment

Property and equipment is comprised of the following:

	June 30,
	2012			2011
	(in thousands)
Land	$	3,009		$	3,009
Buildings and leasehold improvements	18,231			16,029
Computer software and equipment	13,829			14,270
Furniture, fixtures and equipment	14,739			15,847
Construction in Progress	29,045			18,738
	78,853			67,893
Less accumulated depreciation	(30,068		)	(31,074		)
	$	48,785		$	36,819

During the fiscal year ended June 30, 2012, the increase in gross fixed assets from the prior year is largely related to capital expenditures for a new global ERP system that is currently under development. In addition, the Company acquired fixed assets related to various office renovations and new leasehold improvements.

Depreciation expense was $3.5 million, $3.7 million, and $4.1 million, respectively, for the fiscal years ended 2012, 2011, and 2010.

(4) Acquisitions

Algol Europe,GmbH

On November 30, 2009, the Company acquired substantially all of the assets and certain liabilities of Algol Europe, GmbH (“Algol”). Algol, now a part of ScanSource Communications in the international distribution segment, is a value-added distributor of specialty technologies, including voice, data, and video communication products located in Cologne, Germany. This acquisition significantly expanded the footprint of the ScanSource Communications sales unit outside of the United Kingdom and is part of the Company’s strategy to become a pan-European distributor of communication products. The purchase price of this acquisition was allocated to the assets acquired and the liabilities assumed based on their estimated fair values on the transaction date, resulting in goodwill and identifiable intangible assets related to non-compete agreements, distributor agreements and customer relationships as of November 30, 2009. These amounts were recorded in the international segment. All professional fees and other costs associated with the acquisition of Algol’s assets were expensed as incurred. The purchase price, identified intangibles and goodwill as of the acquisition date were as follows:

	Purchase Price		Goodwill		Identifiable Intangible Assets
	(in thousands)
Algol Europe, GmbH	$	9,965	$	712	$	2,287

CDC Brasil S.A.

On April 15, 2011, the Company completed its acquisition of 100% of the shares of CDC, formerly known as CDC Brasil Distribuidora LTDA, Brazil’s leading distributor of AIDC and POS solutions. This acquisition gives the Company an established presence in Latin America’s largest specialty technology market and allows the Company to more easily scale its Latin American operations.

54

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

Under the Share Purchase and Sale Agreement, the Company structured the purchase transaction as an all cash share purchase with an initial payment of $36.2 million, net of cash acquired, and assumed working capital payables and debt at closing. The remaining purchase price will be paid in annual cash installments based upon the financial performance of CDC for the twelve month periods ended on June 30 from 2011 through 2015. As of June 30, 2012, there are four remaining earnout payments to be made to the former shareholders. Please see Note 8, Fair Value of Financial Instruments for further information regarding the fair value accounting for this contingent consideration.

In fiscal 2012 and 2011, the Company incurred $0.3 million and $1.1 million, respectively, of acquisition-related costs, primarily for professional fees incurred for due diligence, legal advice and tax planning. These costs are included in selling, general and administrative expenses in the Company's consolidated income statement.

During the third quarter of this fiscal year, the Company finalized the purchase accounting for the CDC acquisition. The Company has elected to record all purchase accounting adjustments in the current year as opposed to the retrospective application set forth in ASC 805. Management has determined that retrospective application is immaterial to the users of the Company's financial statements. The adjustments made during the year pertain to the finalization of the purchase price allocation to the fair value of customer relationships, pre-acquisition contingency liabilities and corresponding indemnification assets and deferred income taxes. These adjustments are summarized in the following table:

	As of April 15, 2011
	Preliminary Purchase Allocation			Purchase Accounting Adjustments			Revised Purchase Allocation
Consideration	(in thousands)
Initial cash payment, net of cash acquired	$	36,228		$	—		$	36,228
Fair value of earnout obligation	23,952			—			23,952
Total consideration	60,180			—			60,180
Recognized amounts of identifiable assets acquired and liabilities assumed
Accounts receivable, net of allowance	21,378			—			21,378
Inventories	30,560			—			30,560
Prepaid expenses and other assets	3,575			—			3,575
Current deferred income taxes, net	1,409			(3,225		)	(1,816		)
Property and equipment, net	1,741			—			1,741
Intangible assets	18,327			4,278			22,605
Escrowed pre-acquisition contingencies receivable	16,013			7,977			23,990
Short-term borrowings	(1,277		)	—			(1,277		)
Accounts payable	(34,006		)	—			(34,006		)
Accrued expenses and other liabilities	(3,896		)	—			(3,896		)
Income taxes payable	(2,097		)	1,174			(923		)
Escrowed pre-acquisition contingencies payable	(16,013		)	(7,977		)	(23,990		)
Long-term deferred income taxes, net	—			(3,141		)	(3,141		)
Other long-term liabilities	(177		)	—			(177		)
Total identifiable net assets	35,537			(914		)	34,623
Goodwill	$	24,643		$	914		$	25,557

55

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

All measurement period adjustments are presented as of the acquisition date. The Company used a combination of the market, cost and income approaches to estimate the fair values of the CDC’s assets acquired and liabilities assumed.

The revised purchase price allocated to the fair value of identified intangible assets associated with the acquisition of CDC after the finalization of purchase accounting is as follows:

	Amount
Identified intangible assets	(in thousands)
Trade names (2 year useful life)	$	2,746
Customer relationships (6 year useful life)	18,965
Non-compete agreements (5 year useful life)	894
Total identified intangible assets	$	22,605

In the current year, the Company recorded incremental amortization expense to catch up accumulated amortization for the additional purchase price allocated to customer relationships as of March 31, 2012, when purchase accounting was finalized. The weighted average amortization period for these identified intangible assets after purchase accounting adjustments, other than goodwill, is 5 years. Additionally, the Company adjusted the useful life for CDC customer relationships from 7 years to 6 years. The impact of the incremental amortization and related income tax effect recorded in the third quarter of this fiscal year is summarized in the following table:

	June 30, 2012
	(in thousands)
Consolidated income statement
Amortization expense	$	441
Provision for income taxes	$	(150	)

During the Company's due diligence for the CDC acquisition, several pre-acquisition contingencies were identified regarding various Brazilian federal and state tax exposures. The Company is able to record indemnification receivables that are reported gross of the pre-acquisition contingency liabilities as they were escrowed in the Share Purchase and Sale Agreement. As part of the initial payment, the sellers placed $25.5 million into a special and exclusive bank account to be released according to the specifications of the Share Purchase and Sale Agreement to provide for potential indemnification liabilities. However, indemnity claims can be made up to the entire purchase price, which includes the initial payment and all future earnout payments. During fiscal 2012, the Company and former shareholders released $5.3 million from the escrow account for the settlement of a pre-acquisition contingency and $2.5 million was released to the sellers, leaving $12.9 million, after the impact of foreign currency translation, available for future pre-acquisition contingency settlements or to be released to the sellers. The table below summarizes the balances and line item presentation of these pre-acquisition contingencies and corresponding indemnification receivables in the Company's consolidated balance sheet:

56

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

	June 30, 2012		June 30, 2011		April 15, 2011
	(in thousands)
Assets
Prepaid expenses and other assets (current)	$	3,886	$	—	$	—
Other assets (noncurrent)	$	5,112	$	16,250	$	16,013
Liabilities
Other current liabilities	$	3,886	$	—	$	—
Other long-term liabilities	$	5,112	$	16,250	$	16,013

The change in classification and amounts of the pre-acquisition contingencies is due to the finalization of purchase accounting in the third quarter of the current fiscal year, foreign currency translation on a weaker Brazilian real against the U.S. dollar and the expiration of the statute of limitations for one of the identified pre-acquisition contingencies. The Company finalized its quantitative assessments for various state and federal tax exposures and identified the statute of limitations for these exposures in determining the appropriate classification. The amount of reasonably possible undiscounted pre-acquisition contingencies as of June 30, 2012 is estimated to range as high as $12.4 million at this time, of which all exposures are indemnifiable under the Share Purchase and Sale Agreement.

In fiscal year 2011, CDC contributed net sales of approximately $29.6 million and net income of $0.7 million for the period of April 15, 2011 to June 30, 2011. CDC net income for the period included approximately $0.1 million of acquisition-related costs as well as $0.7 million of incremental amortization expense related to identified intangible assets.

The following unaudited pro forma summary presents consolidated information of the Company as if the business combination had occurred on July 1, 2009, based on the final purchase price allocation as adjusted in fiscal 2012 for the additional purchase price allocated to CDC's customer relationships:

	June 30,
	2011		2010
Unaudited, Supplemental Pro Forma Information	(in thousand, except per share information)
Net sales	$	2,786,905	$	2,247,721
Net income	$	75,328	$	52,450
Diluted earnings per share	$	2.76	$	1.95

These pro forma amounts have been calculated after applying the Company’s accounting policies and adjusting CDC’s results to reflect the additional amortization that would have been recorded assuming the fair value of the identified intangibles had been recorded as of July 1, 2009, adjusted for purchase accounting adjustments made during the measurement period. Also, the pro forma amounts reflect the acquisition-related costs incurred by the Company of approximately $0.3 million and $1.1 million in fiscal years 2012 and 2011, respectively, as if incurred in fiscal year 2010.

(5) Goodwill and Other Identifiable Intangible Assets

In accordance with ASC 350, Intangibles - Goodwill and Other, the Company performs its annual goodwill impairment test at the end of each fiscal year, or whenever indicators of impairment are present. This testing includes the determination of each reporting unit's fair value using a discounted cash flows model compared to each reporting unit's carrying value. The reporting units utilized for goodwill impairment tests are North America segment and, in our International segment, various components that are a level below.

57

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

During fiscal years 2012, 2011 and 2010, no impairment charges related to goodwill were recorded. However, as of the latest annual goodwill impairment test, the estimated fair value of the Company's Brazilian goodwill reporting unit exceeded its carrying value by a smaller margin than the Company's other goodwill reporting units. The Brazilian operations were only recently acquired, resulting in a carrying value that approximates its fair value.

The carrying value of the Brazilian goodwill asset as of June 30, 2012 was $19.8 million. The estimated fair value of the Brazilian goodwill reporting unit exceeded its carrying value by 7% in the most recent annual impairment test. The increase in sensitivity to the Brazilian goodwill reporting unit is driven largely by the general macroeconomic environment and lower expectations for future results in this unit. Key assumptions used in determining fair value include projected growth and operating margin, working capital requirements and discount rates. While the Company does not believe that this goodwill reporting unit is impaired at this time, if the Company is not able to achieve its projected operating margins within the expected working capital requirements and/or there are unfavorable changes to the discount rate, a future impairment of goodwill is at least reasonably possible.

Changes in the carrying amount of goodwill for the years ended June 30, 2012 and 2011, by reporting segment, are as follows:

	North American Distribution Segment		International Distribution Segment			Total
	(in thousands)
Balance as of June 30, 2010	$	20,081	$	13,704		$	33,785
Goodwill acquired during 2011	—		24,643			24,643
Fluctuations in foreign currencies	—		662			662
Balance as of June 30, 2011	20,081		39,009			59,090
CDC measurement period adjustments	—		914			914
Fluctuations in foreign currencies	—		(6,119		)	(6,119		)
Balance as of June 30, 2012	$	20,081	$	33,804		$	53,885

During the fiscal year ended June 30, 2012 , the Company's goodwill balances increased due to the finalization of purchase accounting for CDC from measurement period adjustments. For further information regarding CDC purchase accounting adjustments, please see Note 4, Acquisitions. The remaining change in the goodwill balance is due to foreign currency translation.

During the fiscal year ended June 30, 2011, the Company’s goodwill balances increased due to the acquisition of CDC in April, 2011. The goodwill recognized in conjunction with the CDC acquisition is attributable to the depth and breadth of services that it can provide to Latin America’s largest economy, its vast geographical reach beyond that of other distributors in Brazil and its large, specialty product mix that is atypical for the region. The Company expects all of the goodwill acquired with CDC to be deductible for Brazilian tax purposes.

The following table shows the Company’s identifiable intangible assets as of June 30, 2012 and 2011, respectively. These balances are included on the consolidated balance sheet within other assets:

58

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

	June 30, 2012						June 30, 2011
	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
	(in thousands)
Amortized intangible assets:
Customer relationships	$	34,483	$	10,864	$	23,619	$	34,515	$	6,989	$	27,526
Debt issue costs	2,499		967		1,532		1,139		625		514
Trade names	2,127		1,285		842		2,743		286		2,457
Non-compete agreements	938		379		559		2,310		1,085		1,225
Distributor agreements	610		105		505		705		74		631
Total	$	40,657	$	13,600	$	27,057	$	41,412	$	9,059	$	32,353

59

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

In fiscal 2012, the Company incurred 1.4 million in debt issuance costs related to the negotiation and execution of the new credit facility (see note 6). In addition, during the re-measurement period for the valuation of CDC Brasil, the Company determined that the economic life for customer relationships should be reduced from 7 years to 6 years. The Company cumulatively adjusted all amortization so that the asset reflects the accumulated amortization of a 6 year life from the date of purchase in the first quarter of fiscal 2012. Upon receipt of the final valuation of identifiable intangible assets, the value of CDC's customer relationships were increased by $4.3 million in the third quarter of fiscal 2012. Amortization expense was cumulatively adjusted to reflect the appropriate balances. For further information regarding CDC purchase accounting adjustments, please see Note 4, Acquisitions.

In fiscal 2012, the Company wrote off the gross carrying amount and corresponding accumulated amortization for fully amortized non-compete agreements in the amount of $0.9 million. In fiscal 2011, the Company wrote off the gross carrying amount and corresponding accumulated amortization for fully amortized customer lists, non-compete agreements and trade names in the amounts of $0.3 million, $1.8 million and $1.0 million, respectively.

The weighted average amortization period for all intangible assets for the years ended June 30, 2012, 2011 and 2010 was approximately 10 years, 10 years, and 12 years, respectively. Amortization expense for the years ended June 30, 2012, 2011 and 2010 was $6.4 million, $3.0 million and $2.0 million, respectively. Estimated future amortization expense is as follows:

	Amortization Expense
	(in thousands)
Year Ended June 30,
2013	$	5,217
2014	4,342
2015	4,341
2016	4,312
2017	3,437
Thereafter	5,408
Total	$	27,057

(6)Short-Term Borrowings and Long-Term Debt

Short-Term Borrowings

A subsidiary of the Company has a €6.0 million line of credit, which is secured by the assets of our European operations and is guaranteed by ScanSource, Inc. The subsidiary line of credit bears interest at the 30-day Euro Interbank Offered Rate (“EURIBOR”) plus a spread ranging from 1.25% to 2.00% per annum. The spread in effect as of June 30, 2012 was 1.25%. Additionally, the Company is assessed commitment fees ranging from 0.10% to 0.275% on non-utilized borrowing availability if outstanding balances are below €3.0 million. The interest rate and commitment fee spreads are based on the Company's Leverage Ratio for its revolving credit facility, as defined below. The outstanding balances at June 30, 2012 and 2011 are as follows:

	June 30, 2012		June 30, 2011
	(in thousands)
Short-term borrowings	$	4,268	$	3,164

60

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

Revolving Credit Facility

On October 11, 2011, the Company amended and restated its $250 million multi-currency revolving credit facility with a syndicate of banks that was scheduled to mature on September 28, 2012. The Company entered into a five-year, $300 million multi-currency senior secured revolving credit facility pursuant to the terms of an Amended and Restated Credit Agreement (the “New Credit Agreement”) with JPMorgan Chase Bank, N.A., as administrative agent and a syndicate of lenders named therein. The New Credit Agreement allows for the issuance of up to $50 million for letters of credit and has a $150 million accordion feature that allows the Company to increase the availability to $450 million subject to obtaining commitments for the incremental capacity from existing or new lenders. The Company incurred $1.4 million in debt issuance costs that were capitalized to other assets, including identifiable intangible assets, on the consolidated balance sheet and are being amortized on a straight-line basis through October 11, 2016, the maturity date of the New Credit Agreement.

At the Company's option, loans denominated in U.S. dollars under the New Credit Agreement, other than swingline loans, bear interest at a rate equal to a spread over the London Interbank Offered Rate (“LIBOR”) or prime rate depending upon the Company's ratio of total debt (excluding accounts payable and accrued liabilities), measured as of the end of the most recent quarter, to adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the most recently completed four quarters (the “Leverage Ratio”). The Leverage Ratio calculation excludes the Company's subsidiary in Brazil. This spread ranges from 1.00% to 2.25% for LIBOR-based loans and 0.00% to 1.25% for prime rate-based loans. The spread in effect as of June 30, 2012 was 1.00% for LIBOR-based loans and 0.00% for prime rate-based loans. Additionally, the Company is assessed commitment fees ranging from 0.175% to 0.40%, depending upon the Leverage Ratio, on non-utilized borrowing availability, excluding swingline loans. Borrowings under the New Credit Agreement are guaranteed by substantially all of the domestic assets of the Company as well as certain foreign subsidiaries determined to be material under the New Credit Agreement and a pledge of up to 65% of capital stock or other equity interest in each Guarantor as defined in the New Credit Agreement. The Company was in compliance with all covenants under the credit facility as of June 30, 2012. The outstanding balances at June 30, 2012 and June 30, 2011 are as follows:

	June 30, 2012		June 30, 2011
	(in thousands)
Revolving credit facility	$	—	$	26,513

Throughout the year ended June 30, 2012, the Company borrowed $1,408.5 million on the revolving credit facility. The Company repaid $1,433.2 million in addition to the $1.4 million paid for debt issuance costs previously described. The average daily balance on the revolving credit facility was $78.6 million for the year ended June 30, 2012. There was $300.0 million available for additional borrowings as of June 30, 2012, and there were no letters of credit issued.

For the year ended June 30, 2011, the Company borrowed $769.5 million on the revolving credit facility. The Company repaid $743.9 million. The average daily balance on the revolving credit facility was $14.2 million for the year ended June 30, 2011. There was $223.5 million available for additional borrowings as of June 30, 2011, and there were no letters of credit issued.

Long-Term Debt

On January 2, 2008, the Company entered into a $25.0 million promissory note with a third party lender. This note payable accrued interest on the unpaid balance at a rate per annum equal to the 30-day LIBOR plus 0.65% and was scheduled to mature on September 28, 2012. On October 11, 2011, the note was fully repaid using funds obtained through the New Credit Agreement.

61

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

On August 1, 2007, the Company entered into an agreement with the State of Mississippi in order to provide financing for the acquisition and installation of certain equipment to be utilized at the Company’s current Southaven, Mississippi distribution facility, through the issuance of an industrial development revenue bond. The bond matures on September 1, 2032 and accrues interest at the 30-day LIBOR rate plus a spread of 0.85%. The terms of the bond allow for payment of interest only for the first 10 years of the agreement, and then, starting on September 1, 2018 through 2032, principal and interest payments are due until the maturity date or the redemption of the bond. As of June 30, 2012, the Company was in compliance with all covenants under this bond.

The balances on the bond and promissory note as of June 30, 2012 and 2011 are as follows:

	June 30, 2012		June 30, 2011
	(in thousands)
Industrial Development Revenue Bond, monthly payments of interest only, 1.09% variable interest rate at June 30, 2012 and maturing on September 1, 2032	$	5,429	$	5,429
Unsecured note payable to a bank, monthly payments of interest only and maturing in fiscal 2013	—		25,000
	5,429		30,429
Less current portion	—		—
Long-term portion	$	5,429	$	30,429

The book value of debt listed above is considered to approximate fair value, as our debt instruments are indexed to LIBOR or the prime rate using the market approach.

Scheduled maturities of the Company’s revolving credit facility and long-term debt at June 30, 2012 are as follows:

	Future Debt Payments
	(in thousands)
Fiscal year:
2013	$	—
2014	—
2015	—
2016	—
2017	—
Thereafter	5,429
Total principal payments	$	5,429

(7) Derivatives and Hedging Activities

The Company’s results of operations could be materially impacted by significant changes in foreign currency exchange rates and interest rates. These risks and the management of these risks are discussed in greater detail below. In an effort to manage the exposure to these risks, the Company periodically enters into various derivative instruments. The Company’s accounting policies for these instruments are based on whether the instruments are designated as hedge or non-hedge instruments in accordance with U.S. GAAP. The Company records all derivatives on the balance sheet at fair value. Derivatives that are not designated as hedging instruments or the ineffective portions of cash flow hedges are adjusted to fair value through earnings in other income and expense.

62

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

Foreign Currency – The Company conducts a portion of its business internationally in a variety of foreign currencies. The exposure to market risk for changes in foreign currency exchange rates arises from foreign currency denominated assets and liabilities, and transactions arising from non-functional currency financing or trading activities. The Company’s objective is to preserve the economic value of non-functional currency denominated cash flows. The Company attempts to hedge transaction exposures with natural offsets to the fullest extent possible and, once these opportunities have been exhausted, through forward contracts or other hedging instruments with third parties. These contracts will periodically hedge the exchange of various currencies, including the U.S. dollar, euro, British pound, Canadian dollar, Mexican peso and Brazilian real. While the Company utilizes foreign exchange contracts to hedge foreign currency exposure, the Company's foreign exchange policy prohibits the use of financial instruments for speculative purposes.

At June 30, 2012, the Company had contracts outstanding with notional amounts of $62.3 million to exchange foreign currencies. To date, the Company has chosen not to designate these derivatives as hedging instruments, and accordingly, these instruments are adjusted to fair value through earnings in other income and expense. Summarized financial information related to these derivative contracts and changes in the underlying value of the foreign currency exposures are as follows:

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
Net foreign exchange derivative contract gain (loss)	$	(1,480	)	$	(2,706	)	$	(1,065	)
Net foreign currency transactional and re-measurement gain (loss)	$	(2,286	)	$	1,741		$	826
Net foreign currency gain (loss)	$	(3,766	)	$	(965	)	$	(239	)

Net foreign exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign currency exchange contract gains and losses. Foreign exchange losses and gains are generated as the result of fluctuations in the value of the British pound versus the euro, the U.S. dollar versus the euro, U.S. dollar versus the Brazilian real and other currencies versus the U.S. dollar.

In fiscal year 2012, the majority of losses were associated with exposures between the U.S. dollar and Brazilian real. In September 2011, the Company incurred a $2.5 million non-recurring loss in conjunction with an unfavorable forward exchange contract to purchase Brazilian reais. In mid-August, the Company decided to pre-fund a portion of the estimated earnout payments associated with the CDC acquisition. This contract was designed to preserve the currency exchange for the few weeks required to transfer the cash to Brazil. From the time the Company entered into the contract through settlement, the Brazilian real devalued from the contractual rate by 11.8%, ultimately resulting in a $2.5 million loss. Further contributing to the fiscal year 2012 foreign exchange loss, the Brazilian business incurred significant losses on U.S. dollar denominated exposures in the first quarter that were not hedged at the time. Subsequently, the Company has been including these exposures in its daily hedging activities.

Interest Rates – The Company’s earnings are also affected by changes in interest rates due to the impact those changes have on interest expense from floating rate debt instruments. To manage the exposure to interest rates, the Company may enter into interest rate swap agreements. In January 2008, the Company entered into an interest rate swap agreement to hedge the variability in future cash flows of interest payments related to the $25.0 million promissory note payable discussed in Note 6. Interest rate differentials paid or received under the swap agreement are recognized as adjustments to interest expense. To the extent the swap is effective in offsetting the variability of the hedged cash flows, changes in the fair value of the swap are not included in current earnings but are reported as other comprehensive income (loss). The swap expired on September 28, 2011. From the inception of the swap through expiration, there was no ineffectiveness associated with the instrument. Currently, there are no other swap agreements outstanding.

63

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

During fiscal years 2012 and 2011, the Company's sole cash flow hedge pertained to the interest rate swap discussed above. The components of the cash flow hedge included in accumulated other comprehensive income (loss), net of income taxes, in the consolidated statements of shareholders’ equity, are as follows:

	Fiscal Year Ended June 30,
	2012			2011
	(in thousands)
Net interest expense recognized as a result of interest rate swap	$	216		$	859
Unrealized gain (loss) in fair value of interest swap rates	(1		)	(119		)
Net increase (decrease) in accumulated other comprehensive income (loss)	$	215		$	740
Income tax effect	(76		)	(272		)
Net increase (decrease) in accumulated other comprehensive income (loss), net of tax	$	139		$	468

The Company has the following derivative instruments located on the Consolidated Balance Sheets and Income Statements, utilized for the risk management purposes detailed above:

	As of June 30, 2012
	Fair Value of  Derivatives Designated as Hedge Instruments		Fair Value of  Derivatives Not Designated as Hedge Instruments
	(in thousands)
Derivative assets:(a)
Foreign exchange contracts	$	—	$	21
Derivative liabilities:(b)
Foreign exchange contracts	$	—	$	110

(a) All derivative assets are recorded as prepaid expense and other assets in the Consolidated Balance Sheets.

(b) All derivative liabilities are recorded as accrued expenses and other liabilities in the Consolidated Balance Sheets.

(8) Fair Value of Financial Instruments

Accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, the Company is required to classify certain assets and liabilities based on the fair value hierarchy, which groups fair value-measured assets and liabilities based upon the following levels of inputs:

• Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

• Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability;

• Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

64

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

The assets and liabilities maintained by the Company that are required to be measured at fair value on a recurring basis include the Company's various debt instruments, deferred compensation plan investments, outstanding foreign exchange forward contracts and contingent consideration owed to the previous owners of CDC. The carrying value of debt listed in Note 6 is considered to approximate fair value, as the Company's debt instruments are indexed to LIBOR or the prime rate using the market approach (Level 2 criteria). The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2012:

	Total		Quoted prices  in active markets (Level  1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
	(in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion	$	11,635	$	11,635	$	—	$	—
Forward foreign currency exchange contracts	21		—		21		—
Total assets at fair value	$	11,656	$	11,635	$	21	$	—
Liabilities:
Deferred compensation plan investments, current and non-current portion	$	11,635	$	11,635	$	—	$	—
Forward foreign currency exchange contracts	110		—		110		$	—
Liability for contingent consideration, current and non-current	16,653		—		—		16,653
Total liabilities at fair value	$	28,398	$	11,635	$	110	$	16,653

65

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2011:

	Total		Quoted prices  in active markets (Level  1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
	(in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion	$	12,926	$	12,926	$	—	$	—
Forward foreign currency exchange contracts	165		—		165		—
Total assets at fair value	$	13,091	$	12,926	$	165	$	—
Liabilities:
Deferred compensation plan investments, current and non-current portion	$	12,926	$	12,926	$	—	$	—
Forward foreign currency exchange contracts	236		—		236		—
Interest rate swap	215		—		215		—
Liability for contingent consideration, current and non-current	23,794		—		—		23,794
Total liabilities at fair value	$	37,171	$	12,926	$	451	$	23,794

The investments in the deferred compensation plan are held in a rabbi trust and include mutual funds and cash equivalents for payment of non-qualified benefits for certain retired, terminated or active employees. These investments are recorded to prepaid and other assets (current) or other assets (non-current) depending on their corresponding, anticipated distributions to recipients, which are reported in accrued expenses and other liabilities (current) or other long-term liabilities (non-current), respectively.

Foreign currency forward contracts are measured using the market approach on a recurring basis considering foreign currency spot rates and forward rates quoted by banks or foreign currency dealers (Level 2). See Note 7, “Derivatives and Hedging Activities.” Foreign currency contracts are classified in the consolidated balance sheet in prepaid expenses and other assets or accrued expenses and other liabilities, depending on the respective contracts' favorable or unfavorable positions.

The Company recorded a contingent consideration liability at the acquisition date of CDC representing the amounts payable to former CDC shareholders, as outlined under the terms of the Share Purchase and Sale Agreement, based upon the achievement of projected earnings, net of specific pro forma adjustments. The current and non-current portions of this obligation are reported separately on the condensed consolidated balance sheet. The fair value of contingent consideration (Level 3) is determined using a discounted cash flow model. Subsequent changes in the fair value of the contingent consideration liability are recorded to the change in fair value of contingent consideration line item in the consolidated income statement. Fluctuations due to foreign currency translation are captured in other comprehensive income through the changes in foreign currency translation adjustments line item as seen in Note 14, "Accumulated Other Comprehensive Income."

The table below provides a summary of the changes in fair value of the Company’s only financial asset or liability, the contingent consideration for the CDC earnout that is measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the year ended June 30, 2012 and 2011:

66

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

	Contingent Consideration for the Year Ended  June 30, 2012			Contingent Consideration for the Year Ended  June 30, 2011
	(in thousands)
Fair value at beginning of period	$	23,794		$	—
Issuance of contingent consideration	—			23,952
Payments	(2,000		)	—
Change in fair value	120			(128		)
Fluctuation due to foreign currency exchange	(5,261		)	(30		)
Fair value at end of period	$	16,653		$	23,794

The fair value of the liability for the contingent consideration recognized at June 30, 2012 was $16.7 million, of which $5.0 million is classified as current. As of June 30, 2011, the fair value of the contingent consideration was $23.8 million, of which $2.4 million was classified as current. The fair values of amounts owed are recorded in “current portion of contingent consideration” and “long-term portion of contingent consideration” in the Company's consolidated balance sheet. The U.S. dollar amounts of actual disbursements made in conjunction with future earnout payments are subject to change as the liability is denominated in Brazilian reais and subject to foreign exchange fluctuation risk. Also, in accordance with ASC 805, the Company will revalue the contingent consideration liability at each reporting date through the last payment, with changes in the fair value of the contingent consideration reflected in the “change in fair value of contingent consideration” line item on the Company's consolidated income statement that is included in the calculation of operating income. The fair value of the contingent consideration liability associated with future earnout payments is based on several factors, including:

• estimated future results, net of pro forma adjustments set forth in the Share Purchase and Sale Agreement;

• the probability of achieving these results; and

• a discount rate reflective of the Company's creditworthiness and market risk premium associated with the Brazilian market.

A change in any of these unobservable inputs can significantly change the fair value of the contingent consideration. The change in fair value of the contingent consideration recognized in the consolidated income statement contributed a loss of $0.1 million for the year ended June 30, 2012. Generally, the change in fair value of the contingent consideration will generate a loss as the earnout period lapses. In the current fiscal year, the loss was partially offset by a change in the estimated future results from a weaker Brazilian economic outlook from the time of acquisition. In addition, volatility in the foreign exchange between the Brazilian real and the U.S. dollar has driven significant changes in the translation of the real-denominated liability. Although there is no contractual limit, total future undiscounted contingent consideration payments are estimated to be $24.0 million, based on the Company's best estimate as the earnout is based on a multiple of adjusted earnings.

67

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

(9) Share-Based Compensation

Share-Based Compensation Plans

The Company has awards outstanding from four share-based compensation plans (the 1993 Incentive Stock Option Plan, the 1997 Stock Incentive Plan, the 2002 Long-Term Incentive Plan, and the 2003 Director Plan), two of which (the 2002 Long-Term Incentive Plan and the 2003 Director Plan) are available for future grants. As of June 30, 2012, there were 1,888,923 and 88,100 shares available for future grant under the 2002 Long-Term Incentive Plan and the 2003 Director Plan, respectively. All of the Company’s share-based compensation plans are shareholder approved, and it is the Company’s belief that such awards better align the interests of its employees and directors with those of its shareholders. Under the plans, the Company is authorized to award officers, employees, consultants and non-employee members of the Board of Directors various share-based payment awards, including options to purchase common stock and restricted stock. Restricted stock can be in the form of a restricted stock award (“RSA”) or a restricted stock unit (“RSU”). An RSA is common stock that is subject to risk of forfeiture or other restrictions that lapse upon satisfaction of specified conditions. An RSU represents the right to receive shares of common stock in the future with the right to future delivery of the shares subject to risk of forfeiture or other restrictions that lapse upon satisfaction of specified conditions.

The Company accounts for its share-based compensation awards in accordance with ASC 718 – Stock Compensation, which requires all share-based compensation to be recognized in the income statement based on fair value and applies to all awards granted, modified, canceled, or repurchased after the effective date. Total share-based compensation included as a component of selling, general, and administrative expense in our Consolidated Income Statements was as follows:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Share-based compensation related to:
Equity classified stock options	$	2,875	$	3,106	$	4,698
Equity classified restricted stock	3,965		1,771		1,367
Total share-based compensation	$	6,840	$	4,877	$	6,065

Stock Options

During the fiscal year ended June 30, 2012, the Company granted 85,578 stock options to certain employees. These options vest annually over 3 years and have a 10-year contractual life. In accordance with the requirements of the Company’s Equity Award Grant Policy, the options issued during the fiscal year were granted with an exercise price that is no less than 100% of the fair market value of those shares on the date of the grant.

The fair value of each option (for purposes of calculation of share-based compensation) was estimated on the date of grant using the Black-Scholes-Merton option pricing formula that uses assumptions determined at the date of grant. Use of this option pricing model requires the input of subjective assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before exercising them (“expected term”), the estimated volatility of our common stock price over the expected term (“expected volatility”) and the number of options that will ultimately not complete their vesting requirements (“forfeitures”). Changes in the subjective assumptions can materially affect the estimate of the fair value of share-based compensation and, consequently, the related amount recognized in the Consolidated Income Statements.

68

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

The Company used the following weighted average assumptions for the options granted during the following fiscal years:

	Fiscal Year Ended June 30,
	2012			2011			2010
Expected term	6.77 years			6.88 years			6.82 years
Expected volatility	41.33		%	42.92		%	46.27		%
Risk-free interest rate	1.42		%	2.56		%	2.89		%
Dividend yield	0.00		%	0.00		%	0.00		%
Weighted average fair value per option	$	14.94		$	17.21		$	12.43

The weighted average expected term of the options represents the period of time the options are expected to be outstanding based on historical trends and behaviors of certain groups and individuals receiving these awards. The expected volatility is predominately based on the historical volatility of our common stock for a period approximating the expected life. The risk-free interest rate reflects the interest rate at grant date on zero-coupon U.S. governmental bonds that have a remaining life similar to the expected option term. The dividend yield assumption was based on our dividend payment history and expectations of future dividend payments.

A summary of our stock option plans is presented below:

	Fiscal Year Ended June 30, 2012
	Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life	Aggregate Intrinsic Value
Outstanding, beginning of year	1,969,477		$	27.47
Granted during the period	85,578		34.23
Exercised during the period	(415,959	)	21.67
Canceled, forfeited, or expired during the period	(9,137	)	34.42
Outstanding, end of year	1,629,959		29.27		5.67	$	5,970,110
Vested and expected to vest at June 30, 2012	1,629,870		29.27		5.67	$	5,970,070
Exercisable, end of year	1,385,371		$	28.60	5.12	$	5,652,620

The aggregate intrinsic value was calculated using the market price of our stock on June 30, 2012 and the exercise price for only those options that have an exercise price that is less than the market price of our stock. This amount will change as the market price per share changes. The aggregate intrinsic value of options exercised during the fiscal years ended June 30, 2012, 2011, and 2010 was $5.8 million, $5.2 million, and $1.6 million, respectively.

69

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

A summary of the status of the Company’s shares subject to unvested options is presented below:

	Fiscal Year Ended June 30, 2012
	Options		Weighted      Average Exercise Price		Weighted Average Grant     Date Fair-     Value
Unvested, beginning of year	445,010		$	26.29	$	12.25
Granted	85,578		34.23		14.94
Vested	(280,703	)	22.71		10.28
Canceled or forfeited	(5,297	)	33.30		10.42
Unvested, end of year	244,588		$	33.02	$	15.49

As of June 30, 2012, there was approximately $2.3 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the plans in the form of stock options. This cost is expected to be recognized over a weighted-average period of 1.09 years. The total fair value of options vested during the fiscal years ended June 30, 2012, 2011, and 2010 is $2.9 million, $3.5 million and $4.3 million, respectively. The following table summarizes information about stock options outstanding and exercisable as of June 30, 2012:

	Options Outstanding				Options Exercisable
Range of Exercise Prices	Shares   Outstanding	Weighted Average Remaining   Contractual   Life	Weighted     Average Exercise Price		Number   Exercisable	Weighted     Average Exercise Price
$11.01 - $14.68	20,602	0.51	$	13.67	20,602	$	13.67
$14.68 - $18.35	314,396	6.20	18.12		314,396	18.12
$18.35 - $22.01	18,800	1.43	21.58		18,800	21.58
$22.01 - $25.68	189,725	6.41	24.55		137,915	24.56
$25.68 - $29.35	81,500	3.52	27.48		81,500	27.48
$29.35 - $33.02	364,120	4.62	31.46		359,120	31.45
$33.02 - $36.69	640,816	6.34	35.84		453,038	36.03
	1,629,959	5.67	$	29.27	1,385,371	$	28.60

The Company issues shares to satisfy the exercise of options.

Restricted Stock

Grants of Restricted Shares

During the fiscal year ended June 30, 2012, the Company elected to grant 173,246 shares of restricted stock to employees and non-employee directors, of which 159,746 of these shares were issued in the form of RSUs:

70

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

	Fiscal Year Ended June 30, 2012
	Shares granted	Date granted	Grant date fair value		Vesting period
Employees
Certain employees based on promotions	5,000	January 31, 2012	$	37.56	Annually over 3 years
Certain employees based on promotions	4,500	May 1, 2012	32.61		Annually over 3 years
Certain employees	1,000	June 18, 2012	31.33		Annually over 3 years
Certain employees	1,500	November 1, 2012	32.94		Annually over 3 years
Certain employees	147,683	December 2, 2011	34.35		Annually over 3 years
Executive officers, vesting based on certain service and performance conditions	1,563	May 14, 2012	32.01		Annually over 2 years
Non-Employee Directors(1)	12,000	December 2, 2011	$	34.35	6 months

(1) Per the Amended and Restated Director’s Equity Compensation Plan, non-employee directors will receive annual awards of restricted stock, as opposed to stock options. The number of shares of restricted stock to be granted will be established from time to time by the Board of Directors. Currently, the number of shares of restricted stock awarded to each non-employee director will be determined by dividing $80,000 by the fair market value of the common stock on the date of grant. These awards will generally vest in full on the day that is six months after the date of grant or upon the earlier occurrence of (i) the director’s termination of service as a director by reason of death, disability or retirement, or (ii) a change in control by the Company. The compensation expense associated with these awards will be recognized on a pro-rata basis over this period.

A summary of the status of the Company’s outstanding restricted stock is presented below:

	Fiscal Year Ended June 30, 2012
	Shares		Weighted Average Grant Date Fair Value
Outstanding, beginning of year	241,085		$	29.15
Granted during the period	173,246		34.34
Vested during the period	(122,071	)	28.12
Cancelled, forfeited, or expired during the period	(25,002	)	32.00
Outstanding, end of year	267,258		$	32.43

As of June 30, 2012, there was approximately $6.4 million of unrecognized compensation cost related to unvested restricted stock awards granted, which is expected to be recognized over a weighted average period of 1.88 years. The Company withheld 43,122 shares for income taxes during the fiscal year ended June 30, 2012.

(10) Employee Benefit Plans

The Company has a defined contribution plan under Section 401(k) of the Internal Revenue Code of 1986, as amended that covers all employees located in the United States meeting certain eligibility requirements. The Company provided a matching contribution for each period which was equal to one-half of each participant’s contribution, up to a maximum matching contribution per participant of $800. The Company determines its matching contributions annually and can make discretionary contributions in addition to matching contributions. Employer contributions are vested based upon tenure over a five-year period.

71

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Matching contributions	$	473	$	419	$	395
Discretionary contributions	5,066		5,952		3,200
Total contributions	$	5,539	$	6,371	$	3,595

Internationally, the Company contributes to either plans required by local governments or to various employee annuity plans. Additionally, the Company maintains a non-qualified, unfunded, deferred compensation plan that allows eligible executives to defer a portion of their compensation in addition to receiving discretionary matching contributions from the Company. Employer contributions are vested over a five-year period.

In fiscal 2011, the Company made a $2.4 million contribution to the Founder’s SERP for the Company’s founder and former Chief Executive Officer who retired in March 2011. The SERP investments are included within the deferred compensation plan investments referenced in Note 8, Fair Value of Financial Instruments.

(11) Income Taxes

Income tax expense (benefit) consists of:

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
Current:
Federal	$	37,736		$	34,782		$	27,749
State	1,376			248			1,104
Foreign	3,703			5,008			2,922
Total current	42,815			40,038			31,775
Deferred:
Federal	(830		)	(168		)	(4,410		)
State	(44		)	(9		)	(323		)
Foreign	(5,018		)	(1,498		)	(113		)
Total deferred	(5,892		)	(1,675		)	(4,846		)
Provision for income taxes	$	36,923		$	38,363		$	26,929

A reconciliation of the U.S. Federal income tax expense at a statutory rate of 35% to actual income tax expense, excluding any other taxes related to extraordinary gain is as follows:

72

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
U.S. Federal income tax at statutory rate	$	38,924		$	39,160		$	26,509
Increase (decrease) in income taxes due to:
State and local income taxes, net of Federal benefit	1,026			625			935
Tax credits	(1,122		)	(312		)	(633		)
Valuation allowance	24			(195		)	(128		)
Effect of foreign operations, net	(2,309		)	(2,054		)	(1,342		)
Stock compensation	86			239			580
Other	294			900			1,008
Provision for income taxes	$	36,923		$	38,363		$	26,929

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are presented below:

	June 30,
	2012			2011
	(in thousands)
Deferred tax assets derived from:
Allowance for accounts receivable	$	6,456		$	2,857
Inventories	7,336			11,310
Nondeductible accrued expenses	512			2,204
Net operating loss carryforwards	2,931			452
Tax credits	583			241
Deferred compensation	4,331			4,822
Stock compensation	5,631			2,868
Timing of depreciation and other deductions for building and equipment	98			—
Total deferred tax assets	27,878			24,754
Valuation allowance	(541		)	(517		)
Total deferred tax assets	27,337			24,237
Deferred tax liabilities derived from:
Timing of amortization deduction from intangible assets	(5,840		)	(2,717		)
Timing of depreciation and other deductions for building and equipment	—			(238		)
Total deferred tax liabilities	(5,840		)	(2,955		)
Net deferred tax assets	$	21,497		$	21,282

73

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

The components of pretax earnings are as follows:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Domestic	$	103,711	$	96,436	$	65,566
Foreign	7,500		15,450		10,175
Worldwide pretax earnings	$	111,211	$	111,886	$	75,741

At June 30, 2012, the Company has (i) gross net operating loss carry forwards of approximately $0.1 million for U.S. Federal income tax purposes that will begin to expire in 2020; (ii) gross net operating loss carry forwards of approximately $0.9 million for state income tax purposes; (iii) foreign gross net operating loss carry forwards of approximately $8.5 million; (iv) state income tax credit carry forwards of approximately $0.2 million that will begin to expire in 2025; and (v) withholding tax credits of approximately $0.5 million. As of June 30, 2012, the Company reversed $0.4 million of the valuation reserve against foreign net operating loss carry-forwards and established a full valuation reserve of $0.5 million against the withholding tax credits. The Company maintains a $0.1 million valuation allowance for state net operating losses where it was determined that, in accordance with ASC 740, it is more likely than not that they cannot be utilized.

The Company has not provided U.S. income taxes for undistributed earnings of foreign subsidiaries that are considered to be retained indefinitely for reinvestment. The distribution of these earnings would result in additional foreign withholding taxes and additional U.S. federal income taxes to the extent they are not offset by foreign tax credits. It has been the practice of the Company to reinvest those earnings in the business outside the United States. These undistributed earnings amounted to approximately $56.3 million at June 30, 2012. If these earnings were remitted to the U.S. they would be subject to income tax. The tax, after foreign tax credits, is estimated to be approximately $10.0 million.

As of June 30, 2012, the Company had gross unrecognized tax benefits of $1.3 million, $0.8 million of which, if recognized, would affect the effective tax rate. This reflects an increase of $0.1 million on a net basis over the prior fiscal year. The Company does not expect that the total amounts of unrecognized tax benefits will significantly increase or decrease within the next twelve months. The prior year balances have been adjusted to remove interest and penalties that were included in prior period reporting. The total amount of interest and penalties accrued, but excluded from the table below for the years ending 2012, 2011 and 2010 were $1.0 million, $0.9 million and $1.0 million, respectively. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

	2012			2011			2010
	(in thousands)
Beginning Balance	$	1,181		$	1,279		$	1,359
Additions based on tax positions related to the current year	163			173			133
Additions for tax positions of prior years	—			—			—
Reduction for tax positions of prior years	(87		)	(271		)	(213		)
Settlements	—			—			—
Ending Balance	$	1,257		$	1,181		$	1,279

The Company conducts business globally and, as a result, one or more of its subsidiaries files income tax returns in the U.S. federal, various state, local and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities in countries in which it operates. With few exceptions, the Company is no longer subject to state and local, or non-U.S. income tax examinations by tax authorities for the years before 2008.

74

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

The Company’s continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. As of June 30, 2012, the Company had approximately $1.0 million accrued for interest and penalties, of which $0.1 million was a current period expense.

The Company's effective tax rate differs from the federal statutory rate of 35% primarily as a result the mix of income in lower tax rate jurisdictions and state taxes.

(12) Commitments and Contingencies

Leases

The Company leases office and warehouse space under non-cancelable operating leases that expire through November 2020. Lease expense and future minimum lease payments under operating leases are as follows:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Lease expense	$	5,025	$	4,989	$	4,430

	Payments
	(in thousands)
Fiscal Year Ended June 30,
2013	$	4,671
2014	3,999
2015	3,295
2016	3,125
2017	2,605
Thereafter	2,018
Total future minimum lease payments	$	19,713

On April 27, 2007, the Company entered into an agreement to lease approximately 600,000 square feet for distribution, warehousing and storage purposes in a building located in Southaven, Mississippi. The lease also provides for a right of first refusal on an additional 147,000 square feet of expansion space. The term of the lease is 120 months with 2 consecutive 5-year extension options.

Commitments and Contingencies

A majority of the Company’s net revenues in 2012, 2011 and 2010 were received from the sale of products purchased from the Company’s ten largest vendors. The Company has entered into written distribution agreements with substantially all of its major vendors. While the Company’s agreements with most of its vendors contain standard provisions for periodic renewals, these agreements generally permit termination by either party without cause upon 30 to 120 days notice.

The Company or its subsidiaries are, from time to time, parties to lawsuits arising out of operations. Although there can be no assurance, based upon information known to the Company, the Company believes that any liability resulting from an adverse determination of such lawsuits would not have a material adverse effect on the Company’s financial condition or results of operations.

75

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

The Company is in the process of designing and developing a new ERP system. The Company has spent approximately $33.5 million on the project from inception through June 30, 2012. Of the total amount spent, $26.8 million has been in the form of capital expenditures. The Company received a project assessment from a third party service provider, which indicates that the project will take longer to implement and exceed previously disclosed cost estimates, which at the high end was $38.5 million. The Company has revised its projections for the project and believes the total spend could range from $58 million to $72 million and will extend past fiscal year 2013. Capital expenditures for fiscal 2013 could range from $9 million to $15 million for a total capital expenditure of up to $42 million.

(13) Segment Information

The Company is a leading distributor of specialty technology products, providing value-added distribution sales to resellers in the specialty technology markets. The Company has two reporting segments, based on geographic location.

North American Distribution

The North American distribution segment offers products for sale in four primary categories: (i) AIDC and POS equipment sold by the ScanSource POS and Barcoding sales unit, (ii) voice, data and converged communications equipment sold by the Catalyst Telecom sales unit, (iii) video conferencing, telephony, and communications products sold by the ScanSource Communications unit, and (iv) electronic security products and wireless infrastructure products sold by the ScanSource Security sales unit. These products are sold to more than 14,500 resellers and integrators of technology products that are geographically dispersed over the United States and Canada in a pattern that mirrors population concentration. No single account represented more than 6% of the Company’s consolidated net sales for the fiscal years ended June 30, 2012, 2011, and 2010, respectively.

76

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

International Distribution

The international distribution segment sells to two geographic areas, Latin America aggregated with Europe, offers AIDC and POS equipment as well as communications products to more than 15,500 resellers and integrators of technology products. Additionally, the Company offers security products in Latin America. Of this segment’s customers, no single account represented more than 1% of the Company’s consolidated net sales during the fiscal years ended June 30, 2012, 2011, and 2010, respectively.

Inter-segment sales consist primarily of sales by the North American distribution segment to the international distribution segment. All inter-segment revenues and profits have been eliminated in the accompanying Consolidated Financial Statements.

Selected financial information for each business segment is presented below:

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
Sales:
North American distribution	$	2,285,342		$	2,048,767		$	1,688,663
International distribution	778,837			643,863			448,967
Less intersegment sales	(48,883		)	(26,099		)	(22,651		)
	$	3,015,296		$	2,666,531		$	2,114,979
Depreciation and amortization:
North American distribution	$	3,960		$	4,246		$	4,730
International distribution	5,962			2,416			1,334
	$	9,922		$	6,662		$	6,064
Operating income:
North American distribution	$	104,044		$	94,932		$	64,342
International distribution	9,472			18,177			11,434
	$	113,516		$	113,109		$	75,776
Assets:
North American distribution	$	813,889		$	785,057		$	670,467
International distribution	387,917			397,131			189,283
	$	1,201,806		$	1,182,188		$	859,750
Capital expenditures:
North American distribution	$	9,789		$	14,366		$	5,344
International distribution	3,001			503			262
	$	12,790		$	14,869		$	5,606

In prior periods, the Company inappropriately included its intercompany investment and funding arrangements related to foreign subsidiaries in its North American segment assets with the offsetting liabilities and elimination entries included as a reduction to the international segment's assets. This resulted in the understatement of international segment assets and an overstatement of North American segment assets. During the current period, the Company corrected its disclosure of assets by segment by eliminating intercompany investments and funding arrangements from both segments. Management concluded that the correction of prior periods is immaterial and, accordingly, previous filings have not been revised. However, segment assets related to prior periods presented herein have been adjusted to remove intercompany investment and funding arrangements.

77

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

The effect of the segment asset adjustments listed above as of June 30, 2011 was to reduce North American segment assets by $173.7 million, from $958.8 million as previously disclosed to $785.1 million and to increase international segment assets by $173.7 million, from $223.4 million as previously disclosed to $397.1 million. The effect of this adjustment on segment assets listed above as of June 30, 2010 was to reduce North American segment assets by $114.1 million from $784.6 million as previously disclosed to $670.5 million and to increase international segment assets by $114.1 million from $75.2 million as previously disclosed to $189.3 million.

Also in the prior fiscal year, the Company inappropriately excluded shared operating expense allocations from the international distribution segment. This resulted in the overstatement of the international segment's operating income and an understatement of the North American segment's operating income. Management concluded that the correction of the prior period is immaterial and, accordingly, previous filings have not been revised. However, segment operating income related to the prior period presented herein has been adjusted to allocate shared operating expenses to the international distribution segment. The effect of this adjustment on segment operating income listed above for the year ended June 30, 2011 was to increase North American segment operating income by $4.5 million from $90.4 million as previously disclosed to $94.9 million and to decrease international segment operating income by $4.5 million from $22.7 million to $18.2 million.

Selected financial information by product category is presented below:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Sales by Product Category:
POS, barcoding and security products	$	1,837,307	$	1,615,461	$	1,300,525
Communication products	1,177,989		1,051,070		814,454
	$	3,015,296	$	2,666,531	$	2,114,979

(14) Accumulated Other Comprehensive Income

The components of accumulated other comprehensive income, net of tax, are as follows:

	2012			2011			2010
	(in thousands)
Currency translation adjustment	$	(21,691	)	$	3,768		$	(11,127	)
Unrealized gain (loss) on fair value of interest rate swap	—			(139		)	(607		)
Accumulated other comprehensive income (loss)	$	(21,691	)	$	3,629		$	(11,734	)

(15) Related Party Transactions

During fiscal years 2012, 2011, and 2010, the Company had sales of $4.2 million, $5.1 million, and $3.7 million, respectively, to companies affiliated with the former minority shareholder of ScanSource Latin America’s Miami based operations. At June 30, 2012 and 2011, accounts receivable from these companies totaled $0.5 million and $1.2 million, respectively.

During fiscal years 2012 and 2011, the Company had sales of $0.2 million to companies affiliated with a former shareholder of CDC in Brazil. As of June 30, 2012 and 2011, accounts receivable from these customers were less than $0.1 million.

78

SCANSOURCE, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements—(Continued)

June 30, 2012

In previous periods, the Company has reported purchases and accounts payable to a vendor affiliated with the former CEO and current member on the Board of Directors. In January 2012, he divested his interest in this particular vendor. Through January 2012, the Company had purchases of $0.3 million from this vendor. During fiscal year 2011, the Company had purchases of $0.4 million from this vendor. At June 30, 2011, accounts payable to this vendor was $0.1 million.

(16) Subsequent Events

In accordance with ASC 855 – Subsequent Events, the Company evaluated events occurring from the end of the most recent fiscal year through the date the financial statements were filed with the SEC.

79

ITEM 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure.

Not applicable.

ITEM 9A. Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply judgment in evaluating the cost-benefit relationship of those disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Our disclosure controls and procedures are designed to provide reasonable assurance that the controls and procedures will meet their objectives.

Based on their evaluation as of the end of the period covered by this Annual Report on Form 10-K, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures, as of June 30, 2012, were effective in providing reasonable assurance that the objectives of the disclosure controls and procedures are met.

(b) Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) of the Exchange Act. Because of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

We assessed the effectiveness of the Company’s internal control over financial reporting as of June 30, 2012. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control – Integrated Framework. Based on its assessment using those criteria, our management concluded that our internal control over financial reporting was effective as of June 30, 2012.

The effectiveness of our internal control over financial reporting as of June 30, 2012 has been audited by Ernst & Young, LLP, an independent registered public accounting firm, as stated in their Report of Independent Registered Certified Public Accounting Firm on Internal Control Over Financial Reporting which is included with the Financial Statements in Part II, Item 8 of this Annual Report on Form 10-K and is incorporated herein by reference.

(c) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the fiscal year ended June 30, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. Other Information.

Not applicable.

80

PART III

Information called for by Part III (Items 10, 11, 12, 13 and 14) of this Annual Report on Form 10-K has been omitted as the Company intends to file with the SEC not later than 120 days after the end of its fiscal year ended June 30, 2012, a definitive Proxy Statement relating to the 2012 Annual Meeting of Shareholders pursuant to Regulation 14A promulgated under the Exchange Act. Such information will be set forth in such Proxy Statement and is incorporated herein by reference.

ITEM 10. Directors, Executive Officers and Corporate Governance.

Incorporated herein by reference to the information presented under the headings “Board of Directors and Executive Officers,”“Corporate Governance Matters – Section 16(a) Beneficial Reporting Compliance,” “Corporate Governance Matters – Code of Ethics,” “Corporate Governance Matters – Independent Directors,” and “Corporate Governance Matters – Board Meetings and Committees – Audit Committee,” in the Company’s 2012 Proxy Statement, which will be filed with the SEC not later than 120 days after June 30, 2012.

ITEM 11. Executive Compensation.

Incorporated herein by reference to the information presented under the headings “Executive Compensation,”“Corporate Governance Matters – Compensation Committee Interlocks and Insider Participation,” and “Compensation Committee Report” in the Company’s 2012 Proxy Statement, which will be filed with the SEC not later than 120 days after June 30, 2012.

ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

Incorporated herein by reference to the information presented under the headings “Equity Compensation Plan Information” and “Security Ownership of Certain Beneficial Owners and Management” in the Company’s 2012 Proxy Statement, which will be filed with the SEC not later than 120 days after June 30, 2012.

ITEM 13. Certain Relationships and Related Transactions, and Director Independence.

Incorporated herein by reference to the information presented under the heading “Certain Relationships and Related Transactions” and “Corporate Governance Matters – Independent Directors” in the Company’s 2012 Proxy Statement, which will be filed with the SEC not later than 120 days after June 30, 2012.

ITEM 14. Principal Accountant Fees and Services.

Incorporated herein by reference to the information presented under the headings “Proposal Three – Ratification of Appointment of Independent Auditors – Principal Accountant Fees and Services” and “Proposal Three – Ratification of Appointment of Independent Auditors – Audit Committee’s Pre-Approval Policies and Procedures” in the Company’s 2012 Proxy Statement, which will be filed with the SEC not later than 120 days after June 30, 2012.

81

PART IV

ITEM 15. Exhibits and Financial Statement Schedules.

(a)(1) Financial Statements. For a list of the financial statements included in this Annual Report on Form 10-K, see “Index to the Financial Statements” on page 34.

(a)(2) Financial Statement Schedules. Schedule II – “Valuation and Qualifying Accounts” appears below.

(a)(3) Exhibits. The list of exhibits filed as a part of this Annual Report on Form 10-K is set forth on the Exhibit Index immediately preceding such exhibits and is incorporated by reference in this Item 15(a)(3).

(b) Exhibits. See Exhibit Index.

(c) Separate Financial Statements and Schedules. None.

82

SCHEDULE II

SCANSOURCE, INC. AND SUBSIDIARIES

Valuation and Qualifying Accounts

(in thousands)

Description	Balance at Beginning of Period		Amounts Charged to Expense	Reductions (1)		Other (2)	Balance at End of Period
Valuation account for trade and notes receivable:
Year ended June 30, 2010	$	16,883	10,854	(7,097	)	1,267	$	21,907
Trade and current note receivable allowance							$	21,907
Long-term note allowance							$	—
Year ended June 30, 2011	$	21,907	7,488	(11,098	)	8,265	$	26,562
Trade and current note receivable allowance							$	26,562
Long-term note allowance							$	—
Year ended June 30, 2012	$	26,562	7,134	(7,249	)	902	$	27,349
Trade and current note receivable allowance							$	27,349
Long-term note allowance							$	—

(1) “Reductions” amounts represent write-offs for the years indicated.

(2) “Other” amounts include recoveries and the effect of foreign currency fluctuations. The amount in 2011 includes $3.9 million of recoveries and $3.1 million of accounts receivable reserves acquired with CDC Brasil, S.A., on April 15, 2011.

83

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

August 24, 2012

SCANSOURCE, INC.
By:	/s/ MICHAEL L. BAUR
	Michael L. Baur
	Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature	Title	Date
/s/ STEVEN R. FISCHER	Chairman of the Board	August 24, 2012
Steven R. Fischer
/s/ MICHAEL L. BAUR	Chief Executive Officer and Director	August 24, 2012
Michael L. Baur	(principal executive officer)
/s/ RICHARD P. CLEYS	Chief Financial Officer	August 24, 2012
Richard P. Cleys	(principal financial officer)
/s/ GERALD LYONS	Senior Vice President of Finance and Principal Accounting Officer	August 24, 2012
Gerald Lyons	(principal accounting officer)
/s/ MICHAEL J. GRAINGER	Director	August 24, 2012
Michael J. Grainger
/s/ STEVEN H. OWINGS	Director	August 24, 2012
Steven H. Owings
/s/ JOHN P. REILLY	Director	August 24, 2012
John P. Reilly
/s/ CHARLES R. WHITCHURCH	Director	August 24, 2012
Charles R. Whitchurch

84

Exhibit Number	Description	Filed herewith	Form	Period Ending	Exhibit	Filing Date
2.1	Share Purchase and Sale Agreement by and among ScanSource DO Brasil Participacoes LTDA as Buyer, Alexandre Machado De Campos Conde, Marcelo Duarte Hirsch, Gustavo Conde, Rosania De Souza Possebom, Juliane Possebom, Daniele Possebom, Gabriela Possebom, Adolar Nardes Junior and Caio Vinicius Domingos Nardes as Sellers; and CDC Brasil S.A., formerly called CDC Brasil Distribuidora LTDA, AECO Participacoes LTDA, Rhouse Participacoes LTDA and Nardes Administracao LTDA (as Agreeing Parties) dated April 7, 2011		8-K		2.1	4/15/2011
3.1	Amended and Restated Articles of Incorporation of the Registrant and Articles of Amendment Amending the Amended and Restated Articles of Incorporation of the Registrant		10-Q	12/31/2004	3.1	2/3/2005
3.2	Amended and Restated Bylaws of the Registrant, effective December 5, 2008		8-K		3.1	12/9/2008
4.1	Form of Common Stock Certificate		SB-2		4.1	2/7/1994
	Executive Compensation Plans and Arrangements
10.1	1993 Incentive Stock Option Plan, as amended, of the Registrant and Form of Stock Option Agreement		S-1		10.10	1/23/1997
10.2	1997 Stock Incentive Plan, as amended, of the Registrant and Form of Stock Option Agreement		10-K	6/30/1999	10.13	9/28/1999
10.3	ScanSource, Inc. Amended and Restated Directors Equity Compensation Plan		10-Q	12/31/2010	10.1	2/4/2011
10.4	Form of Restricted Stock Award (for ScanSource, Inc. Amended and Restated Directors Equity Compensation Plan)		10-Q	3/31/2011	10.3	5/6/2011
10.5	Amended and Restated 2002 Long-Term Incentive Plan		8-K		10.1	12/7/2009
10.6	Form of Incentive Stock Option Award Certificate under the Amended and Restated 2002 Long-Term Incentive Plan for grants on or after December 3, 2010		10-Q	12/31/2010	10.2	2/4/2011
10.7	Form of Non-Qualified Stock Option Award Certificate under the Amended and Restated 2002 Long-Term Incentive Plan for grants on or after December 3, 2010		10-Q	12/31/2010	10.3	2/4/2011
10.8	Form of Restricted Stock Unit Award Certificate under the Amended and Restated 2002 Long-Term Incentive Plan for grants on or after December 3, 2010		10-Q	12/31/2010	10.4	2/4/2011
10.9	Form of Restricted Stock Award Certificate under the Amended and Restated 2002 Long-Term Incentive Plan for grants on or after December 3, 2010		10-Q	12/31/2010	10.5	2/4/2011
10.10	Form of Restricted Stock Award Certificate (US) under the 2002 Amended and Restated Long-Term Incentive Plan		10-Q	12/31/2008	10.1	2/4/2009
10.11	Form of Restricted Stock Award Certificate (UK) under the 2002 Amended and Restated Long-Term Incentive Plan		10-Q	12/31/2008	10.2	2/4/2009

85

10.12	Form of Restricted Stock Award Certificate (Europe, not UK) under the 2002 Amended and Restated Long-Term Incentive Plan	10-Q	12/31/2008	10.3	2/4/2009
10.13	Form of Restricted Stock Award Certificate under the Amended and Restated 2002 Long-Term Incentive Plan for grants on or after December 3, 2009	8-K		10.2	12/7/2009
10.14	Form of Incentive Stock Option Award Certificate under the Amended and Restated 2002 Long-Term Incentive Plan for grants on or after December 3, 2009	8-K		10.3	12/7/2009
10.15	Form of Non-Qualified Stock Option Award Certificate under the Amended and Restated 2002 Long-Term Incentive Plan for grants on or after December 3, 2009	8-K		10.4	12/7/2009
10.16	Founder’s Supplemental Executive Retirement Plan Agreement	10-Q	3/31/2011	10.2	5/6/2011
10.17	ScanSource, Inc. Nonqualified Deferred Compensation Plan, as amended and restated effective January 1, 2005	10-Q	9/30/2009	10.2	11/9/2009
10.18	Amended and Restated Employment Agreement, effective as of June 6, 2011, between the Registrant and Michael L. Baur	10-K	6/30/2011	10.18	8/29/2011
10.19	Amended and Restated Employment Agreement, effective as of June 6, 2011, between the Registrant and Richard P. Cleys	10-K	6/30/2011	10.19	8/29/2011
10.20	Amended and Restated Employment Agreement, effective as of June 6, 2011, between the Registrant and R. Scott Benbenek	10-K	6/30/2011	10.20	8/29/2011
10.21	Amended and Restated Employment Agreement, effective as of June 6, 2011, between the Registrant and Andrea D. Meade	10-K	6/30/2011	10.21	8/29/2011
10.22	Amended and Restated Employment Agreement, dated June 6, 2011, between the Registrant and John J. Ellsworth	10-K	6/30/2011	10.22	8/29/2011
10.23	Form of Amendment to Stock Option Agreement and Promise to Make Cash Payment for Andrea D. Meade and R. Scott Benbenek	10-Q	12/31/2007	10.1	2/6/2008
10.24	Amendment to Stock Option Agreement and Promise to Make Cash Payment for Richard P. Cleys and Bobby McLain	10-Q	12/31/2007	10.2	2/6/2008
10.25	Form of Restricted Stock Award Certificate for R. Scott Benbenek, dated May 21, 2009	10-K	6/30/2009	10.2	8/27/2009
10.26	Form of Restricted Stock Award Certificate for Andrea D. Meade, dated May 21, 2009	10-K	6/30/2009	10.2	8/27/2009
10.27	Form of Restricted Stock Award Certificate for John J. Ellsworth, dated May 17, 2010	10-K	6/30/2010	10.2	8/26/2010
10.28	Form of Restricted Stock Award Agreement for R. Scott Benbenek, dated June 6, 2011	10-K	6/30/2011	10.26	8/29/2011
10.29	Form of Restricted Stock Award Agreement for Andrea D. Meade, dated June 6, 2011	10-K	6/30/2011	10.27	8/29/2011
10.30	Form of Restricted Stock Award Agreement for Richard P. Cleys, dated June 6, 2011	10-K	6/30/2011	10.28	8/29/2011

86

10.31	Form of Performance and Service-Based Restricted Stock Unit Award Agreement for John J. Ellsworth dated May 14, 2012	X
	Bank Agreements
10.32	Amended and Restated Credit Agreement entered into on October 11, 2011, among ScanSource, Inc., the Subsidiary Borrowers party thereto, J.P. Morgan Chase Bank, N.A., individually and as administrative agent and the other financial institutions signatory thereto		10-Q	9/30/2011	10.1	11/4/2011
	Other Agreements
10.33+	Industrial Lease Agreement dated April 27, 2007 between Registrant and Industrial Developments International, Inc.		10-K	6/30/2007	10.3	8/29/2007
10.34+	US Avaya Contract with ScanSource, Inc.		10-K	6/30/2010	10.4	8/26/2010
10.35+	US Motorola (f/k/a Symbol Technologies) Contract with ScanSource, Inc.		10-K	6/30/2010	10.4	8/26/2010
10.36+	Letter Agreement with US Motorola		10-K	6/30/2010	10.4	8/26/2010
21.1	Subsidiaries of the Company	X
23.1	Consent of Ernst & Young LLP	X
31.1	Certification of the Chief Executive Officer, Pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	X
31.2	Certification of the Chief Financial Officer, Pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	X
32.1	Certification of the Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	X
32.2	Certification of the Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	X
99.1	Consent Order for Final Approval of Settlement		8-K		99.1	6/19/2009
99.2	Stipulation of Compromise and Settlement, dated as of April 15, 2009		8-K		99.1	4/15/2009
101++	The following materials from our Annual Report on Form 10-K for the year ended June 30, 2012, formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets as of June 30, 2012 and June 30, 2011, (ii) the Condensed Consolidated Income Statements for the years ended June 30, 2012, June 30, 2011 and June 30, 2010, (iii) the Condensed Consolidated Statements of Shareholders’ Equity for the years ended June 30, 2012, June 30, 2011 and June 30, 2010, (iv) the Condensed Consolidated Statements of Cash Flows for the years ended June 30, 2012, June 30, 2011 and June 30, 2010, and (v) the Notes to the Condensed Consolidated Financial Statements, tagged as blocks of text	X

87

+	Confidential treatment has been granted with respect to certain portions of this Exhibit, which portions have been omitted and filed separately with the Commission as part of an application for confidential treatment.
++	The XBRL-related information has been furnished electronically herewith. This exhibit, regardless of whether it is an exhibit to a document incorporated by reference into any of our filings and except to the extent specifically stated otherwise, is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
	Our SEC file number for documents filed with the SEC pursuant to the Securities Exchange Act of 1934, as amended, is 000-26926.

88

EX-10.31

Exhibit 10.31

RESTRICTED STOCK UNIT AWARD CERTIFICATE

Non-transferable

GRANT TO

JOHN J. ELLSWORTH

(the “Grantee”)

by ScanSource, Inc. (the “Company”) of

the right to acquire 1,563 shares of its common stock, no par value (the “Shares”)

On May 14, 2012 (the “Grant Date”)

pursuant to and subject to the provisions of the ScanSource, Inc. Amended and Restated 2002 Long-Term Incentive Plan (the “Plan”) and to the terms and conditions set forth in this Award Certificate (the “Award Certificate”). This Award Certificate describes terms and conditions of the Restricted Stock Unit Award (or the “Award”) granted herein and constitutes an agreement between the Grantee and the Company.

The Award shall become earned and vested only if and to the extent that the conditions stated in Section 2 or Section 3 of the Certificate are met, subject to the other terms of the Award Certificate and the Plan.

IN WITNESS WHEREOF, ScanSource, Inc., acting by and through its duly authorized officers, has caused this Award Certificate to be duly executed.

SCANSOURCE, INC.
By:	/s/ Michael L. Baur
	Its: Authorized Officer
	Grant Date: May 14, 2012

Exhibit 10.31

AWARD CERTIFICATE TERMS AND CONDITIONS

1.    Grant of Award. The Company hereby grants to the Grantee, subject to the restrictions and the other terms and conditions set forth in the Plan and in this Award Certificate, a Restricted Stock Unit Award (or the “Award”) for the number of Shares indicated on Page 1 hereof. For the purposes herein, the Shares subject to the Award are units that will be reflected in a book account maintained by the Company and that will be settled in shares of Stock if and only to the extent permitted under the Plan and this Award Certificate. Prior to issuance of any Shares upon vesting of the Award, the Award shall represent an unsecured obligation of the Company, payable (if at all) only from the Company’s general assets. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Plan.

2.    Vesting and Earning of the Award.

(a) The Award shall be deemed earned and vested only if (and to the extent that) the conditions stated in Section 2 are met. The Committee has sole discretion to determine if the Award (or portion thereof) has been earned and vested.

(b) The Award is subject to both continued service and performance requirements as follows:

(i) First tranche: Up to fifty percent (50%) of the Shares subject to the Award (that is, 781 shares) shall (except as otherwise provided in Section 2(c) herein) vest and be earned if (A) the Grantee is employed by the Company on June 30, 2013 and has been an employee continuously since the Grant Date and (B) operating income (as defined below, “operating income”) for the Company for the fiscal year ended June 30, 2013 equals or exceeds $114,904,000. If both the continued service condition described in Section 2(b)(i)(A) and the performance condition described in Section 2(b)(i)(B) are not met, then none of the Shares subject to the first tranche of the Award shall vest; that is, both conditions must be met in order for any of such Shares to vest.

(ii) Second tranche: Up to fifty percent (50%) of the Shares subject to the Award (that is, 782 shares) shall (except as otherwise provided in Section 2(c) herein) vest and be earned if (A) the Grantee is employed by the Company on June 30, 2014 and has been an employee continuously since the Grant Date and (B) operating income for the fiscal year ended June 30, 2014 equals or exceeds $121,627,000. If both the continued service condition described in Section 2(b)(ii)(A) and the performance condition described in Section 2(b)(ii)(B) are not met, then none of the Shares subject to the second tranche of the Award shall vest; that is, both conditions must be met in order for any of such Shares to vest.

(iii) The Award shall not be deemed vested and earned with respect to a particular tranche until both of the following events have occurred: (A) the completion of the Company’s audited financial statements for the particular fiscal year and (B) the Committee’s written certification regarding if and to the extent the applicable performance goals have been met.

(iv) For the purposes herein, “operating income” shall mean the amount reflected for the line item identified as Operating Income on the Company’s audited consolidated financial statements for each respective fiscal year referenced above. The Company’s calculation of operating income shall be conclusive and binding absent fraud or manifest and material error.

(c) Notwithstanding that the conditions referenced in Section 2(b)(i) and/or Section 2(b)(ii) herein may have been met, the Committee shall have sole discretion to reduce (but not increase) the number of Shares deemed earned and vested (but not below 391 shares, that is 50% of the number of shares subject to the particular tranche) if the Committee determines that such reduction is appropriate based on the Committee’s evaluation of the Grantee’s performance in the following areas: (1) acquisitions and integration of acquisitions; (2) organizational development and succession planning; (3) acquisition and implementation of the Company-wide information technology project involving a new enterprise resource planning software package; and (4) any other corporate, divisional or individual criteria determined by the Compensation Committee.

Exhibit 10.31

The period during which the Shares (or portion thereof) have not yet vested and been earned (or been forfeited) shall be referred to herein as the “Restricted Period.”

3.     Effect of Termination; Forfeiture.

(a) If the Grantee’s employment with the Company terminates for any reason other than as set forth in Section 3(b) herein, then the Grantee shall forfeit all of the Grantee’s right, title and interest in the Award (and the underlying Shares), to the extent not vested and earned as of the date of the Grantee’s termination of employment, and such Restricted Shares shall revert to the Company (without the payment by the Company of any consideration for such Shares) immediately following the event of forfeiture.

(b) Notwithstanding the provisions of Section 2 and Section 3(a) herein, the Award shall be deemed earned and vested on the earliest to occur of the following:

(i) as to all of the Shares, upon the termination of the Grantee’s employment due to death or Disability; or

(ii) as to all of the Shares, upon the Grantee’s termination of employment by the Company without Cause or by the Grantee for Good Reason if such termination occurs within twelve (12) months after the effective date of a Change in Control (or as may otherwise be permitted under the Plan).

4.     Restrictions. The Award and the underlying Shares are subject to the following restrictions: No right or interest of the Grantee in the Award, to the extent restricted, may be pledged, encumbered or hypothecated to or in favor of any party other than the Company or an Affiliate or shall be subject to any lien, obligation or liability of the Grantee to any other party other than the Company or an Affiliate. Except as otherwise provided in the Plan, the Award to the extent restricted, shall not be assignable or transferable by the Grantee other than by will or the laws of descent and distribution. Prior to vesting, the Shares subject to the Award may not be sold, transferred, exchanged, assigned, pledged, hypothecated or otherwise encumbered. The restrictions imposed under this section shall apply to all Shares or other securities issued with respect to Shares hereunder in connection with any merger, reorganization, consolidation, recapitalization, stock dividend or other change in corporate structure affecting the Stock of the Company.

5.     Settlement of Award; Delivery of Shares. No certificate or certificates for the Shares shall be issued at the time of grant of the Award. A certificate or certificates for the Shares underlying the Award (or, in the case of uncertificated Shares, other written evidence of ownership in accordance with applicable laws) shall be issued in the name of the Grantee (or his beneficiary) only in the event, and to the extent, that the Award has vested. Notwithstanding the foregoing, the following provisions shall apply: (a) any Shares or other benefits payable pursuant to the Award shall, upon vesting of the Award, be distributed to the Grantee (or his beneficiary) no later than the later of (i) the 15th day of the third month following the end of the Grantee’s first taxable year in which the amount is no longer subject to a substantial risk of forfeiture, or (ii) the 15th day of the third month following the end of the Company’s first taxable year in which the amount is no longer subject to a substantial risk of forfeiture; (b)  if the Grantee is or may be a “specified employee” (as defined under Code Section 409A), and the distribution is due to separation from service, then such distribution shall be subject to delay as provided in Section 16.16(c) of the Plan (or any successor provision thereto); and (c) delivery of the Shares may be postponed for such period as may be required for the Company with reasonable diligence to comply, if deemed advisable by the Company, with registration requirements under the 1933 Act, listing requirements under the rules of any stock exchange, and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.

6.     Voting and Dividend Rights. The Grantee shall not be deemed to be the holder of any Shares subject to the Award and shall not have any dividend rights, voting rights or other rights as a shareholder unless and until (and only to the extent that) the Award has vested and certificates for such Shares have been issued to him (or, in the case of uncertificated shares, other written evidence of ownership in accordance with applicable laws shall have been provided).

7.     No Right of Continued Employment. Nothing in this Award Certificate shall interfere with or limit in any way the right of the Company or any Affiliate to terminate the Grantee’s employment or service at any time, nor confer upon the Grantee any right to continue in the employ or service of the Company or any Affiliate.

Exhibit 10.31

8.     Payment of Taxes. The Grantee will, no later than the date as of which any amount related to the Shares first becomes includable in the Grantee’s gross income for federal income tax purposes, pay to the Company, or make other arrangements satisfactory to the Committee regarding payment of, any federal, state, local and foreign taxes (including FICA taxes) required by law to be withheld with respect to such amount. The withholding requirement may be satisfied, in whole or in part, at the election of the Company, by withholding from this award Shares having a Fair Market Value on the date of withholding equal to the minimum amount (and not any greater amount) required to be withheld for tax purposes, all in accordance with such procedures as the Committee establishes. The obligations of the Company under this Award Certificate will be conditional on such payment or arrangements, and the Company, or, where applicable, its Affiliates, will, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the Grantee. The Grantee acknowledges that the Company has made no warranties or representations to the Grantee with respect to the legal, tax or investment consequences (including but not limited to income tax consequences) related to the grant of the Award or receipt or disposition of the Shares (or any other benefit), and the Grantee is in no manner relying on the Company or its representatives for legal, tax or investment advice related to the Award or the Shares. The Grantee acknowledges that there may be adverse tax consequences upon the grant of the Award and/or the acquisition or disposition of the Shares (or other benefit) subject to the Award and that the Grantee has been advised that he should consult with his or her own attorney, accountant and/or tax advisor regarding the transactions contemplated by the Award and this Award Certificate. The Grantee also acknowledges that the Company has no responsibility to take or refrain from taking any actions in order to achieve a certain tax result for the Grantee.

9.     Plan Controls. The terms contained in the Plan are incorporated into and made a part of this Award Certificate and this Award Certificate shall be governed by and construed in accordance with the Plan. In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of this Award Certificate, the provisions of the Plan shall be controlling and determinative (unless the Committee determines otherwise).

10.     Successors. This Award Certificate shall be binding upon any successor of the Company, in accordance with the terms of this Award Certificate and the Plan.

11.     Severability. If any one or more of the provisions contained in this Award Certificate is invalid, illegal or unenforceable, the other provisions of this Award Certificate will be construed and enforced as if the invalid, illegal or unenforceable provision had never been included.

12.     Notice. Notices and communications under this Award Certificate must be in writing and either personally delivered or sent by registered or certified United States mail, return receipt requested, postage prepaid. Notices to the Company must be addressed to ScanSource, Inc., 6 Logue Court, Greenville, South Carolina 29615, Attn: Secretary, or any other address designated by the Company in a written notice to the Grantee. Notices to the Grantee will be directed to the address of the Grantee then currently on file with the Company, or at any other address given by the Grantee in a written notice to the Company.

13.     Beneficiary Designation. The Grantee may, in the manner determined by the Committee, designate a beneficiary to exercise the rights of the Grantee hereunder and to receive any distribution with respect to the Award upon the Grantee’s death. A beneficiary, legal guardian, legal representative, or other person claiming any rights hereunder is subject to all terms and conditions of this Award Certificate and the Plan and to any additional restrictions deemed necessary or appropriate by the Committee. If no beneficiary has been designated or survives the Grantee, the Grantee’s rights with respect to the Award may be exercised by the legal representative of the Grantee’s estate, and payment shall be made to the Grantee’s estate. Subject to the foregoing, a beneficiary designation may be changed or revoked by the Grantee at any time provided the change or revocation is filed with the Company.

EX-21.1

Exhibit 21.1

ScanSource,Inc.

Schedule of Subsidiaries

Name of Subsidiary	State/Country of Incorporation	Percentage of Voting Securities Owned by Immediate Parent
4100 Quest, LLC	South Carolina	100%
ScanSource Properties, LLC	South Carolina	100%
Logue Court Properties, LLC	South Carolina	100%
8650 Commerce Drive, LLC	Mississippi	100%
Partner Services, Inc.	South Carolina	100%
ScanSource Security Distribution, Inc.	South Carolina	100%
ScanSource Communications, Inc.	South Carolina	100%
ScanSource Canada, Inc.	Canada	100%
ScanSource de Mexico S, de R.L. de C.V.	Mexico	99.9%1
Outsourcing Unlimited, Inc.	Georgia	100%
Netpoint International, Inc.	Florida	100%
ScanSource France SARL	France	100%
ScanSource Europe Limited	United Kingdom	100%
ScanSource UK Limited	United Kingdom	100%
ScanSource EDC Limited	United Kingdom	100%
ScanSource Europe SPRL	Belgium 2	99.9%3
ScanSource Germany GmbH	Germany	100%
ScanSource Communications Limited f/k/a MTV Telecom (Distribution) Limited	United Kingdom	100%
ScanSource Europe CV	Amsterdam	100%
ScanSource Europe BV	Amsterdam	100%
ScanSource Europe Italy	Italy	100%
ScanSource Europe Netherlands	Netherlands	100%
ScanSource Communications GmbH	Germany	100%
CDC Brasil, S.A.	Brazil	99.9%4

1	Mr. Baur, the CEO of ScanSource, Inc., owns interests representing .000019%.
2	ScanSource Europe SPRL has branch offices that operate under the names ScanSource Italia and ScanSource Netherlands.
3	Mr. Baur, the CEO of ScanSource, Inc., owns one share, representing .10%.
4	ScanSource Europe SPRL owns one share representing 0.0000037%.

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1) Registration Statement (Form S-8 No. 333-94640) of ScanSource, Inc. dated July 17, 1995;

(2) Registration Statement (Form S-8 No. 333-08884) of ScanSource, Inc. dated April 10, 1998;

(3) Registration Statement (Form S-8 No. 333-49879) of ScanSource, Inc. dated April 10, 1998;

(4) Registration Statement (Form S-8 No. 333-78281) of ScanSource, Inc. dated May 12, 1999;

(5) Registration Statement (Form S-8 No. 333-36766) of ScanSource, Inc. dated May 11, 2000;

(6) Registration Statement (Form S-8 No. 333-110220) of ScanSource, Inc. dated November 4, 2003;

(7) Registration Statement (Form S-8 No. 333-115534) of ScanSource, Inc. dated May 14, 2004;

(8) Registration Statement (Form S-8 No. 333-144121) of ScanSource, Inc. dated June 28, 2007;

(9) Registration Statement (Form S-8 No. 333-153653) of ScanSource, Inc. dated September 24, 2008;

(10) Registration Statement (Form S-8 No. 333-169064) of ScanSource, Inc. dated August 10, 2010

of our reports dated August 24, 2012, with respect to the consolidated financial statements and schedule of ScanSource, Inc. and subsidiaries, and the effectiveness of internal control over financial reporting of ScanSource, Inc. and subsidiaries included in this Annual Report (Form 10-K) of ScanSource, Inc. and subsidiaries for the year ended June 30, 2012.

/s/ Ernst & Young LLP

Greenville, South Carolina

August 24, 2012

EX-31.1

Exhibit 31.1

Certification Pursuant to Rule 13a-14(a) or 15d-14(a)

of the Exchange Act, as adopted Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

I, Michael L. Baur, certify that:

1. I have reviewed this Annual Report on Form 10-K of ScanSource, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Michael L. Baur

Michael L. Baur, Chief Executive Officer

(Principal Executive Officer)

Date: August 24, 2012

EX-31.2

Exhibit 31.2

Certification Pursuant to Rule 13a-14(a) or 15d-14(a)

of the Exchange Act, as adopted Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

I, Richard P. Cleys, certify that:

1. I have reviewed this Annual Report on Form 10-K of ScanSource, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Richard P. Cleys

Richard P. Cleys, Chief Financial Officer

(Principal Financial Officer)

Date: August 24, 2012

EX-32.1

Exhibit 32.1

Certification of the Chief Executive Officer of ScanSource, Inc.

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to § 906

of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report of ScanSource, Inc. (the “Company”) on Form 10-K for the year ended June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1) The Report fully complies with the requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”); and

2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 24, 2012	/s/ Michael L. Baur
	Michael L. Baur, Chief Executive Officer
	(Principal Executive Officer)

This certification is being furnished solely to comply with the provisions of § 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the accompanying Report, including for purposes of Section 18 of the Exchange Act, or as a separate disclosure document. A signed original of this written certification required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written certification required by Section 906, has been provided to the Company and will be rendered by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

Certification of the Chief Financial Officer of ScanSource, Inc.

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to § 906

of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report of ScanSource, Inc. (the “Company”) on Form 10-K for the year ended June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1) The Report fully complies with the requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”); and

2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 24, 2012	/s/ Richard P. Cleys
	Richard P. Cleys Chief Financial Officer (Principal Financial Officer)

This certification is being furnished solely to comply with the provisions of § 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the accompanying Report, including for purposes of Section 18 of the Exchange Act, or as a separate disclosure document. A signed original of this written certification required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written certification required by Section 906, has been provided to the Company and will be rendered by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Summary of Significant Accounting Policies (Narrative) (Details) (USD $)	12 Months Ended
	Jun. 30, 2012 installment segment	Jun. 30, 2011	Jun. 30, 2010
Number of geographic distribution segments	2
Checks released, not cleared	$ 48,200,000	$ 73,600,000
Maximum remaining maturity of foreign currency derivatives	90 days
Deferred compensation plan assets	11,635,000	12,926,000
Portion of investment obligation in current liabilities	1,200,000	3,100,000
Intangible assets, estimated useful life minimum (years)	10 years	10 years	12 years
Impairment of long-lived assets	0	0	0
Earnout payment	2,000,000	0
Earnout payments, remaining installments	3
Service revenue as a percent of net sales, maximum	2.00%	2.00%	2.00%
Shipping revenue	$ 12,200,000	$ 11,500,000	$ 10,200,000
Buildings [Member]
Property and equipment, estimated useful life (years)	40 years
Building Improvements [Member]
Property and equipment, estimated useful life (years)	15 years
Minimum [Member] | Furniture [Member]
Property and equipment, estimated useful life (years)	3 years
Minimum [Member] | Equipment [Member]
Property and equipment, estimated useful life (years)	3 years
Minimum [Member] | Software [Member]
Property and equipment, estimated useful life (years)	3 years
Minimum [Member] | Customer Relationships [Member]
Intangible assets, estimated useful life minimum (years)	5 years
Minimum [Member] | Trade Names [Member]
Intangible assets, estimated useful life minimum (years)	1 year
Maximum [Member] | Furniture [Member]
Property and equipment, estimated useful life (years)	10 years
Maximum [Member] | Equipment [Member]
Property and equipment, estimated useful life (years)	10 years
Maximum [Member] | Software [Member]
Property and equipment, estimated useful life (years)	10 years
Maximum [Member] | Customer Relationships [Member]
Intangible assets, estimated useful life minimum (years)	15 years
Maximum [Member] | Trade Names [Member]
Intangible assets, estimated useful life minimum (years)	2 years
Customer Concentration Risk [Member] | Maximum [Member]
Concentration risk percentage	6.00%	6.00%	6.00%
Supplier Concentration Risk [Member] | Minimum [Member] | Motorola and Avaya [Member]
Concentration risk percentage	10.00%	10.00%	10.00%

XML

Short-Term Borrowings and Long-Term Debt (Long-Term Debt) (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Jun. 30, 2011
Long-term debt	$ 5,429	$ 30,429
Less current portion	0	0
Long-term portion	5,429	30,429
Industrial Development Revenue Bond [Member]
Long-term debt	5,429	5,429
Variable interest rate of debt	1.09%
Unsecured Notes Payable to Bank [Member]
Long-term debt	$ 0	$ 25,000

XML

Goodwill and Other Identifiable Intangible Assets (Narrative) (Details) (USD $)	12 Months Ended									12 Months Ended		12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011 Customer Lists [Member]	Jun. 30, 2012 Non-compete Agreements [Member]	Jun. 30, 2011 Non-compete Agreements [Member]	Jun. 30, 2011 Trade Names [Member]	Jun. 30, 2012 Multi-Currency Revolving Credit Facility [Member]	Jun. 30, 2012 BRAZIL	Jun. 30, 2012 CDC Brasil S A [Member]	Apr. 15, 2011 CDC Brasil S A [Member]	Jun. 30, 2012 CDC Brasil S A [Member] Customer Relationships [Member]	Jun. 30, 2011 CDC Brasil S A [Member] Customer Relationships [Member]	Jun. 30, 2012 CDC Brasil S A [Member] Non-compete Agreements [Member]	Jun. 30, 2012 CDC Brasil S A [Member] Trade Names [Member]	Apr. 15, 2011 CDC Brasil S A [Member] Purchase Price Allocation Adjustments [Member]	Apr. 15, 2011 CDC Brasil S A [Member] Purchase Price Allocation Adjustments [Member] Customer Relationships [Member]
Goodwill impairment charges	$ 0	$ 0	$ 0
Goodwill	53,885,000	59,090,000	33,785,000						19,800,000
Goodwill, fair value exceeds carrying value, percent									7.00%
Deferred finance costs, noncurrent, gross								1,400,000
Identified intangible assets useful life										5 years		6 years	7 years	5 years	2 years
Intangible assets										22,605,000	22,605,000	18,965,000		894,000	2,746,000	4,278,000	4,300,000
Gross carrying amount and accumulated amortization written off				300,000	900,000	1,800,000	1,000,000
Weighted average amortization period	10 years	10 years	12 years
Amortization expense	$ 6,400,000	$ 3,000,000	$ 2,000,000

XML

Employee Benefit Plans (Employer Contributions) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Employer contributions	$ 5,539	$ 6,371	$ 3,595
Matching Contributions [Member]
Employer contributions	473	419	395
Discretionary Contributions [Member]
Employer contributions	$ 5,066	$ 5,952	$ 3,200

XML

Short-Term Borrowings and Long-Term Debt (Maturities of Revolving Credit Facility and Long-term Debt) (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012
Debt Disclosure [Abstract]
2013	$ 0
2014	0
2015	0
2016	0
2017	0
Thereafter	5,429
Total principal payments	$ 5,429

XML

Commitments and Contingencies (Lease Expense) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Commitments and Contingencies Disclosure [Abstract]
Lease expense	$ 5,025	$ 4,989	$ 4,430

XML

Acquisitions Acquisitions (Impact Of The Incremental Amortization And Related Tax Effect) (Details) (CDC Brasil S A [Member], USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
CDC Brasil S A [Member]
Business Acquisition [Line Items]
Amortization expense	$ 441	$ 700,000
Provision for income taxes	$ (150)

XML

Share-Based Compensation (Tables)

12 Months Ended

Jun. 30, 2012

Share-based Compensation [Abstract]

Schedule of Share-Based Compensation

Total share-based compensation included as a component of selling, general, and administrative expense in our Consolidated Income Statements was as follows:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Share-based compensation related to:
Equity classified stock options	$	2,875	$	3,106	$	4,698
Equity classified restricted stock	3,965		1,771		1,367
Total share-based compensation	$	6,840	$	4,877	$	6,065

Weighted Average Assumptions for the Options Granted During the Following Fiscal Years

The Company used the following weighted average assumptions for the options granted during the following fiscal years:

	Fiscal Year Ended June 30,
	2012			2011			2010
Expected term	6.77 years			6.88 years			6.82 years
Expected volatility	41.33		%	42.92		%	46.27		%
Risk-free interest rate	1.42		%	2.56		%	2.89		%
Dividend yield	0.00		%	0.00		%	0.00		%
Weighted average fair value per option	$	14.94		$	17.21		$	12.43

Stock Option Plans

A summary of our stock option plans is presented below:

	Fiscal Year Ended June 30, 2012
	Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life	Aggregate Intrinsic Value
Outstanding, beginning of year	1,969,477		$	27.47
Granted during the period	85,578		34.23
Exercised during the period	(415,959	)	21.67
Canceled, forfeited, or expired during the period	(9,137	)	34.42
Outstanding, end of year	1,629,959		29.27		5.67	$	5,970,110
Vested and expected to vest at June 30, 2012	1,629,870		29.27		5.67	$	5,970,070
Exercisable, end of year	1,385,371		$	28.60	5.12	$	5,652,620

Unvested Shares

A summary of the status of the Company’s shares subject to unvested options is presented below:

	Fiscal Year Ended June 30, 2012
	Options		Weighted      Average Exercise Price		Weighted Average Grant     Date Fair-     Value
Unvested, beginning of year	445,010		$	26.29	$	12.25
Granted	85,578		34.23		14.94
Vested	(280,703	)	22.71		10.28
Canceled or forfeited	(5,297	)	33.30		10.42
Unvested, end of year	244,588		$	33.02	$	15.49

Stock Options Outstanding

The following table summarizes information about stock options outstanding and exercisable as of June 30, 2012:

	Options Outstanding				Options Exercisable
Range of Exercise Prices	Shares   Outstanding	Weighted Average Remaining   Contractual   Life	Weighted     Average Exercise Price		Number   Exercisable	Weighted     Average Exercise Price
$11.01 - $14.68	20,602	0.51	$	13.67	20,602	$	13.67
$14.68 - $18.35	314,396	6.20	18.12		314,396	18.12
$18.35 - $22.01	18,800	1.43	21.58		18,800	21.58
$22.01 - $25.68	189,725	6.41	24.55		137,915	24.56
$25.68 - $29.35	81,500	3.52	27.48		81,500	27.48
$29.35 - $33.02	364,120	4.62	31.46		359,120	31.45
$33.02 - $36.69	640,816	6.34	35.84		453,038	36.03
	1,629,959	5.67	$	29.27	1,385,371	$	28.60

Restricted Stock Outstanding

During the fiscal year ended June 30, 2012, the Company elected to grant 173,246 shares of restricted stock to employees and non-employee directors, of which 159,746 of these shares were issued in the form of RSUs:

	Fiscal Year Ended June 30, 2012
	Shares granted	Date granted	Grant date fair value		Vesting period
Employees
Certain employees based on promotions	5,000	January 31, 2012	$	37.56	Annually over 3 years
Certain employees based on promotions	4,500	May 1, 2012	32.61		Annually over 3 years
Certain employees	1,000	June 18, 2012	31.33		Annually over 3 years
Certain employees	1,500	November 1, 2012	32.94		Annually over 3 years
Certain employees	147,683	December 2, 2011	34.35		Annually over 3 years
Executive officers, vesting based on certain service and performance conditions	1,563	May 14, 2012	32.01		Annually over 2 years
Non-Employee Directors(1)	12,000	December 2, 2011	$	34.35	6 months

(1) Per the Amended and Restated Director’s Equity Compensation Plan, non-employee directors will receive annual awards of restricted stock, as opposed to stock options. The number of shares of restricted stock to be granted will be established from time to time by the Board of Directors. Currently, the number of shares of restricted stock awarded to each non-employee director will be determined by dividing $80,000 by the fair market value of the common stock on the date of grant. These awards will generally vest in full on the day that is six months after the date of grant or upon the earlier occurrence of (i) the director’s termination of service as a director by reason of death, disability or retirement, or (ii) a change in control by the Company. The compensation expense associated with these awards will be recognized on a pro-rata basis over this period.

A summary of the status of the Company’s outstanding restricted stock is presented below:

	Fiscal Year Ended June 30, 2012
	Shares		Weighted Average Grant Date Fair Value
Outstanding, beginning of year	241,085		$	29.15
Granted during the period	173,246		34.34
Vested during the period	(122,071	)	28.12
Cancelled, forfeited, or expired during the period	(25,002	)	32.00
Outstanding, end of year	267,258		$	32.43

XML

Commitments and Contingencies (Future Minimum Lease Payments) (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012
Commitments and Contingencies Disclosure [Abstract]
2013	$ 4,671
2014	3,999
2015	3,295
2016	3,125
2017	2,605
Thereafter	2,018
Total future minimum lease payments	$ 19,713

XML

Income Taxes (Reconciliation of U.S.Federal Income Tax Expense) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Income Tax Expense (Benefit) [Abstract]
U.S. Federal income tax at statutory rate	$ 38,924	$ 39,160	$ 26,509
State and local income taxes, net of Federal benefit	1,026	625	935
Tax credits	(1,122)	(312)	(633)
Valuation allowance	24	(195)	(128)
Effect of foreign operations, net	(2,309)	(2,054)	(1,342)
Stock compensation	86	239	580
Other	294	900	1,008
Provision for income taxes	$ 36,923	$ 38,363	$ 26,929

XML

Derivatives and Hedging Activities (Derivative Contracts and Changes in Underlying Value of the Foreign Currency Exposures) (Details) (USD $) In Thousands, unless otherwise specified	1 Months Ended	12 Months Ended
	Sep. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
General Discussion of Derivative Instruments and Hedging Activities [Abstract]
Net foreign exchange derivative contract gain (loss)	$ 2,500	$ (1,480)	$ (2,706)	$ (1,065)
Net foreign currency transaction and remeasurement gain (loss)		(2,286)	1,741	826
Net foreign currency gain (loss)		$ (3,766)	$ (965)	$ (239)

XML

Income Taxes (Reconciliation of Unrecognized Tax Benefits) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning Balance	$ 1,181	$ 1,279	$ 1,359
Additions based on tax positions related to the current year	163	173	133
Additions for tax positions of prior years	0	0	0
Reduction for tax positions of prior years	(87)	(271)	(213)
Settlements	0	0	0
Ending Balance	$ 1,257	$ 1,181	$ 1,279

XML

Segment Information (Financial Information by Segment) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Sales	$ 3,015,296	$ 2,666,531	$ 2,114,979
Depreciation and amortization	9,922	6,662	6,064
Operating income	113,516	113,109	75,776
Assets	1,201,806	1,182,188	859,750
Capital expenditures	12,790	14,869	5,606
North American Distribution [Member]
Sales	2,285,342	2,048,767	1,688,663
Depreciation and amortization	3,960	4,246	4,730
Operating income	104,044	94,932	64,342
Assets	813,889	785,057	670,467
Capital expenditures	9,789	14,366	5,344
International Distribution [Member]
Sales	778,837	643,863	448,967
Depreciation and amortization	5,962	2,416	1,334
Operating income	9,472	18,177	11,434
Assets	387,917	397,131	189,283
Capital expenditures	3,001	503	262
Intersegment Elimination [Member]
Sales	$ (48,883)	$ (26,099)	$ (22,651)

XML

Commitments and Contingencies (Narrative) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended		12 Months Ended					12 Months Ended
	Jun. 30, 2012 extension	Apr. 27, 2007	Jun. 30, 2012 Minimum [Member] D	Jun. 30, 2012 Maximum [Member] D	Jun. 30, 2011 Maximum [Member]	Apr. 27, 2007 Current Square Footage [Member] sqft	Apr. 27, 2007 Expansion Square Footage [Member] sqft	Jun. 30, 2012 Supplier Concentration Risk [Member] Sales [Member] vendor	Jun. 30, 2011 Supplier Concentration Risk [Member] Sales [Member] vendor	Jun. 30, 2010 Supplier Concentration Risk [Member] Sales [Member] vendor
Area leased under lease agreement (in square feet)						600,000	147,000
Term of lease (in months)		120 months
Number of lease extension options	2
Length of lease extension options	5 years
Concentration risk, supplier								10	10	10
Termination period under terms of distribution agreement (days)			30	120
Cumulative expenditures on ERP system	$ 33.5
Cumulative capitalized expenditures on ERP system	26.8
Total expenditures expected on ERP system			58.0	72.0	38.5
Expected capitalized expenditures on ERP system in next fiscal year			9.0	15.0
Expected capital expenditures on ERP system	$ 42.0

XML

Income Taxes (Narrative) (Details) (USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2009
Statutory rate percentage of federal income tax expense	35.00%
Valuation allowance, amount	$ 500,000
Gross unrecognized tax benefits	1,257,000	1,181,000	1,279,000	1,359,000
Unrecognized tax benefits that would impact effective tax rate if recognized	800,000
Unrecognized tax benefits, period increase	100,000
Income tax penalties and interest accrued	1,000,000	900,000	1,000,000
Income tax penalties and interest expensed	100,000
Federal [Member]
Operating loss carry forwards	100,000
State and Local [Member]
Operating loss carry forwards	900,000
Tax credit carry forwards	200,000
Operating loss carry forwards, valuation allowance	100,000
Withholding Tax Credits [Member]
Tax credit carry forwards	500,000
Foreign [Member]
Operating loss carry forwards	8,500,000
Undistributed earnings of foreign subsidiaries	56,300,000
Undistributed earnings of foreign subsidiaries, tax effect	10,000,000
Valuation Allowance, Operating Loss Carryforwards [Member] | Foreign [Member]
Valuation allowance, deferred tax asset, change in amount	$ 400,000

XML

Business and Summary of Significant Accounting Policies (Policy)

12 Months Ended

Jun. 30, 2012

Accounting Policies [Abstract]

Business Description

Business Description

ScanSource, Inc. and its subsidiaries (the “Company”) is a leading wholesale distributor of specialty technology products, providing value-added distribution sales to resellers in the specialty technology markets. The Company has two geographic distribution segments: the North American distribution segment serving the United States and Canada from the Southaven, Mississippi distribution center, and an international segment currently serving Latin America and Europe from distribution centers located in Florida, Mexico and Brazil, and in Belgium, respectively. The North American distribution segment markets automatic identification and data capture (“AIDC”) and point-of-sale (“POS”) products through its ScanSource POS and Barcoding sales unit; voice, data and converged communications equipment through its Catalyst Telecom sales unit; video conferencing, telephony, and communications products through its ScanSource Communications unit; and electronic security products and wireless infrastructure products through its ScanSource Security Distribution unit. The international distribution segment markets AIDC, POS, communications and security products through its ScanSource Latin America sales unit; AIDC and POS products through its ScanSource Europe sales unit; and communication products through its ScanSource Communications sales unit in Europe.

On April 15, 2011, the Company purchased all of the shares of CDC Brasil S.A. (“CDC”), formerly known as CDC Brasil Distribuidora LTDA. CDC, the leading POS and Barcoding distributor in Brazil, is now included under the ScanSource Latin America operating unit.

Consolidation Policy

Consolidation Policy

The consolidated financial statements include the accounts of the Company. All significant inter-company accounts and transactions have been eliminated.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to the allowance for uncollectible accounts receivable and inventory reserves. Management bases its estimates on assumptions that management believes to be reasonable under the circumstances, the results of which form a basis for making judgments about the carrying value of assets and liabilities that are not readily available from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, management believes that its estimates, including those for the above described items, are reasonable and that the actual results will not vary significantly from the estimated amounts.

Allowances for Trade and Notes Receivable

Allowances for Trade and Notes Receivable

The Company maintains an allowance for uncollectible accounts receivable for estimated losses resulting from customers’ failure to make payments on accounts receivable due to the Company.

Management determines the estimate of the allowance for uncollectible accounts receivable by considering a number of factors, including: (1) historical experience, (2) aging of the accounts receivable and (3) specific information obtained by the Company on the financial condition and the current creditworthiness of its customers. If the financial condition of the Company’s customers were to deteriorate and reduce the ability of the Company’s customers to make payments on their accounts, the Company may be required to increase its allowance by recording additional bad debt expense. Likewise, should the financial condition of the Company’s customers improve and result in payments or settlements of previously reserved amounts, the Company may be required to record a reduction in bad debt expense to reverse the recorded allowance. A provision for estimated returns and allowances and associated losses is recorded and based on historical experience.

Inventory Reserves

Inventory Reserves

Management determines the inventory reserves required to reduce inventories to the lower of cost or market based principally on the effects of technological changes, quantities of goods on hand, and other factors. An estimate is made of the market value, less cost to dispose, of products whose value is determined to be impaired. If these products are ultimately sold at less than estimated amounts, additional reserves may be required. The estimates used to calculate these reserves are applied consistently. The adjustments are recorded in the period in which the loss of utility of the inventory occurs, which establishes a new cost basis for the inventory. This new cost basis is maintained until such time that the reserved inventory is disposed of, returned to the vendor or sold. To the extent that specifically reserved inventory is sold, cost of goods sold is expensed for the new cost basis of the inventory sold.

Reclassifications

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation in the accompanying consolidated financial statements.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company maintains some zero-balance, disbursement accounts at various financial institutions in which the Company does not maintain significant depository relationships. Due to the nature of the Company’s banking relationships with these institutions, the Company does not have the right to offset most if not all outstanding checks written from these accounts against cash on hand. Checks released but not yet cleared from these accounts in the amounts of $48.2 million and $73.6 million are classified to accounts payable as of June 30, 2012 and June 30, 2011, respectively.

The Company maintains its cash with various financial institutions globally that are monitored regularly for credit quality. At times, such investments may be in excess of FDIC or other federally insured limits.

Concentration of Credit Risk

Concentration of Credit Risk

The Company sells its products to a large base of value-added resellers throughout North America, Latin America and Europe. The Company performs ongoing credit evaluations of its customers’ financial condition. In certain cases, the Company will accept tangible assets as collateral to increase the trade credit of its customers. No single customer accounted for more than 6% of the Company’s net sales for fiscal 2012, 2011, or 2010.

The Company has established arrangements with certain customers for longer term financing. The Company accounts for these arrangements by recording them at their historical cost less specific allowances at balance sheet dates. Interest income is recognized in the period earned and is recorded as interest income in the Consolidated Income Statement.

Derivative Financial Instruments

Derivative Financial Instruments

The Company uses derivative instruments to manage certain exposures related to foreign currency as well as changes in interest rates as a result of our borrowing activities. We record all derivative instruments as either assets or liabilities in the balance sheet at fair value. The Company currently does not use derivative financial instruments for trading or speculative purposes.

The Company’s foreign currency exposure results from purchasing and selling internationally in several foreign currencies. In addition, the Company has foreign currency risk related to debt that is denominated in currencies other than the U.S. dollar. The Company may reduce its exposure to fluctuations in foreign exchange rates by creating offsetting positions through the use of derivative financial instruments or multi-currency borrowings. The market risk related to the foreign exchange agreements is offset by changes in the valuation of the underlying items. Derivative financial instruments related to foreign currency exposure are accounted for on an accrual basis with gains or losses on these contracts recorded in income in the period in which their value changes, with the offsetting entry for unsettled positions reflected in either other assets or other liabilities. These contracts are generally for a duration of 90 days or less. The Company has elected not to designate its foreign currency contracts as hedging instruments. They are, therefore, marked-to-market with changes in their fair value recorded in the Consolidated Income Statement each period. The Company's foreign currencies are denominated primarily by British pounds, euros, Mexican pesos, Brazilian real and Canadian dollars.

During the fiscal year ended June 30, 2008, the Company entered into an interest rate swap and designated this instrument as a hedge of the cash flows on certain variable rate debt. The interest rate swap matured on September 28, 2011 of the current fiscal year. To the extent the derivative instrument was effective in offsetting the variability of the hedged cash flows, changes in the fair value of the derivative instrument were not included in current earnings, but were reported as other comprehensive income (loss). There was no ineffective portion to be recorded as an adjustment to earnings. There have been no other interest rate swap agreements executed in fiscal year June 30, 2012.

Investments

Investments

The Company has investments that are held in a grantor trust formed by the Company related to the ScanSource, Inc. Nonqualified Deferred Compensation Plan and Founder’s Supplemental Executive Retirement Plan (“SERP”). The Company has classified these investments as trading securities, and they are recorded at fair market value with unrealized gains and losses included in the accompanying Consolidated Income Statements. The Company’s obligations under this deferred compensation plan change in concert with the performance of the investments along with contributions and withdrawals to and from the plan. The fair value of these investments and the corresponding deferred compensation obligation was $11.6 million and $12.9 million as of June 30, 2012 and June 30, 2011, respectively. These investments are classified as either current assets or other non-current assets in the Consolidated Balance Sheets depending on the timing of planned disbursements. The deferred compensation obligation is classified either within current liabilities or other long-term liabilities as well. The amounts of these investments classified as current assets with corresponding current liabilities were $1.2 million and $3.1 million at June 30, 2012 and June 30, 2011, respectively.

Inventories

Inventories

Inventories (consisting entirely of finished goods) are stated at the lower of cost (first-in, first-out method) or market.

Vendor Programs

Vendor Programs

The Company receives incentives from vendors related to cooperative advertising allowances, volume rebates and other incentive agreements. These incentives are generally under quarterly, semi-annual or annual agreements with the vendors. Some of these incentives are negotiated on an ad hoc basis to support specific programs mutually developed between the Company and the vendor. Vendors generally require that we use their cooperative advertising allowances exclusively for advertising or other marketing programs. Incentives received from vendors for specifically identified incremental cooperative advertising programs are recorded as adjustments to selling, general and administrative expenses. The Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 605 – Revenue Recognition, addresses accounting by a customer (including a reseller) for certain consideration received from a vendor. This guidance requires that the portion of these vendor funds in excess of our costs be reflected as a reduction of inventory. Such funds are recognized as a reduction of the cost of products sold when the related inventory is sold.

The Company records unrestricted volume rebates received as a reduction of inventory and as a reduction of the cost of goods sold when the related inventory is sold. Amounts received or receivables from vendors that are not yet earned are deferred in the Consolidated Balance Sheets. In addition, the Company may receive early payment discounts from certain vendors. The Company records early payment discounts received as a reduction of inventory and recognizes the discount as a reduction of cost of goods sold when the related inventory is sold. ASC 605 requires management to make certain estimates of the amounts of vendor incentives that will be received. Actual recognition of the vendor consideration may vary from management estimates based on actual results.

Vendor Concentration

Vendor Concentration

The Company sells products from many suppliers, however, sales from products supplied by Motorola and Avaya each constituted more than 10% of the Company’s net sales for years ended June 30, 2012, 2011 and 2010, respectively.

Product Warranty

Product Warranty

The Company’s vendors generally provide a warranty on the products distributed by the Company and allow the Company to return defective products, including those that have been returned to the Company by its customers. In two of our product lines, the Company offers a self-branded warranty program, in which Management has determined that the Company is the primary obligor of these programs. The Company purchases contracts from unrelated third parties, generally the original equipment manufacturers, to fulfill any obligation to service or replace defective product claimed on these warranty programs. As such, the Company has not recorded a provision for estimated service warranty costs. For all other product lines, the Company does not independently provide a warranty on the products it distributes; however, to maintain customer relations, the Company facilitates returns of defective products from the Company’s customers by accepting for exchange, with the Company’s prior approval, most defective products within 30 days of invoicing.

Property and Equipment

Property and Equipment

Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over estimated useful lives of 3 to 10 years for furniture, equipment and computer software, 40 years for buildings and 15 years for building improvements. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life. Maintenance, repairs and minor renewals are charged to expense as incurred. Additions, major renewals and betterments to property and equipment are capitalized. In fiscal 2010, the Company began the design and development of a new Enterprise Resource Planning System (“ERP”). The compensation costs of employees associated with this process are capitalized to the construction in process asset related to this project.

To the extent that the Company has longstanding, "in-process" projects that have not been implemented for their intended operational use, the Company capitalizes the portion of interest expense incurred during the asset's acquisition period that theoretically could have been avoided in accordance with ASC 835. The amount capitalized is determined by applying the appropriate capitalization rate to the average amount of accumulated expenditures for the asset during the reporting period. The capitalization rate used is based on the rates applicable to borrowings outstanding during the reporting period. Currently, the Company is capitalizing interest expense to its only significant, in-process asset recorded for the new ERP system discussed in the Management, Discussion and Analysis section of this Form 10-K and in Note 3.

Goodwill

Goodwill

The Company accounts for recorded goodwill in accordance with ASC 350, Goodwill and Other Intangible Assets, which requires that goodwill is reviewed annually for impairment or more frequently if impairment indicators exist.Goodwill testing utilizes a two-step impairment analysis, whereby the Company compares the carrying value of each identified reporting unit to its fair value. The carrying value of goodwill is reviewed at a reporting unit level at least annually for impairment, or more frequently if impairment indicators exist. Our goodwill reporting units are our North America segment and, in our international segment, various components one-level below. The fair values of the reporting units are estimated using the net present value of discounted cash flows generated by each reporting unit. Considerable judgment is necessary in estimating future cash flows, discount rates and other factors affecting the estimated fair value of the reporting units, including the operating and macroeconomic factors. Historical financial information, internal plans and projections, and industry information is used in making such estimates.

In the two-step impairment analysis, goodwill is first tested for impairment by comparing the fair value of the reporting unit with the reporting unit's carrying amount to identify any potential impairment. If fair value is determined to be less than carrying value, a second step is used whereby the implied fair value of the reporting unit's goodwill, determined through a hypothetical purchase price allocation, is compared with the carrying amount of the reporting units' goodwill. If the implied fair value of the reporting unit's goodwill is less than its carrying amount, an impairment charge is recorded in current earnings for the difference. We also assess the recoverability of goodwill if facts and circumstances indicate goodwill may be impaired. In our most recent annual test, we estimated the fair value of our reporting units primarily based on the income approach utilizing the discounted cash flow method. We also utilized fair value estimates derived from the market approach utilizing the public company market multiple method to validate the results of the discounted cash flow method, which required us to make assumptions about the applicability of those multiples to our reporting units. The discounted cash flow method required us to estimate future cash flows and discount those amounts to present value. The key assumptions utilized in determining fair value included:

•Industry weighted-average cost of capital ("WACC"): We utilized a WACC relative to each reporting unit's respective geography and industry as the discount rate for estimated future cash flows. The WACC is intended to represent a rate of return that would be expected by a market place participant in each respective geography.

•Operating income: We utilized historical and expected revenue growth rates, gross margins and operating expense percentages, which varied based on the projections of each reporting unit being evaluated.

•Cash flows from working capital changes: We utilized a projected cash flow impact pertaining to expected changes in working capital as each of our goodwill reporting units grow.

See Note 5 to the consolidated financial statements for more information regarding goodwill.

Intangible Assets

Intangible Assets

Intangible assets consist of customer relationships, debt issuance costs, trade names, distributor agreements and non-compete agreements. Customer relationships and distributor agreements are amortized using the straight-line method over their estimated useful lives, which range from 5 to 15 years. Debt issuance costs are amortized over the term of the credit facility.

Trade names are amortized over a period ranging from 1 to 2 years. Non-compete agreements are amortized over their contract life. These assets are included in other assets and are shown in detail in Note 5, Goodwill and Other Identifiable Intangible Assets.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset or asset group may not be recoverable. Tests for recoverability of a long-lived asset to be held and used are measured by comparing the carrying amount of the long-lived asset to the sum of the estimated future discounted cash flows expected to be generated by the asset. In estimating the future discounted cash flows we use projections of cash flows directly associated with, and which are expected to arise as a direct result of, the use and eventual disposition of the assets. If it is determined that a long-lived asset is not recoverable, an impairment loss would be calculated equal to the excess of the carrying amount of the long-lived asset over its fair value. The Company did not record any material impairment charges for the fiscal years ended June 30, 2012, 2011 and 2010.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. The carrying values of financial instruments such as accounts receivable, accounts payable, accrued liabilities, borrowings under the revolving credit facility and subsidiary lines of credit approximate fair value based upon either short maturities or variable interest rates of these instruments. For additional information related to the fair value of derivatives, please see Note 8, Fair Value of Financial Instruments.

Liability for Contingent Consideration

Liability for Contingent Consideration

In addition to the initial cash consideration paid to former CDC shareholders, the Company is obligated to make additional earnout payments based on future results through fiscal year 2015 based on a multiple of the subsidiary’s pro forma net income as defined in Exhibit 2.1.(b)(2) of the Share Purchase and Sale Agreement by and among the Company’s Brazilian subsidiary, the former shareholders and CDC, dated April 7, 2011. Future payments are to be paid in Brazilian currency, the real. The Company made its first payment in January 2012 to the former shareholders of $2.0 million. The next payment is anticipated to be made on August 31, 2012 based on the pro forma results of the twelve month period ended June 30, 2012. The remaining earnout payments will become payable in three additional installments on August 31, 2013 and 2014 with the final payment on October 31, 2015. In accordance with ASC Topic 805, the Company determined the fair value of this liability for contingent consideration on the acquisition date using a discounted cash flow model following the income approach. Each period the Company reflects the contingent consideration liability at fair value with changes recorded in the change in fair value of contingent consideration line item in the Consolidated Income Statements.

Contingencies

Contingencies

The Company accrues for contingent obligations, including estimated legal costs, when it is probable that a liability is incurred and the amount is reasonably estimable. As facts concerning contingencies become known, management reassesses its position and makes appropriate adjustments to the financial statements. Estimates that are particularly sensitive to future changes include tax, legal, and other regulatory matters, which are subject to change as events evolve, and as additional information becomes available during the administrative and litigation process.

Revenue Recognition

Revenue Recognition

Revenue is recognized once four criteria are met: (1) the Company must have persuasive evidence that an arrangement exists; (2) delivery must occur (this includes the transfer of both title and risk of loss, provided that no significant obligations remain); (3) the price must be fixed and determinable; and (4) collectability must be reasonably assured. The Company allows its customers to return product for exchange or credit subject to certain limitations. A provision for estimated losses on returns is recorded based on historical experience.

Service revenue associated with configuration and marketing services is recognized when the work is complete and the four criteria discussed above have been substantially met. The Company also distributes third-party service contracts, typically for product maintenance and support. Since the Company acts as an agent on behalf of most of these service contracts sold, revenue is recognized net of cost at the time of sale. However, the Company distributes some self-branded warranty programs and engages a third party (generally the original equipment manufacturer) to cover the fulfillment of any obligations arising from these contracts. These revenues and associated third party costs are amortized over the life of the contract and presented in net sales and cost of goods sold, respectively. Other service revenue associated with configuration, marketing, service contracts and other services approximates 2% or less of consolidated net sales for fiscal years 2012, 2011 and 2010.

During the fiscal years ended June 30, 2012, 2011 and 2010, the Company has not engaged in any sales transactions involving multiple element arrangements. Had any arrangements with multiple deliverables occurred, the Company would follow the guidance set forth in ASC 605.

Shipping Revenue and Costs

Shipping Revenue and Costs

Shipping revenue is included in net sales, and related costs are included in cost of goods sold. Shipping revenue for the years ended June 30, 2012, 2011 and 2010 was $12.2 million, $11.5 million and $10.2 million, respectively.

Advertising Costs

Advertising Costs

The Company defers advertising-related costs until the advertising is first run in trade or other publications, or in the case of brochures, until the brochures are printed and available for distribution. Advertising costs, included in marketing costs, after vendor reimbursement, were not significant in any of the three fiscal years ended June 30, 2012. Deferred advertising costs at June 30, 2012 and 2011 were also not significant.

Foreign Currency

Foreign Currency

The currency effects of translating the financial statements of the Company’s foreign entities that operate in their local currency are included in the cumulative currency translation adjustment component of accumulated other comprehensive income or loss. The Company's functional currencies include dollars, euros, British pounds and Brazilian real. The assets and liabilities of these foreign entities are translated into U.S. dollars using the exchange rate at the end of the respective period. Sales, costs and expenses are translated at average exchange rates effective during the respective period. Foreign currency transactional and re-measurement gains and losses are included in other expense (income) in the consolidated income statement. Such amounts are not significant to any of the periods presented.

Income Taxes

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred income taxes reflect tax consequences on future years of differences between the tax bases of assets and liabilities and their financial reporting amounts. Valuation allowances are provided against deferred tax assets when it is more likely than not that an asset will not be realized in accordance with ASC 740, Accounting for Income Taxes. Federal income taxes are not assessed on the undistributed earnings of foreign subsidiaries because it has been the practice of the Company to reinvest those earnings in the business outside the United States. See Note 11 for further discussion.

Additionally, the Company maintains reserves for uncertain tax provisions in accordance with ASC 740. See Note 11 for more information.

Share-Based Payments

Share-Based Payments

The Company accounts for share-based compensation using the provisions of ASC 718, Accounting for Stock Compensation, which requires the recognition of the fair value of share-based compensation. Share-based compensation is estimated at the grant date based on the fair value of the awards, in accordance with the provisions of ASC 718. Since this compensation cost is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company has elected to expense grants of awards with graded vesting on a straight-line basis over the requisite service period for each separately vesting portion of the award.

Comprehensive Income

Comprehensive Income

ASC 220, Comprehensive Income, defines comprehensive income as the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The primary components of comprehensive income for the Company include net income, foreign currency translation adjustments arising from the consolidation of the Company’s foreign subsidiaries, and any unrealized gains or losses on effectively hedged transactions, net of tax. Currently, the Company is not engaged in any fair value of cash flow hedges that qualify for comprehensive income treatment.

Business Combinations

Business Combinations

The Company accounts for business combinations in accordance with ASC Topic 805, Business Combinations. ASC 805 establishes principles and requirements for recognizing the total consideration transferred to and the assets acquired, liabilities assumed and any non-controlling interest in the acquired target in a business combination. ASC 805 also provides guidance for recognizing and measuring goodwill acquired in a business combination and requires the acquirer to disclose information that users may need to evaluate and understand the financial impact of the business combination. See Note 4 for further discussion.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS. The amendments in this update are the result of the work of the FASB and the International Accounting Standards Board (“IASB”) to develop common requirements for measuring fair value and for disclosing information about fair value measurements. The amendment became effective for interim and annual periods beginning after December 15, 2011, which was the interim period ended March 31, 2012 for the Company. This amendment has had no impact on the Company's consolidated financial statements.

In June 2011, the FASB issued ASU 2011-05, Presentation of Comprehensive Income. The objective of this update is to improve the comparability, consistency and transparency of financial reporting and to increase the prominence of items reported in other comprehensive income. The update will become effective for fiscal years, and the interim periods within those years, beginning after December 15, 2011, which will be fiscal 2013 for the Company. The update will eliminate the option to present components of other comprehensive income as part of the statement of changes in stockholders' equity, which is the Company's current practice, and will require companies to present all nonowner changes in stockholders' equity either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The Company is currently determining which method of presentation will be used in future filings.

In September 2011, the FASB issued ASU 2011-08, Testing Goodwill for Impairment. The objective of this update is to simplify how entities, both public and nonpublic, test goodwill for impairment. The amendments in the update permit an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test described in Topic 350. The more likely than not threshold is defined as having a likelihood of more than 50 percent. This amendment is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011, which will be fiscal 2013 for the Company. Early adoption is permitted. The Company is currently assessing the future impact of this ASU on its consolidated financial statements.

In December 2011, the FASB issued ASU 2011-11, Disclosures about Offsetting Assets and Liabilities. The objective of this update is to converge the differences in U.S. GAAP and IFRS in disclosures regarding offsetting (netting) assets and liabilities in the presentation of financial statements. This amendment will enhance disclosures required by U.S. GAAP by requiring improved information about financial instruments and derivative instruments that are either (1) offset in accordance with either Section 210-20-45 or Section 815-10-45 or (2) subject to an enforceable master netting arrangement or similar agreement. The Company currently does not offset any financial instruments or derivatives and is currently assessing the future impact of this ASU on its consolidated financial statements.

In July 2012, the FASB issued ASU 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment. The objective of this update is to simplify how entities, both public and nonpublic, test indefinite-lived intangible assets other than goodwill. This amendment allows companies to first assess qualitative factors of impairment of all indefinite-lived intangible assets, similar to the provisions in ASU 2011-08. The Company currently does not have any indefinite-lived intangible assets, other than goodwill and is currently assessing the future impact of this ASU on its consolidated financial statements.

XML

Goodwill and Other Identifiable Intangible Assets (Identifiable Intangible Assets) (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Jun. 30, 2011
Gross Carrying Amount	$ 40,657	$ 41,412
Accumulated Amortization	13,600	9,059
Net Book Value	27,057	32,353
Customer Relationships [Member]
Gross Carrying Amount	34,483	34,515
Accumulated Amortization	10,864	6,989
Net Book Value	23,619	27,526
Trade Names [Member]
Gross Carrying Amount	2,127	2,743
Accumulated Amortization	1,285	286
Net Book Value	842	2,457
Non-compete Agreements [Member]
Gross Carrying Amount	938	2,310
Accumulated Amortization	379	1,085
Net Book Value	559	1,225
Distributor Agreements [Member]
Gross Carrying Amount	610	705
Accumulated Amortization	105	74
Net Book Value	505	631
Other Intangible Assets [Member]
Gross Carrying Amount	2,499	1,139
Accumulated Amortization	967	625
Net Book Value	$ 1,532	$ 514

XML

Property and Equipment (Components of Property and Equipment) (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Jun. 30, 2011
Property, Plant and Equipment [Abstract]
Land	$ 3,009	$ 3,009
Buildings and leasehold improvements	18,231	16,029
Computer software and equipment	13,829	14,270
Furniture, fixtures and equipment	14,739	15,847
Construction in Progress	29,045	18,738
Property and equipment, gross	78,853	67,893
Less accumulated depreciation	(30,068)	(31,074)
Property and equipment, net	$ 48,785	$ 36,819

XML

Income Taxes (Components of Pretax Earnings) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Income Tax Expense (Benefit) [Abstract]
Domestic	$ 103,711	$ 96,436	$ 65,566
Foreign	7,500	15,450	10,175
Income before income taxes	$ 111,211	$ 111,886	$ 75,741

XML

Segment Information (Tables)

12 Months Ended

Jun. 30, 2012

Segment Reporting, Measurement Disclosures [Abstract]

Financial Information by Segment

Selected financial information for each business segment is presented below:

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
Sales:
North American distribution	$	2,285,342		$	2,048,767		$	1,688,663
International distribution	778,837			643,863			448,967
Less intersegment sales	(48,883		)	(26,099		)	(22,651		)
	$	3,015,296		$	2,666,531		$	2,114,979
Depreciation and amortization:
North American distribution	$	3,960		$	4,246		$	4,730
International distribution	5,962			2,416			1,334
	$	9,922		$	6,662		$	6,064
Operating income:
North American distribution	$	104,044		$	94,932		$	64,342
International distribution	9,472			18,177			11,434
	$	113,516		$	113,109		$	75,776
Assets:
North American distribution	$	813,889		$	785,057		$	670,467
International distribution	387,917			397,131			189,283
	$	1,201,806		$	1,182,188		$	859,750
Capital expenditures:
North American distribution	$	9,789		$	14,366		$	5,344
International distribution	3,001			503			262
	$	12,790		$	14,869		$	5,606

Financial Information by Product Category

Selected financial information by product category is presented below:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Sales by Product Category:
POS, barcoding and security products	$	1,837,307	$	1,615,461	$	1,300,525
Communication products	1,177,989		1,051,070		814,454
	$	3,015,296	$	2,666,531	$	2,114,979

XML

Short-Term Borrowings and Long-Term Debt (Narrative) (Details)	12 Months Ended				12 Months Ended							12 Months Ended				12 Months Ended				12 Months Ended		12 Months Ended
	Jun. 30, 2012 USD ($) quarter	Jun. 30, 2011 USD ($)	Jun. 30, 2010 USD ($)	Jun. 30, 2012 Foreign Line of Credit [Member] EUR (€)	Jun. 30, 2012 Multi-Currency Revolving Credit Facility [Member] USD ($)	Jun. 30, 2011 Multi-Currency Revolving Credit Facility [Member] USD ($)	Oct. 11, 2011 Multi-Currency Revolving Credit Facility [Member] USD ($)	Jun. 30, 2012 Multi-Currency Revolving Credit Facility, Accordion Feature [Member] USD ($)	Jun. 30, 2012 Multi-Currency Revolving Credit Facility, Combined with Accordion Feature [Member] USD ($)	Jun. 30, 2012 Libor-Based Loans [Member]	Jun. 30, 2012 Prime Rate-Based Loans [Member]	Jun. 30, 2012 Minimum [Member] Foreign Line of Credit [Member]	Jun. 30, 2012 Minimum [Member] Multi-Currency Revolving Credit Facility [Member]	Jun. 30, 2012 Minimum [Member] Libor-Based Loans [Member]	Jun. 30, 2012 Minimum [Member] Prime Rate-Based Loans [Member]	Jun. 30, 2012 Maximum [Member] Foreign Line of Credit [Member] EUR (€)	Jun. 30, 2012 Maximum [Member] Multi-Currency Revolving Credit Facility [Member]	Jun. 30, 2012 Maximum [Member] Libor-Based Loans [Member]	Jun. 30, 2012 Maximum [Member] Prime Rate-Based Loans [Member]	Jun. 30, 2012 Unsecured Notes Payable to Bank [Member]	Jan. 02, 2008 Unsecured Notes Payable to Bank [Member] USD ($)	Jun. 30, 2012 Industrial Development Revenue Bond [Member]	Jun. 30, 2012 Letter of Credit [Member] Maximum [Member] Multi-Currency Revolving Credit Facility [Member] USD ($)
Borrowing capacity under credit facility				€ 6,000,000	$ 300,000,000		$ 250,000,000	$ 150,000,000	$ 450,000,000														$ 50,000,000
Percentage spread points on variable rate debt instrument				1.25%						1.00%	0.00%	1.25%		1.00%	0.00%	2.00%		2.25%	1.25%	0.65%		0.85%
Line of credit facility, unused capacity, commitment fee percentage												0.10%	0.175%			0.275%	0.40%
Line of credit facility, unused capacity, threshhold for commitment fees																3,000,000
Line of credit facility, term (in years)					5 years
Debt issuance costs paid					1,400,000
Maturity of credit facility					Oct. 11, 2016
Debt instrument, covenant requirement, leverage ratio, EBITDA, number of quarters in measurement period	4
Revolving credit facility, amount borrowed					1,408,500,000	769,500,000
Revolving credit facility, amount repaid					1,433,200,000	743,900,000
Net cash flows on revolving credit facility	(25,999,000)	25,376,000	0
Percentage of capital stock or other equity interest pledged per credit agreement					65.00%
Revolving credit facility, amount outstanding					0	26,513,000
Average daily balance on revolving credit facility					78,600,000	14,200,000
Amount available for additional borrowings					300,000,000	223,500,000
Face amount of debt																					$ 25,000,000
Maturity date of debt instrument																				Sep. 28, 2012		Sep. 01, 2032
Maximum time period of interest (in years)																						10 years

XML

Share-Based Compensation (Restricted Stock Granted) (Details) (Restricted Stock [Member], USD $)	12 Months Ended
	Jun. 30, 2012
Shares granted	173,246
Grant date fair value	$ 34.34
Certain Employees Based on Promotions, Granted January 31, 2012 [Member]
Shares granted	5,000
Date granted	Jan. 31, 2012
Grant date fair value	$ 37.56
Vesting period	3 years
Certain Employees Based on Promotions, Granted May 1, 2012 [Member]
Shares granted	4,500
Date granted	May 01, 2012
Grant date fair value	$ 32.61
Vesting period	3 years
Certain Employees, Granted June 18, 2012 [Member]
Shares granted	1,000
Date granted	Jun. 18, 2012
Grant date fair value	$ 31.33
Vesting period	3 years
Certain Employees, Granted November 1, 2012 [Member]
Shares granted	1,500
Date granted	Nov. 01, 2012
Grant date fair value	$ 32.94
Vesting period	3 years
Certain Employees, Granted December 2, 2011 [Member]
Shares granted	147,683
Date granted	Dec. 02, 2011
Grant date fair value	$ 34.35
Vesting period	3 years
Executive Officers, Vesting Based on Certain Service and Performance Conditions [Member]
Shares granted	1,563
Date granted	May 14, 2012
Grant date fair value	$ 32.01
Vesting period	2 years
Non-Employee Directors [Member]
Shares granted	12,000	[1]
Date granted	Dec. 02, 2011	[1]
Grant date fair value	$ 34.35	[1]
Vesting period	6 months	[1]

[1] Per the Amended and Restated Director’s Equity Compensation Plan, non-employee directors will receive annual awards of restricted stock, as opposed to stock options. The number of shares of restricted stock to be granted will be established from time to time by the Board of Directors. Currently, the number of shares of restricted stock awarded to each non-employee director will be determined by dividing $80,000 by the fair market value of the common stock on the date of grant. These awards will generally vest in full on the day that is six months after the date of grant or upon the earlier occurrence of (i) the director’s termination of service as a director by reason of death, disability or retirement, or (ii) a change in control by the Company. The compensation expense associated with these awards will be recognized on a pro-rata basis over this period.

XML

Fair Value of Financial Instruments (Fair Value, Business Acquisition, Liability for Contingent Consideration) (Details) (USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value at beginning of period	$ 23,794,000	$ 0
Issuance of contingent consideration	0	23,952,000
Payments	(2,000,000)	0
Change in fair value	120,000	(128,000)
Fluctuation due to foreign currency exchange	(5,261,000)	(30,000)
Fair value at end of period	16,653,000	23,794,000
Liability for contingent consideration, current	4,976,000	2,398,000
Undiscounted contingent consideration payments, maximum	$ 24,000,000

XML

Acquisitions (Supplemental Pro Forma Information) (Details) (CDC Brasil S A [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
CDC Brasil S A [Member]
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Net sales	$ 2,786,905	$ 2,247,721
Net income	$ 75,328	$ 52,450
Diluted earnings per share	$ 2.76	$ 1.95

XML

Earnings per Share

12 Months Ended

Jun. 30, 2012

Earnings Per Share [Abstract]

Earnings per Share

Earnings per Share

Basic earnings per share are computed by dividing net income by the weighted-average number of common shares outstanding. Diluted earnings per share are computed by dividing net income by the weighted-average number of common and potential common shares outstanding.

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands, except per share data)
Fiscal Year Ended June 30, 2012:
Net income	$	74,288	$	73,523	$	48,812
Denominator:
Weighted-average shares, basic	27,362		26,872		26,605
Dilutive effect of share-based payments	389		374		264
Weighted-average shares, diluted	27,751		27,246		26,869
Net income per common share, basic	$	2.72	$	2.74	$	1.83
Net income per common share, diluted	$	2.68	$	2.70	$	1.82

For the years ended June 30, 2012, 2011 and 2010, there were 583,000, 947,000 and 1,208,000 weighted average shares, respectively, excluded from the computation of diluted earnings per share because their effect would have been antidilutive.

XML

Share-Based Compensation (Narrative) (Details) (USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Options granted during period	85,578
Exercise price percentage of fair market value at grant date	100.00%
Total aggregate intrinsic value of options exercised	$ 5,800,000	$ 5,200,000	$ 1,600,000
Fair value of shares vested	2,900,000	3,500,000	4,300,000
Stock Options [Member]
Options granted during period	85,578
Vesting period (years)	3 years
Contractual life (years)	10
Unrecognized compensation cost	2,300,000
Weighted-average period of recognition of unrecognized compensation cost (years)	1 year 1 month 2 days
Restricted Stock [Member]
Unrecognized compensation cost	6,400,000
Weighted-average period of recognition of unrecognized compensation cost (years)	1 year 10 months 17 days
Shares granted	173,246
Amount to be divided by fair market value of common stock	$ 80,000
Shares withheld for income taxes for share based compensation	43,122
Restricted Stock Units (RSUs) [Member]
Shares granted	159,746
2002 Long-Term Incentive Plan [Member]
Shares available for future grant	1,888,923
2003 Director Plan [Member]
Shares available for future grant	88,100

XML

Acquisitions (Narrative) (Details) (USD $)	12 Months Ended			0 Months Ended	3 Months Ended	12 Months Ended
	Jun. 30, 2012 installment	Jun. 30, 2011	Jun. 30, 2010	Apr. 15, 2011 CDC Brasil S A [Member]	Jun. 30, 2011 CDC Brasil S A [Member]	Jun. 30, 2012 CDC Brasil S A [Member]	Jun. 30, 2011 CDC Brasil S A [Member]	Jun. 30, 2012 Customer Relationships [Member] CDC Brasil S A [Member]	Jun. 30, 2011 Customer Relationships [Member] CDC Brasil S A [Member]	Jun. 30, 2012 Other Current Assets [Member] CDC Brasil S A [Member]	Jun. 30, 2011 Other Current Assets [Member] CDC Brasil S A [Member]	Apr. 15, 2011 Other Current Assets [Member] CDC Brasil S A [Member]	Jun. 30, 2012 Other Assets [Member] CDC Brasil S A [Member]	Jun. 30, 2011 Other Assets [Member] CDC Brasil S A [Member]	Apr. 15, 2011 Other Assets [Member] CDC Brasil S A [Member]	Jun. 30, 2012 Accrued Liabilities [Member] CDC Brasil S A [Member]	Jun. 30, 2011 Accrued Liabilities [Member] CDC Brasil S A [Member]	Apr. 15, 2011 Accrued Liabilities [Member] CDC Brasil S A [Member]	Jun. 30, 2012 Other Long-Term Liabilities [Member] CDC Brasil S A [Member]	Jun. 30, 2011 Other Long-Term Liabilities [Member] CDC Brasil S A [Member]	Apr. 15, 2011 Other Long-Term Liabilities [Member] CDC Brasil S A [Member]
Business Acquisition [Line Items]
Escrowed pre-acquisition contingencies receivable				$ 23,990,000						$ 3,886,000	$ 0	$ 0	$ 5,112,000	$ 16,250,000	$ 16,013,000
Accrued expenses and other liabilities				3,896,000												3,886,000	0	0	5,112,000	16,250,000	16,013,000
Percentage of company equity acquired				100.00%
Name of company acquisition				CDC Brasil S.A.
Business combination, acquisition related costs					100,000	300,000	1,100,000
Initial payment for cash share purchase				36,228,000
Earnout payments, installments	4
Liability for contingent consideration, current and non-current	16,653,000	23,794,000	0
Liability for contingent consideration, current	4,976,000	2,398,000
Liability for contingent consideration, non-current	11,677,000	21,396,000
Undiscounted contingent consideration payments, maximum	24,000,000
Change in fair value of the contingent consideration recognized in the consolidated financial statements	(120,000)	128,000	0
Cash paid to escrow				25,500,000		12,900,000
Business acquisition, escrow deposit disbursements, pre-acquisition contingency						5,300,000
Business acquisition, escrow deposit disbursements to seller						2,500,000
Undiscounted range of indemnification assets and contingent liabilities, maximum						12,400,000
Revenue contributed by CDC							29,600,000
Net income contributed by CDC							700,000
Incremental amortization expense						$ 441	$ 700,000
Weighted average amortization period						5 years		6 years	7 years

XML

Goodwill and Other Identifiable Intangible Assets (Tables)

12 Months Ended

Jun. 30, 2012

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in the Carrying Amount of Goodwill

Changes in the carrying amount of goodwill for the years ended June 30, 2012 and 2011, by reporting segment, are as follows:

	North American Distribution Segment		International Distribution Segment			Total
	(in thousands)
Balance as of June 30, 2010	$	20,081	$	13,704		$	33,785
Goodwill acquired during 2011	—		24,643			24,643
Fluctuations in foreign currencies	—		662			662
Balance as of June 30, 2011	20,081		39,009			59,090
CDC measurement period adjustments	—		914			914
Fluctuations in foreign currencies	—		(6,119		)	(6,119		)
Balance as of June 30, 2012	$	20,081	$	33,804		$	53,885

Identifiable Intangible Assets

The following table shows the Company’s identifiable intangible assets as of June 30, 2012 and 2011, respectively. These balances are included on the consolidated balance sheet within other assets:

	June 30, 2012						June 30, 2011
	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
	(in thousands)
Amortized intangible assets:
Customer relationships	$	34,483	$	10,864	$	23,619	$	34,515	$	6,989	$	27,526
Debt issue costs	2,499		967		1,532		1,139		625		514
Trade names	2,127		1,285		842		2,743		286		2,457
Non-compete agreements	938		379		559		2,310		1,085		1,225
Distributor agreements	610		105		505		705		74		631
Total	$	40,657	$	13,600	$	27,057	$	41,412	$	9,059	$	32,353

Estimated Future Amortization Expense

Estimated future amortization expense is as follows:

	Amortization Expense
	(in thousands)
Year Ended June 30,
2013	$	5,217
2014	4,342
2015	4,341
2016	4,312
2017	3,437
Thereafter	5,408
Total	$	27,057

XML

Acquisitions (Tables)

12 Months Ended

Jun. 30, 2012

Algol Europe GmbH [Member]

Business Acquisition [Line Items]

Acquisition Related Purchase Price Allocation

The purchase price, identified intangibles and goodwill as of the acquisition date were as follows:

	Purchase Price		Goodwill		Identifiable Intangible Assets
	(in thousands)
Algol Europe, GmbH	$	9,965	$	712	$	2,287

CDC Brasil S A [Member]

Business Acquisition [Line Items]

Acquisition Related Purchase Price Allocation

These adjustments are summarized in the following table:

	As of April 15, 2011
	Preliminary Purchase Allocation			Purchase Accounting Adjustments			Revised Purchase Allocation
Consideration	(in thousands)
Initial cash payment, net of cash acquired	$	36,228		$	—		$	36,228
Fair value of earnout obligation	23,952			—			23,952
Total consideration	60,180			—			60,180
Recognized amounts of identifiable assets acquired and liabilities assumed
Accounts receivable, net of allowance	21,378			—			21,378
Inventories	30,560			—			30,560
Prepaid expenses and other assets	3,575			—			3,575
Current deferred income taxes, net	1,409			(3,225		)	(1,816		)
Property and equipment, net	1,741			—			1,741
Intangible assets	18,327			4,278			22,605
Escrowed pre-acquisition contingencies receivable	16,013			7,977			23,990
Short-term borrowings	(1,277		)	—			(1,277		)
Accounts payable	(34,006		)	—			(34,006		)
Accrued expenses and other liabilities	(3,896		)	—			(3,896		)
Income taxes payable	(2,097		)	1,174			(923		)
Escrowed pre-acquisition contingencies payable	(16,013		)	(7,977		)	(23,990		)
Long-term deferred income taxes, net	—			(3,141		)	(3,141		)
Other long-term liabilities	(177		)	—			(177		)
Total identifiable net assets	35,537			(914		)	34,623
Goodwill	$	24,643		$	914		$	25,557

Identified Intangible Assets

The revised purchase price allocated to the fair value of identified intangible assets associated with the acquisition of CDC after the finalization of purchase accounting is as follows:

	Amount
Identified intangible assets	(in thousands)
Trade names (2 year useful life)	$	2,746
Customer relationships (6 year useful life)	18,965
Non-compete agreements (5 year useful life)	894
Total identified intangible assets	$	22,605

Impact Of Incremental Amortization And Related Tax Effect

The impact of the incremental amortization and related income tax effect recorded in the third quarter of this fiscal year is summarized in the following table:

	June 30, 2012
	(in thousands)
Consolidated income statement
Amortization expense	$	441
Provision for income taxes	$	(150	)

Business Acquisition, Pre-acquisition Contingencies and Related Indemnification Receivables

The table below summarizes the balances and line item presentation of these pre-acquisition contingencies and corresponding indemnification receivables in the Company's consolidated balance sheet:

	June 30, 2012		June 30, 2011		April 15, 2011
	(in thousands)
Assets
Prepaid expenses and other assets (current)	$	3,886	$	—	$	—
Other assets (noncurrent)	$	5,112	$	16,250	$	16,013
Liabilities
Other current liabilities	$	3,886	$	—	$	—
Other long-term liabilities	$	5,112	$	16,250	$	16,013

Supplemental Pro Forma Information

The following unaudited pro forma summary presents consolidated information of the Company as if the business combination had occurred on July 1, 2009, based on the final purchase price allocation as adjusted in fiscal 2012 for the additional purchase price allocated to CDC's customer relationships:

	June 30,
	2011		2010
Unaudited, Supplemental Pro Forma Information	(in thousand, except per share information)
Net sales	$	2,786,905	$	2,247,721
Net income	$	75,328	$	52,450
Diluted earnings per share	$	2.76	$	1.95

XML

Derivatives and Hedging Activities (Narrative) (Details) (USD $)	1 Months Ended	12 Months Ended
	Sep. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Notional amount of foreign currency contracts outstanding		$ 62,300,000
Loss on foreign currency derivative instruments not designated as hedging instruments	$ 2,500,000	$ (1,480,000)	$ (2,706,000)	$ (1,065,000)
Currency devaluation, percentage		11.80%

XML

Acquisitions (Acquisition Related Purchase Price Allocation) (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Jun. 30, 2011	Nov. 30, 2009 Algol Europe GmbH [Member]	Jun. 30, 2012 CDC Brasil S A [Member]	Apr. 15, 2011 CDC Brasil S A [Member]	Apr. 15, 2011 Preliminary Purchase Allocation [Member] CDC Brasil S A [Member]	Apr. 15, 2011 Purchase Price Allocation Adjustments [Member] CDC Brasil S A [Member]
Initial cash payment, net of cash acquired					$ 36,228	$ 36,228	$ 0
Fair value of earnout obligation	0	23,952			23,952	23,952	0
Total consideration			9,965		60,180	60,180	0
Accounts receivable, net of allowance					21,378	21,378	0
Inventories					30,560	30,560	0
Prepaid expenses and other assets					3,575	3,575	0
Current deferred income taxes, net					(1,816)	1,409	(3,225)
Property and equipment, net					1,741	1,741	0
Intangible assets			2,287	22,605	22,605	18,327	4,278
Escrowed pre-acquisition contingencies receivable					23,990	16,013	7,977
Short-term borrowings					(1,277)	(1,277)	0
Accounts payable					(34,006)	(34,006)	0
Accrued expenses and other liabilities					(3,896)	(3,896)	0
Income taxes payable					(923)	(2,097)	1,174
Escrowed pre-acquisition contingencies payable					(23,990)	(16,013)	(7,977)
Long-term deferred income taxes, net					(3,141)	0	(3,141)
Other long-term liabilities					(177)	(177)	0
Total identifiable net assets					34,623	35,537	(914)
Goodwill			$ 712		$ 25,557	$ 24,643	$ 914

XML

Short-Term Borrowings and Long-Term Debt (Tables)

12 Months Ended

Jun. 30, 2012

Debt Disclosure [Abstract]

Short-term Borrowings

The outstanding balances at June 30, 2012 and 2011 are as follows:

	June 30, 2012		June 30, 2011
	(in thousands)
Short-term borrowings	$	4,268	$	3,164

Revolving Credit Facility

The outstanding balances at June 30, 2012 and June 30, 2011 are as follows:

	June 30, 2012		June 30, 2011
	(in thousands)
Revolving credit facility	$	—	$	26,513

Long-Term Debt

The balances on the bond and promissory note as of June 30, 2012 and 2011 are as follows:

	June 30, 2012		June 30, 2011
	(in thousands)
Industrial Development Revenue Bond, monthly payments of interest only, 1.09% variable interest rate at June 30, 2012 and maturing on September 1, 2032	$	5,429	$	5,429
Unsecured note payable to a bank, monthly payments of interest only and maturing in fiscal 2013	—		25,000
	5,429		30,429
Less current portion	—		—
Long-term portion	$	5,429	$	30,429

Maturities of Revolving Credit Facility and Long-term Debt

Scheduled maturities of the Company’s revolving credit facility and long-term debt at June 30, 2012 are as follows:

	Future Debt Payments
	(in thousands)
Fiscal year:
2013	$	—
2014	—
2015	—
2016	—
2017	—
Thereafter	5,429
Total principal payments	$	5,429

XML

Derivatives and Hedging Activities (Tables)

12 Months Ended

Jun. 30, 2012

General Discussion of Derivative Instruments and Hedging Activities [Abstract]

Derivative Contracts and Changes in Underlying Value of the Foreign Currency Exposures

Summarized financial information related to these derivative contracts and changes in the underlying value of the foreign currency exposures are as follows:

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
Net foreign exchange derivative contract gain (loss)	$	(1,480	)	$	(2,706	)	$	(1,065	)
Net foreign currency transactional and re-measurement gain (loss)	$	(2,286	)	$	1,741		$	826
Net foreign currency gain (loss)	$	(3,766	)	$	(965	)	$	(239	)

Components of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (loss)

The components of the cash flow hedge included in accumulated other comprehensive income (loss), net of income taxes, in the consolidated statements of shareholders’ equity, are as follows:

	Fiscal Year Ended June 30,
	2012			2011
	(in thousands)
Net interest expense recognized as a result of interest rate swap	$	216		$	859
Unrealized gain (loss) in fair value of interest swap rates	(1		)	(119		)
Net increase (decrease) in accumulated other comprehensive income (loss)	$	215		$	740
Income tax effect	(76		)	(272		)
Net increase (decrease) in accumulated other comprehensive income (loss), net of tax	$	139		$	468

Derivative Instruments

The Company has the following derivative instruments located on the Consolidated Balance Sheets and Income Statements, utilized for the risk management purposes detailed above:

	As of June 30, 2012
	Fair Value of  Derivatives Designated as Hedge Instruments		Fair Value of  Derivatives Not Designated as Hedge Instruments
	(in thousands)
Derivative assets:(a)
Foreign exchange contracts	$	—	$	21
Derivative liabilities:(b)
Foreign exchange contracts	$	—	$	110

(a) All derivative assets are recorded as prepaid expense and other assets in the Consolidated Balance Sheets.

(b) All derivative liabilities are recorded as accrued expenses and other liabilities in the Consolidated Balance Sheets.

XML

Business and Summary of Significant Accounting Policies

12 Months Ended

Jun. 30, 2012

Accounting Policies [Abstract]

Business and Summary of Significant Accounting Policies

Business and Summary of Significant Accounting Policies

Business Description

ScanSource, Inc. and its subsidiaries (the “Company”) is a leading wholesale distributor of specialty technology products, providing value-added distribution sales to resellers in the specialty technology markets. The Company has two geographic distribution segments: the North American distribution segment serving the United States and Canada from the Southaven, Mississippi distribution center, and an international segment currently serving Latin America and Europe from distribution centers located in Florida, Mexico and Brazil, and in Belgium, respectively. The North American distribution segment markets automatic identification and data capture (“AIDC”) and point-of-sale (“POS”) products through its ScanSource POS and Barcoding sales unit; voice, data and converged communications equipment through its Catalyst Telecom sales unit; video conferencing, telephony, and communications products through its ScanSource Communications unit; and electronic security products and wireless infrastructure products through its ScanSource Security Distribution unit. The international distribution segment markets AIDC, POS, communications and security products through its ScanSource Latin America sales unit; AIDC and POS products through its ScanSource Europe sales unit; and communication products through its ScanSource Communications sales unit in Europe.

On April 15, 2011, the Company purchased all of the shares of CDC Brasil S.A. (“CDC”), formerly known as CDC Brasil Distribuidora LTDA. CDC, the leading POS and Barcoding distributor in Brazil, is now included under the ScanSource Latin America operating unit.

Consolidation Policy

The consolidated financial statements include the accounts of the Company. All significant inter-company accounts and transactions have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to the allowance for uncollectible accounts receivable and inventory reserves. Management bases its estimates on assumptions that management believes to be reasonable under the circumstances, the results of which form a basis for making judgments about the carrying value of assets and liabilities that are not readily available from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, management believes that its estimates, including those for the above described items, are reasonable and that the actual results will not vary significantly from the estimated amounts.

The following significant accounting policies relate to the more significant judgments and estimates used in the preparation of the Consolidated Financial Statements:

(a) Allowances for Trade and Notes Receivable

The Company maintains an allowance for uncollectible accounts receivable for estimated losses resulting from customers’ failure to make payments on accounts receivable due to the Company.

Management determines the estimate of the allowance for uncollectible accounts receivable by considering a number of factors, including: (1) historical experience, (2) aging of the accounts receivable and (3) specific information obtained by the Company on the financial condition and the current creditworthiness of its customers. If the financial condition of the Company’s customers were to deteriorate and reduce the ability of the Company’s customers to make payments on their accounts, the Company may be required to increase its allowance by recording additional bad debt expense. Likewise, should the financial condition of the Company’s customers improve and result in payments or settlements of previously reserved amounts, the Company may be required to record a reduction in bad debt expense to reverse the recorded allowance. A provision for estimated returns and allowances and associated losses is recorded and based on historical experience.

(b) Inventory Reserves

Management determines the inventory reserves required to reduce inventories to the lower of cost or market based principally on the effects of technological changes, quantities of goods on hand, and other factors. An estimate is made of the market value, less cost to dispose, of products whose value is determined to be impaired. If these products are ultimately sold at less than estimated amounts, additional reserves may be required. The estimates used to calculate these reserves are applied consistently. The adjustments are recorded in the period in which the loss of utility of the inventory occurs, which establishes a new cost basis for the inventory. This new cost basis is maintained until such time that the reserved inventory is disposed of, returned to the vendor or sold. To the extent that specifically reserved inventory is sold, cost of goods sold is expensed for the new cost basis of the inventory sold.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation in the accompanying consolidated financial statements.

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company maintains some zero-balance, disbursement accounts at various financial institutions in which the Company does not maintain significant depository relationships. Due to the nature of the Company’s banking relationships with these institutions, the Company does not have the right to offset most if not all outstanding checks written from these accounts against cash on hand. Checks released but not yet cleared from these accounts in the amounts of $48.2 million and $73.6 million are classified to accounts payable as of June 30, 2012 and June 30, 2011, respectively.

The Company maintains its cash with various financial institutions globally that are monitored regularly for credit quality. At times, such investments may be in excess of FDIC or other federally insured limits.

Concentration of Credit Risk

The Company sells its products to a large base of value-added resellers throughout North America, Latin America and Europe. The Company performs ongoing credit evaluations of its customers’ financial condition. In certain cases, the Company will accept tangible assets as collateral to increase the trade credit of its customers. No single customer accounted for more than 6% of the Company’s net sales for fiscal 2012, 2011, or 2010.

The Company has established arrangements with certain customers for longer term financing. The Company accounts for these arrangements by recording them at their historical cost less specific allowances at balance sheet dates. Interest income is recognized in the period earned and is recorded as interest income in the Consolidated Income Statement.

Derivative Financial Instruments

The Company uses derivative instruments to manage certain exposures related to foreign currency as well as changes in interest rates as a result of our borrowing activities. We record all derivative instruments as either assets or liabilities in the balance sheet at fair value. The Company currently does not use derivative financial instruments for trading or speculative purposes.

The Company’s foreign currency exposure results from purchasing and selling internationally in several foreign currencies. In addition, the Company has foreign currency risk related to debt that is denominated in currencies other than the U.S. dollar. The Company may reduce its exposure to fluctuations in foreign exchange rates by creating offsetting positions through the use of derivative financial instruments or multi-currency borrowings. The market risk related to the foreign exchange agreements is offset by changes in the valuation of the underlying items. Derivative financial instruments related to foreign currency exposure are accounted for on an accrual basis with gains or losses on these contracts recorded in income in the period in which their value changes, with the offsetting entry for unsettled positions reflected in either other assets or other liabilities. These contracts are generally for a duration of 90 days or less. The Company has elected not to designate its foreign currency contracts as hedging instruments. They are, therefore, marked-to-market with changes in their fair value recorded in the Consolidated Income Statement each period. The Company's foreign currencies are denominated primarily by British pounds, euros, Mexican pesos, Brazilian real and Canadian dollars.

During the fiscal year ended June 30, 2008, the Company entered into an interest rate swap and designated this instrument as a hedge of the cash flows on certain variable rate debt. The interest rate swap matured on September 28, 2011 of the current fiscal year. To the extent the derivative instrument was effective in offsetting the variability of the hedged cash flows, changes in the fair value of the derivative instrument were not included in current earnings, but were reported as other comprehensive income (loss). There was no ineffective portion to be recorded as an adjustment to earnings. There have been no other interest rate swap agreements executed in fiscal year June 30, 2012.

Investments

The Company has investments that are held in a grantor trust formed by the Company related to the ScanSource, Inc. Nonqualified Deferred Compensation Plan and Founder’s Supplemental Executive Retirement Plan (“SERP”). The Company has classified these investments as trading securities, and they are recorded at fair market value with unrealized gains and losses included in the accompanying Consolidated Income Statements. The Company’s obligations under this deferred compensation plan change in concert with the performance of the investments along with contributions and withdrawals to and from the plan. The fair value of these investments and the corresponding deferred compensation obligation was $11.6 million and $12.9 million as of June 30, 2012 and June 30, 2011, respectively. These investments are classified as either current assets or other non-current assets in the Consolidated Balance Sheets depending on the timing of planned disbursements. The deferred compensation obligation is classified either within current liabilities or other long-term liabilities as well. The amounts of these investments classified as current assets with corresponding current liabilities were $1.2 million and $3.1 million at June 30, 2012 and June 30, 2011, respectively.

Inventories

Inventories (consisting entirely of finished goods) are stated at the lower of cost (first-in, first-out method) or market.

Vendor Programs

The Company receives incentives from vendors related to cooperative advertising allowances, volume rebates and other incentive agreements. These incentives are generally under quarterly, semi-annual or annual agreements with the vendors. Some of these incentives are negotiated on an ad hoc basis to support specific programs mutually developed between the Company and the vendor. Vendors generally require that we use their cooperative advertising allowances exclusively for advertising or other marketing programs. Incentives received from vendors for specifically identified incremental cooperative advertising programs are recorded as adjustments to selling, general and administrative expenses. The Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 605 – Revenue Recognition, addresses accounting by a customer (including a reseller) for certain consideration received from a vendor. This guidance requires that the portion of these vendor funds in excess of our costs be reflected as a reduction of inventory. Such funds are recognized as a reduction of the cost of products sold when the related inventory is sold.

The Company records unrestricted volume rebates received as a reduction of inventory and as a reduction of the cost of goods sold when the related inventory is sold. Amounts received or receivables from vendors that are not yet earned are deferred in the Consolidated Balance Sheets. In addition, the Company may receive early payment discounts from certain vendors. The Company records early payment discounts received as a reduction of inventory and recognizes the discount as a reduction of cost of goods sold when the related inventory is sold. ASC 605 requires management to make certain estimates of the amounts of vendor incentives that will be received. Actual recognition of the vendor consideration may vary from management estimates based on actual results.

Vendor Concentration

The Company sells products from many suppliers, however, sales from products supplied by Motorola and Avaya each constituted more than 10% of the Company’s net sales for years ended June 30, 2012, 2011 and 2010, respectively.

Product Warranty

The Company’s vendors generally provide a warranty on the products distributed by the Company and allow the Company to return defective products, including those that have been returned to the Company by its customers. In two of our product lines, the Company offers a self-branded warranty program, in which Management has determined that the Company is the primary obligor of these programs. The Company purchases contracts from unrelated third parties, generally the original equipment manufacturers, to fulfill any obligation to service or replace defective product claimed on these warranty programs. As such, the Company has not recorded a provision for estimated service warranty costs. For all other product lines, the Company does not independently provide a warranty on the products it distributes; however, to maintain customer relations, the Company facilitates returns of defective products from the Company’s customers by accepting for exchange, with the Company’s prior approval, most defective products within 30 days of invoicing.

Property and Equipment

Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over estimated useful lives of 3 to 10 years for furniture, equipment and computer software, 40 years for buildings and 15 years for building improvements. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life. Maintenance, repairs and minor renewals are charged to expense as incurred. Additions, major renewals and betterments to property and equipment are capitalized. In fiscal 2010, the Company began the design and development of a new Enterprise Resource Planning System (“ERP”). The compensation costs of employees associated with this process are capitalized to the construction in process asset related to this project.

To the extent that the Company has longstanding, "in-process" projects that have not been implemented for their intended operational use, the Company capitalizes the portion of interest expense incurred during the asset's acquisition period that theoretically could have been avoided in accordance with ASC 835. The amount capitalized is determined by applying the appropriate capitalization rate to the average amount of accumulated expenditures for the asset during the reporting period. The capitalization rate used is based on the rates applicable to borrowings outstanding during the reporting period. Currently, the Company is capitalizing interest expense to its only significant, in-process asset recorded for the new ERP system discussed in the Management, Discussion and Analysis section of this Form 10-K and in Note 3.

Goodwill

The Company accounts for recorded goodwill in accordance with ASC 350, Goodwill and Other Intangible Assets, which requires that goodwill is reviewed annually for impairment or more frequently if impairment indicators exist.Goodwill testing utilizes a two-step impairment analysis, whereby the Company compares the carrying value of each identified reporting unit to its fair value. The carrying value of goodwill is reviewed at a reporting unit level at least annually for impairment, or more frequently if impairment indicators exist. Our goodwill reporting units are our North America segment and, in our international segment, various components one-level below. The fair values of the reporting units are estimated using the net present value of discounted cash flows generated by each reporting unit. Considerable judgment is necessary in estimating future cash flows, discount rates and other factors affecting the estimated fair value of the reporting units, including the operating and macroeconomic factors. Historical financial information, internal plans and projections, and industry information is used in making such estimates.

In the two-step impairment analysis, goodwill is first tested for impairment by comparing the fair value of the reporting unit with the reporting unit's carrying amount to identify any potential impairment. If fair value is determined to be less than carrying value, a second step is used whereby the implied fair value of the reporting unit's goodwill, determined through a hypothetical purchase price allocation, is compared with the carrying amount of the reporting units' goodwill. If the implied fair value of the reporting unit's goodwill is less than its carrying amount, an impairment charge is recorded in current earnings for the difference. We also assess the recoverability of goodwill if facts and circumstances indicate goodwill may be impaired. In our most recent annual test, we estimated the fair value of our reporting units primarily based on the income approach utilizing the discounted cash flow method. We also utilized fair value estimates derived from the market approach utilizing the public company market multiple method to validate the results of the discounted cash flow method, which required us to make assumptions about the applicability of those multiples to our reporting units. The discounted cash flow method required us to estimate future cash flows and discount those amounts to present value. The key assumptions utilized in determining fair value included:

•Industry weighted-average cost of capital ("WACC"): We utilized a WACC relative to each reporting unit's respective geography and industry as the discount rate for estimated future cash flows. The WACC is intended to represent a rate of return that would be expected by a market place participant in each respective geography.

•Operating income: We utilized historical and expected revenue growth rates, gross margins and operating expense percentages, which varied based on the projections of each reporting unit being evaluated.

•Cash flows from working capital changes: We utilized a projected cash flow impact pertaining to expected changes in working capital as each of our goodwill reporting units grow.

See Note 5 to the consolidated financial statements for more information regarding goodwill.

Intangible Assets

Intangible assets consist of customer relationships, debt issuance costs, trade names, distributor agreements and non-compete agreements. Customer relationships and distributor agreements are amortized using the straight-line method over their estimated useful lives, which range from 5 to 15 years. Debt issuance costs are amortized over the term of the credit facility.

Trade names are amortized over a period ranging from 1 to 2 years. Non-compete agreements are amortized over their contract life. These assets are included in other assets and are shown in detail in Note 5, Goodwill and Other Identifiable Intangible Assets.

Impairment of Long-Lived Assets

The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset or asset group may not be recoverable. Tests for recoverability of a long-lived asset to be held and used are measured by comparing the carrying amount of the long-lived asset to the sum of the estimated future discounted cash flows expected to be generated by the asset. In estimating the future discounted cash flows we use projections of cash flows directly associated with, and which are expected to arise as a direct result of, the use and eventual disposition of the assets. If it is determined that a long-lived asset is not recoverable, an impairment loss would be calculated equal to the excess of the carrying amount of the long-lived asset over its fair value. The Company did not record any material impairment charges for the fiscal years ended June 30, 2012, 2011 and 2010.

Fair Value of Financial Instruments

The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. The carrying values of financial instruments such as accounts receivable, accounts payable, accrued liabilities, borrowings under the revolving credit facility and subsidiary lines of credit approximate fair value based upon either short maturities or variable interest rates of these instruments. For additional information related to the fair value of derivatives, please see Note 8, Fair Value of Financial Instruments.

Liability for Contingent Consideration

In addition to the initial cash consideration paid to former CDC shareholders, the Company is obligated to make additional earnout payments based on future results through fiscal year 2015 based on a multiple of the subsidiary’s pro forma net income as defined in Exhibit 2.1.(b)(2) of the Share Purchase and Sale Agreement by and among the Company’s Brazilian subsidiary, the former shareholders and CDC, dated April 7, 2011. Future payments are to be paid in Brazilian currency, the real. The Company made its first payment in January 2012 to the former shareholders of $2.0 million. The next payment is anticipated to be made on August 31, 2012 based on the pro forma results of the twelve month period ended June 30, 2012. The remaining earnout payments will become payable in three additional installments on August 31, 2013 and 2014 with the final payment on October 31, 2015. In accordance with ASC Topic 805, the Company determined the fair value of this liability for contingent consideration on the acquisition date using a discounted cash flow model following the income approach. Each period the Company reflects the contingent consideration liability at fair value with changes recorded in the change in fair value of contingent consideration line item in the Consolidated Income Statements.

Contingencies

The Company accrues for contingent obligations, including estimated legal costs, when it is probable that a liability is incurred and the amount is reasonably estimable. As facts concerning contingencies become known, management reassesses its position and makes appropriate adjustments to the financial statements. Estimates that are particularly sensitive to future changes include tax, legal, and other regulatory matters, which are subject to change as events evolve, and as additional information becomes available during the administrative and litigation process.

Revenue Recognition

Revenue is recognized once four criteria are met: (1) the Company must have persuasive evidence that an arrangement exists; (2) delivery must occur (this includes the transfer of both title and risk of loss, provided that no significant obligations remain); (3) the price must be fixed and determinable; and (4) collectability must be reasonably assured. The Company allows its customers to return product for exchange or credit subject to certain limitations. A provision for estimated losses on returns is recorded based on historical experience.

Service revenue associated with configuration and marketing services is recognized when the work is complete and the four criteria discussed above have been substantially met. The Company also distributes third-party service contracts, typically for product maintenance and support. Since the Company acts as an agent on behalf of most of these service contracts sold, revenue is recognized net of cost at the time of sale. However, the Company distributes some self-branded warranty programs and engages a third party (generally the original equipment manufacturer) to cover the fulfillment of any obligations arising from these contracts. These revenues and associated third party costs are amortized over the life of the contract and presented in net sales and cost of goods sold, respectively. Other service revenue associated with configuration, marketing, service contracts and other services approximates 2% or less of consolidated net sales for fiscal years 2012, 2011 and 2010.

During the fiscal years ended June 30, 2012, 2011 and 2010, the Company has not engaged in any sales transactions involving multiple element arrangements. Had any arrangements with multiple deliverables occurred, the Company would follow the guidance set forth in ASC 605.

Shipping Revenue and Costs

Shipping revenue is included in net sales, and related costs are included in cost of goods sold. Shipping revenue for the years ended June 30, 2012, 2011 and 2010 was $12.2 million, $11.5 million and $10.2 million, respectively.

Advertising Costs

The Company defers advertising-related costs until the advertising is first run in trade or other publications, or in the case of brochures, until the brochures are printed and available for distribution. Advertising costs, included in marketing costs, after vendor reimbursement, were not significant in any of the three fiscal years ended June 30, 2012. Deferred advertising costs at June 30, 2012 and 2011 were also not significant.

Foreign Currency

The currency effects of translating the financial statements of the Company’s foreign entities that operate in their local currency are included in the cumulative currency translation adjustment component of accumulated other comprehensive income or loss. The Company's functional currencies include dollars, euros, British pounds and Brazilian real. The assets and liabilities of these foreign entities are translated into U.S. dollars using the exchange rate at the end of the respective period. Sales, costs and expenses are translated at average exchange rates effective during the respective period. Foreign currency transactional and re-measurement gains and losses are included in other expense (income) in the consolidated income statement. Such amounts are not significant to any of the periods presented.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred income taxes reflect tax consequences on future years of differences between the tax bases of assets and liabilities and their financial reporting amounts. Valuation allowances are provided against deferred tax assets when it is more likely than not that an asset will not be realized in accordance with ASC 740, Accounting for Income Taxes. Federal income taxes are not assessed on the undistributed earnings of foreign subsidiaries because it has been the practice of the Company to reinvest those earnings in the business outside the United States. See Note 11 for further discussion.

Additionally, the Company maintains reserves for uncertain tax provisions in accordance with ASC 740. See Note 11 for more information.

Share-Based Payments

The Company accounts for share-based compensation using the provisions of ASC 718, Accounting for Stock Compensation, which requires the recognition of the fair value of share-based compensation. Share-based compensation is estimated at the grant date based on the fair value of the awards, in accordance with the provisions of ASC 718. Since this compensation cost is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company has elected to expense grants of awards with graded vesting on a straight-line basis over the requisite service period for each separately vesting portion of the award.

Comprehensive Income

ASC 220, Comprehensive Income, defines comprehensive income as the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. The primary components of comprehensive income for the Company include net income, foreign currency translation adjustments arising from the consolidation of the Company’s foreign subsidiaries, and any unrealized gains or losses on effectively hedged transactions, net of tax. Currently, the Company is not engaged in any fair value of cash flow hedges that qualify for comprehensive income treatment.

Business Combinations

The Company accounts for business combinations in accordance with ASC Topic 805, Business Combinations. ASC 805 establishes principles and requirements for recognizing the total consideration transferred to and the assets acquired, liabilities assumed and any non-controlling interest in the acquired target in a business combination. ASC 805 also provides guidance for recognizing and measuring goodwill acquired in a business combination and requires the acquirer to disclose information that users may need to evaluate and understand the financial impact of the business combination. See Note 4 for further discussion.

Recent Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS. The amendments in this update are the result of the work of the FASB and the International Accounting Standards Board (“IASB”) to develop common requirements for measuring fair value and for disclosing information about fair value measurements. The amendment became effective for interim and annual periods beginning after December 15, 2011, which was the interim period ended March 31, 2012 for the Company. This amendment has had no impact on the Company's consolidated financial statements.

In June 2011, the FASB issued ASU 2011-05, Presentation of Comprehensive Income. The objective of this update is to improve the comparability, consistency and transparency of financial reporting and to increase the prominence of items reported in other comprehensive income. The update will become effective for fiscal years, and the interim periods within those years, beginning after December 15, 2011, which will be fiscal 2013 for the Company. The update will eliminate the option to present components of other comprehensive income as part of the statement of changes in stockholders' equity, which is the Company's current practice, and will require companies to present all nonowner changes in stockholders' equity either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The Company is currently determining which method of presentation will be used in future filings.

In September 2011, the FASB issued ASU 2011-08, Testing Goodwill for Impairment. The objective of this update is to simplify how entities, both public and nonpublic, test goodwill for impairment. The amendments in the update permit an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test described in Topic 350. The more likely than not threshold is defined as having a likelihood of more than 50 percent. This amendment is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011, which will be fiscal 2013 for the Company. Early adoption is permitted. The Company is currently assessing the future impact of this ASU on its consolidated financial statements.

In December 2011, the FASB issued ASU 2011-11, Disclosures about Offsetting Assets and Liabilities. The objective of this update is to converge the differences in U.S. GAAP and IFRS in disclosures regarding offsetting (netting) assets and liabilities in the presentation of financial statements. This amendment will enhance disclosures required by U.S. GAAP by requiring improved information about financial instruments and derivative instruments that are either (1) offset in accordance with either Section 210-20-45 or Section 815-10-45 or (2) subject to an enforceable master netting arrangement or similar agreement. The Company currently does not offset any financial instruments or derivatives and is currently assessing the future impact of this ASU on its consolidated financial statements.

In July 2012, the FASB issued ASU 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment. The objective of this update is to simplify how entities, both public and nonpublic, test indefinite-lived intangible assets other than goodwill. This amendment allows companies to first assess qualitative factors of impairment of all indefinite-lived intangible assets, similar to the provisions in ASU 2011-08. The Company currently does not have any indefinite-lived intangible assets, other than goodwill and is currently assessing the future impact of this ASU on its consolidated financial statements.

XML

Fair Value of Financial Instruments (Tables)

12 Months Ended

Jun. 30, 2012

Fair Value Disclosures [Abstract]

Short-term Investments and Financial Instruments

The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2012:

	Total		Quoted prices  in active markets (Level  1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
	(in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion	$	11,635	$	11,635	$	—	$	—
Forward foreign currency exchange contracts	21		—		21		—
Total assets at fair value	$	11,656	$	11,635	$	21	$	—
Liabilities:
Deferred compensation plan investments, current and non-current portion	$	11,635	$	11,635	$	—	$	—
Forward foreign currency exchange contracts	110		—		110		$	—
Liability for contingent consideration, current and non-current	16,653		—		—		16,653
Total liabilities at fair value	$	28,398	$	11,635	$	110	$	16,653

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2011:

	Total		Quoted prices  in active markets (Level  1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
	(in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion	$	12,926	$	12,926	$	—	$	—
Forward foreign currency exchange contracts	165		—		165		—
Total assets at fair value	$	13,091	$	12,926	$	165	$	—
Liabilities:
Deferred compensation plan investments, current and non-current portion	$	12,926	$	12,926	$	—	$	—
Forward foreign currency exchange contracts	236		—		236		—
Interest rate swap	215		—		215		—
Liability for contingent consideration, current and non-current	23,794		—		—		23,794
Total liabilities at fair value	$	37,171	$	12,926	$	451	$	23,794

Fair Value, Business Acquisition, Liability for Contingent Consideration

The table below provides a summary of the changes in fair value of the Company’s only financial asset or liability, the contingent consideration for the CDC earnout that is measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the year ended June 30, 2012 and 2011:

	Contingent Consideration for the Year Ended  June 30, 2012			Contingent Consideration for the Year Ended  June 30, 2011
	(in thousands)
Fair value at beginning of period	$	23,794		$	—
Issuance of contingent consideration	—			23,952
Payments	(2,000		)	—
Change in fair value	120			(128		)
Fluctuation due to foreign currency exchange	(5,261		)	(30		)
Fair value at end of period	$	16,653		$	23,794

XML

Accumulated Other Comprehensive Income (Components Of Accumulated Other Comprehensive Income, Net Of Tax) (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Currency translation adjustment	$ (21,691)	$ 3,768	$ (11,127)
Unrealized gain (loss) on fair value of interest rate swap	0	(139)	(607)
Accumulated other comprehensive income (loss)	$ (21,691)	$ 3,629	$ (11,734)

XML

Earnings per Share (Details) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Earnings Per Share [Abstract]
Net income	$ 74,288	$ 73,523	$ 48,812
Denominator: Weighted-average shares, basic	27,362,000	26,872,000	26,605,000
Denominator: Dilutive effect of share-based payments	389,000	374,000	264,000
Denominator: Weighted-average shares, diluted	27,751,000	27,246,000	26,869,000
Net income per common share, basic	$ 2.72	$ 2.74	$ 1.83
Net income per common share, diluted	$ 2.68	$ 2.70	$ 1.82
Weighted average shares excluded from the computation of diluted earnings per share	583,000	947,000	1,208,000

XML

Short-Term Borrowings and Long-Term Debt (Short-Term Borrowings) (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Jun. 30, 2011
Debt Disclosure [Abstract]
Short-term borrowings	$ 4,268	$ 3,164

XML

Income Taxes (Income Tax Expense (Benefit)) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Income Tax Expense (Benefit) [Abstract]
Federal, current	$ 37,736	$ 34,782	$ 27,749
State, current	1,376	248	1,104
Foreign, current	3,703	5,008	2,922
Total current	42,815	40,038	31,775
Federal, deferred	(830)	(168)	(4,410)
State, deferred	(44)	(9)	(323)
Foreign, deferred	(5,018)	(1,498)	(113)
Total deferred	(5,892)	(1,675)	(4,846)
Provision for income taxes	$ 36,923	$ 38,363	$ 26,929

XML

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Jun. 30, 2011
Assets
Cash and cash equivalents	$ 29,173	$ 28,747
Accounts receivable, less allowance of $27,349 at June 30, 2012 and $26,562 at June 30, 2011	470,808	462,102
Inventories	475,479	467,350
Prepaid expenses and other assets	41,846	35,421
Deferred income taxes	14,624	15,894
Total current assets	1,031,930	1,009,514
Property and equipment, net	48,785	36,819
Goodwill	53,885	59,090
Other assets, including identifiable intangible assets	67,206	76,765
Total assets	1,201,806	1,182,188
Liabilities and Shareholders' Equity
Short-term borrowings	4,268	3,164
Current portion of contingent consideration	4,976	2,398
Accounts payable	419,683	406,453
Accrued expenses and other liabilities	67,776	60,157
Income taxes payable	1,698	5,175
Total current liabilities	498,401	477,347
Long-term debt	5,429	30,429
Borrowings under revolving credit facility	0	26,513
Long-term portion of contingent consideration	11,677	21,396
Other long-term liabilities	33,988	39,109
Total liabilities	549,495	594,794
Commitments and contingencies
Shareholders' equity:
Preferred stock, no par value; 3,000,000 shares authorized, none issued	0	0
Common stock, no par value; 45,000,000 shares authorized, 27,604,840 and 27,109,932 shares issued and outstanding at June 30, 2012 and June 30, 2011, respectively	139,557	123,608
Retained earnings	534,445	460,157
Accumulated other comprehensive (loss) income	(21,691)	3,629
Total shareholders' equity	652,311	587,394
Total liabilities and shareholders' equity	$ 1,201,806	$ 1,182,188

XML

Acquisitions (Identified Intangible Assets) (Details) (CDC Brasil S A [Member], USD $) In Thousands, unless otherwise specified	12 Months Ended		12 Months Ended
	Jun. 30, 2012	Apr. 15, 2011	Jun. 30, 2012 Trade Names [Member]	Jun. 30, 2012 Customer Relationships [Member]	Jun. 30, 2011 Customer Relationships [Member]	Jun. 30, 2012 Non-compete Agreements [Member]
Business Acquisition [Line Items]
Identifiable intangible assets	$ 22,605	$ 22,605	$ 2,746	$ 18,965		$ 894
Identified intangible assets useful life	5 years		2 years	6 years	7 years	5 years

XML

Consolidated Statements of Shareholders' Equity (Parenthetical) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Statement of Stockholders' Equity [Abstract]
Unrealized gain on hedged transaction, tax	$ 76	$ 272	$ 85

XML

Derivatives and Hedging Activities (Derivative Instruments) (Details) (Foreign Exchange Contracts [Member], USD $) In Thousands, unless otherwise specified	Jun. 30, 2012
Designated as Hedge Instruments [Member]
Derivative assets: foreign exchange contracts	$ 0	[1]
Derivative liabilities: foreign exchange contracts	0	[2]
Not Designated as Hedge Instruments [Member]
Derivative assets: foreign exchange contracts	21	[1]
Derivative liabilities: foreign exchange contracts	$ 110	[2]

[1] All derivative assets are recorded as prepaid expense and other assets in the Consolidated Balance Sheets.

[2] All derivative liabilities are recorded as accrued expenses and other liabilities in the Consolidated Balance Sheets.

XML

Income Taxes (Tables)

12 Months Ended

Jun. 30, 2012

Income Tax Expense (Benefit) [Abstract]

Income Tax Expense (Benefit)

Income tax expense (benefit) consists of:

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
Current:
Federal	$	37,736		$	34,782		$	27,749
State	1,376			248			1,104
Foreign	3,703			5,008			2,922
Total current	42,815			40,038			31,775
Deferred:
Federal	(830		)	(168		)	(4,410		)
State	(44		)	(9		)	(323		)
Foreign	(5,018		)	(1,498		)	(113		)
Total deferred	(5,892		)	(1,675		)	(4,846		)
Provision for income taxes	$	36,923		$	38,363		$	26,929

Reconciliation of U.S.Federal Income Tax Expense

A reconciliation of the U.S. Federal income tax expense at a statutory rate of 35% to actual income tax expense, excluding any other taxes related to extraordinary gain is as follows:

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
U.S. Federal income tax at statutory rate	$	38,924		$	39,160		$	26,509
Increase (decrease) in income taxes due to:
State and local income taxes, net of Federal benefit	1,026			625			935
Tax credits	(1,122		)	(312		)	(633		)
Valuation allowance	24			(195		)	(128		)
Effect of foreign operations, net	(2,309		)	(2,054		)	(1,342		)
Stock compensation	86			239			580
Other	294			900			1,008
Provision for income taxes	$	36,923		$	38,363		$	26,929

Deferred Tax Assets and Liabilities

he tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are presented below:

	June 30,
	2012			2011
	(in thousands)
Deferred tax assets derived from:
Allowance for accounts receivable	$	6,456		$	2,857
Inventories	7,336			11,310
Nondeductible accrued expenses	512			2,204
Net operating loss carryforwards	2,931			452
Tax credits	583			241
Deferred compensation	4,331			4,822
Stock compensation	5,631			2,868
Timing of depreciation and other deductions for building and equipment	98			—
Total deferred tax assets	27,878			24,754
Valuation allowance	(541		)	(517		)
Total deferred tax assets	27,337			24,237
Deferred tax liabilities derived from:
Timing of amortization deduction from intangible assets	(5,840		)	(2,717		)
Timing of depreciation and other deductions for building and equipment	—			(238		)
Total deferred tax liabilities	(5,840		)	(2,955		)
Net deferred tax assets	$	21,497		$	21,282

Components of Pretax Earnings

The components of pretax earnings are as follows:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Domestic	$	103,711	$	96,436	$	65,566
Foreign	7,500		15,450		10,175
Worldwide pretax earnings	$	111,211	$	111,886	$	75,741

Reconciliation of Unrecognized Tax Benefits

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

	2012			2011			2010
	(in thousands)
Beginning Balance	$	1,181		$	1,279		$	1,359
Additions based on tax positions related to the current year	163			173			133
Additions for tax positions of prior years	—			—			—
Reduction for tax positions of prior years	(87		)	(271		)	(213		)
Settlements	—			—			—
Ending Balance	$	1,257		$	1,181		$	1,279

XML

Share-Based Compensation (Stock Option Plans) (Details) (USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, beginning of year, Options	1,969,477
Outstanding, beginning of year, Weighted-Average Exercise Price	$ 27.47
Outstanding, beginning of year, Weighted-Average Remaining Contractual Life	5 years 8 months 1 day
Granted during the period, Options	85,578
Granted during the period, Weighted Average Exercise Price	$ 34.23
Exercised during the period, Options	(415,959)
Exercised during the period, Weighted-Average Exercise Price	$ 21.67
Canceled, forfeited, or expired during the period, Options	(9,137)
Canceled, forfeited, or expired during the period, Weighted-Average Exercise Price	$ 34.42
Outstanding, end of year, Options	1,629,959	1,969,477
Outstanding, end of year, Weighted-Average Exercise Price	$ 29.27	$ 27.47
Outstanding, end of year, Weighted-Average Remaining Contractual Life (years)	5 years 8 months 1 day
Outstanding, end of year, Aggregate Intrinsic Value	$ 5,970,110
Vested and expected to vest, Options	1,629,870
Vested and expected to vest, Weighted-Average Exercise Price	$ 29.27
Vested and expected to vest, Weighted-Average Remaining Contractual Life (years)	5 years 8 months 1 day
Vested and expected to vest, Aggregate Intrinsic Value	5,970,070
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	1,385,371
Exercisable, end of year, Weighted-Average Exercise Price	$ 28.60
Exercisable, end of Year, Weighted-Average Remaining Contractual Life (years)	5 years 1 month 13 days
Exercisable, end of Year, Aggregate Intrinsic Value	$ 5,652,620
Granted during period, Weighted Average Grand Date Fair-Value	$ 14.94	$ 17.21	$ 12.43
Unvested Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, beginning of year, Options	445,010
Outstanding, beginning of year, Weighted-Average Exercise Price	$ 26.29
Granted during the period, Options	85,578
Granted during the period, Weighted Average Exercise Price	$ 34.23
Vested during period, Weighted Average Exercise Price	$ 22.71
Canceled, forfeited, or expired during the period, Options	(5,297)
Canceled, forfeited, or expired during the period, Weighted-Average Exercise Price	$ 33.30
Outstanding, end of year, Options	244,588
Outstanding, end of year, Weighted-Average Exercise Price	$ 33.02
Outstanding, beginning of year, Weighted Average Grants Date Fair-Value	$ 12.25
Granted during period, Weighted Average Grand Date Fair-Value	$ 14.94
Vested during period, Options	(280,703)
Vested during period, Weighted Average Grant Date Fair-Value	$ 10.28
Canceled or forfeited during period, Weighted Average Grant Date Fair-Value	$ 10.42
Outstanding, end of year, Weighted Average Grants Date Fair-Value	$ 15.49

XML

Related Party Transactions

12 Months Ended

Jun. 30, 2012

Related Party Transactions [Abstract]

Related Party Transactions

Related Party Transactions

During fiscal years 2012, 2011, and 2010, the Company had sales of $4.2 million, $5.1 million, and $3.7 million, respectively, to companies affiliated with the former minority shareholder of ScanSource Latin America’s Miami based operations. At June 30, 2012 and 2011, accounts receivable from these companies totaled $0.5 million and $1.2 million, respectively.

During fiscal years 2012 and 2011, the Company had sales of $0.2 million to companies affiliated with a former shareholder of CDC in Brazil. As of June 30, 2012 and 2011, accounts receivable from these customers were less than $0.1 million.

In previous periods, the Company has reported purchases and accounts payable to a vendor affiliated with the former CEO and current member on the Board of Directors. In January 2012, he divested his interest in this particular vendor. Through January 2012, the Company had purchases of $0.3 million from this vendor. During fiscal year 2011, the Company had purchases of $0.4 million from this vendor. At June 30, 2011, accounts payable to this vendor was $0.1 million.

XML

Commitments and Contingencies (Tables)

12 Months Ended

Jun. 30, 2012

Commitments and Contingencies Disclosure [Abstract]

Lease Expense

Lease expense and future minimum lease payments under operating leases are as follows:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Lease expense	$	5,025	$	4,989	$	4,430

Future Minimum Lease Payments

	Payments
	(in thousands)
Fiscal Year Ended June 30,
2013	$	4,671
2014	3,999
2015	3,295
2016	3,125
2017	2,605
Thereafter	2,018
Total future minimum lease payments	$	19,713

XML

Valuation And Qualifying Accounts

12 Months Ended

Jun. 30, 2012

Valuation and Qualifying Accounts [Abstract]

Valuation And Qualifying Accounts

SCHEDULE II

SCANSOURCE, INC. AND SUBSIDIARIES

Valuation and Qualifying Accounts

(in thousands)

Description	Balance at Beginning of Period		Amounts Charged to Expense	Reductions (1)		Other (2)	Balance at End of Period
Valuation account for trade and notes receivable:
Year ended June 30, 2010	$	16,883	10,854	(7,097	)	1,267	$	21,907
Trade and current note receivable allowance							$	21,907
Long-term note allowance							$	—
Year ended June 30, 2011	$	21,907	7,488	(11,098	)	8,265	$	26,562
Trade and current note receivable allowance							$	26,562
Long-term note allowance							$	—
Year ended June 30, 2012	$	26,562	7,134	(7,249	)	902	$	27,349
Trade and current note receivable allowance							$	27,349
Long-term note allowance							$	—

(1) “Reductions” amounts represent write-offs for the years indicated.

(2) “Other” amounts include recoveries and the effect of foreign currency fluctuations. The amount in 2011 includes $3.9 million of recoveries and $3.1 million of accounts receivable reserves acquired with CDC Brasil, S.A., on April 15, 2011.

XML

Share-Based Compensation (Restricted Stock Outstanding) (Details) (Restricted Stock [Member], USD $)	12 Months Ended
	Jun. 30, 2012
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested, beginning of year, restricted stock	241,085
Shares granted	173,246
Vested during period, Shares	(122,071)
Canceled, forfeited, or expired during the period, Shares	(25,002)
Unvested, end of year, restricted stock	267,258
Outstanding, beginning of year, Weighted Average Grant Date Fair-Value	$ 29.15
Granted, Weighted Average Grant Date Fair-Value	$ 34.34
Vested, Weighted Average Grant Date Fair-Value	$ 28.12
Canceled, forfeited or expired, Weighted Average Grant Date Fair-Value	$ 32.00
Outstanding, end of year, Weighted Average Grant Date Fair-Value	$ 32.43

XML

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Cash flows from operating activities:
Net income	$ 74,288	$ 73,523	$ 48,812
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	9,922	6,662	6,064
Allowance for accounts and notes receivable	7,134	7,488	10,854
Share-based compensation and restricted stock	6,840	4,877	6,065
Deferred income taxes	(6,377)	(1,431)	(4,658)
Excess tax benefits from share-based payment arrangements	(1,720)	(203)	(227)
Change in fair value of the contingent consideration	120	(128)	0
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(36,666)	(77,305)	(79,145)
Inventories	(27,043)	(79,654)	(133,492)
Prepaid expenses and other assets	(4,103)	(17,392)	884
Other noncurrent assets	1,166	(10,279)	(2,660)
Accounts payable	28,306	78,298	57,977
Accrued expenses and other liabilities	8,371	31,060	6,876
Income taxes payable	(280)	(4,828)	4,486
Net cash provided by (used in) operating activities	59,958	10,688	(78,164)
Cash flows from investing activities:
Capital expenditures	(12,790)	(14,869)	(5,606)
Cash paid for business acquisitions, net of cash acquired	0	(36,228)	(9,994)
Net cash provided by (used in) investing activities	(12,790)	(51,097)	(15,600)
Cash flows from financing activities:
Increases (decreases) in short-term borrowings, net	1,345	1,706	0
Borrowings (repayments) on revolving credit, net of expenses	(25,999)	25,376	0
Borrowings (repayments) on long-term debt	(25,000)	0	0
Contingent consideration payments	(2,000)	0	0
Exercise of stock options	7,642	6,372	1,095
Excess tax benefits from share-based payment arrangements	1,720	203	227
Net cash provided by (used in) financing activities	(42,292)	33,657	1,322
Effect of exchange rate changes on cash and cash equivalents	(4,450)	894	(617)
Increase (decrease) in cash and cash equivalents	426	(5,858)	(93,059)
Cash and cash equivalents at beginning of period	28,747	34,605	127,664
Cash and cash equivalents at end of period	29,173	28,747	34,605
Supplemental disclosure of cash flow information:
Interest paid during the year	1,578	1,705	1,391
Income taxes paid during the year	$ 46,057	$ 43,233	$ 23,210

XML

Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Jun. 30, 2012	Jun. 30, 2011
Current assets:
Allowance for accounts receivable	$ 27,349	$ 26,562
Shareholders' equity:
Preferred stock, par value	$ 0	$ 0
Preferred stock, shares authorized	3,000,000	3,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$ 0	$ 0
Common stock, shares authorized	45,000,000	45,000,000
Common stock, shares issued	27,604,840	27,109,932
Common stock, shares outstanding	27,604,840	27,109,932

XML

Employee Benefit Plans

12 Months Ended

Jun. 30, 2012

Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]

Employee Benefit Plans

Employee Benefit Plans

The Company has a defined contribution plan under Section 401(k) of the Internal Revenue Code of 1986, as amended that covers all employees located in the United States meeting certain eligibility requirements. The Company provided a matching contribution for each period which was equal to one-half of each participant’s contribution, up to a maximum matching contribution per participant of $800. The Company determines its matching contributions annually and can make discretionary contributions in addition to matching contributions. Employer contributions are vested based upon tenure over a five-year period.

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Matching contributions	$	473	$	419	$	395
Discretionary contributions	5,066		5,952		3,200
Total contributions	$	5,539	$	6,371	$	3,595

Internationally, the Company contributes to either plans required by local governments or to various employee annuity plans. Additionally, the Company maintains a non-qualified, unfunded, deferred compensation plan that allows eligible executives to defer a portion of their compensation in addition to receiving discretionary matching contributions from the Company. Employer contributions are vested over a five-year period.

In fiscal 2011, the Company made a $2.4 million contribution to the Founder’s SERP for the Company’s founder and former Chief Executive Officer who retired in March 2011. The SERP investments are included within the deferred compensation plan investments referenced in Note 8, Fair Value of Financial Instruments.

XML

Document and Entity Information (USD $)	12 Months Ended
	Jun. 30, 2012	Aug. 22, 2012	Dec. 31, 2011
Document And Entity Information
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jun. 30, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	FY
Entity Registrant Name	SCANSOURCE INC
Entity Central Index Key	0000918965
Current Fiscal Year End Date	--06-30
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		27,609,840
Entity Current Reporting Status	Yes
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Public Float			$ 973,035,756

XML

Income Taxes

12 Months Ended

Jun. 30, 2012

Income Tax Expense (Benefit) [Abstract]

Income Taxes

Income Taxes

Income tax expense (benefit) consists of:

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
Current:
Federal	$	37,736		$	34,782		$	27,749
State	1,376			248			1,104
Foreign	3,703			5,008			2,922
Total current	42,815			40,038			31,775
Deferred:
Federal	(830		)	(168		)	(4,410		)
State	(44		)	(9		)	(323		)
Foreign	(5,018		)	(1,498		)	(113		)
Total deferred	(5,892		)	(1,675		)	(4,846		)
Provision for income taxes	$	36,923		$	38,363		$	26,929

A reconciliation of the U.S. Federal income tax expense at a statutory rate of 35% to actual income tax expense, excluding any other taxes related to extraordinary gain is as follows:

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
U.S. Federal income tax at statutory rate	$	38,924		$	39,160		$	26,509
Increase (decrease) in income taxes due to:
State and local income taxes, net of Federal benefit	1,026			625			935
Tax credits	(1,122		)	(312		)	(633		)
Valuation allowance	24			(195		)	(128		)
Effect of foreign operations, net	(2,309		)	(2,054		)	(1,342		)
Stock compensation	86			239			580
Other	294			900			1,008
Provision for income taxes	$	36,923		$	38,363		$	26,929

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are presented below:

	June 30,
	2012			2011
	(in thousands)
Deferred tax assets derived from:
Allowance for accounts receivable	$	6,456		$	2,857
Inventories	7,336			11,310
Nondeductible accrued expenses	512			2,204
Net operating loss carryforwards	2,931			452
Tax credits	583			241
Deferred compensation	4,331			4,822
Stock compensation	5,631			2,868
Timing of depreciation and other deductions for building and equipment	98			—
Total deferred tax assets	27,878			24,754
Valuation allowance	(541		)	(517		)
Total deferred tax assets	27,337			24,237
Deferred tax liabilities derived from:
Timing of amortization deduction from intangible assets	(5,840		)	(2,717		)
Timing of depreciation and other deductions for building and equipment	—			(238		)
Total deferred tax liabilities	(5,840		)	(2,955		)
Net deferred tax assets	$	21,497		$	21,282

The components of pretax earnings are as follows:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Domestic	$	103,711	$	96,436	$	65,566
Foreign	7,500		15,450		10,175
Worldwide pretax earnings	$	111,211	$	111,886	$	75,741

At June 30, 2012, the Company has (i) gross net operating loss carry forwards of approximately $0.1 million for U.S. Federal income tax purposes that will begin to expire in 2020; (ii) gross net operating loss carry forwards of approximately $0.9 million for state income tax purposes; (iii) foreign gross net operating loss carry forwards of approximately $8.5 million; (iv) state income tax credit carry forwards of approximately $0.2 million that will begin to expire in 2025; and (v) withholding tax credits of approximately $0.5 million. As of June 30, 2012, the Company reversed $0.4 million of the valuation reserve against foreign net operating loss carry-forwards and established a full valuation reserve of $0.5 million against the withholding tax credits. The Company maintains a $0.1 million valuation allowance for state net operating losses where it was determined that, in accordance with ASC 740, it is more likely than not that they cannot be utilized.

The Company has not provided U.S. income taxes for undistributed earnings of foreign subsidiaries that are considered to be retained indefinitely for reinvestment. The distribution of these earnings would result in additional foreign withholding taxes and additional U.S. federal income taxes to the extent they are not offset by foreign tax credits. It has been the practice of the Company to reinvest those earnings in the business outside the United States. These undistributed earnings amounted to approximately $56.3 million at June 30, 2012. If these earnings were remitted to the U.S. they would be subject to income tax. The tax, after foreign tax credits, is estimated to be approximately $10.0 million.

As of June 30, 2012, the Company had gross unrecognized tax benefits of $1.3 million, $0.8 million of which, if recognized, would affect the effective tax rate. This reflects an increase of $0.1 million on a net basis over the prior fiscal year. The Company does not expect that the total amounts of unrecognized tax benefits will significantly increase or decrease within the next twelve months. The prior year balances have been adjusted to remove interest and penalties that were included in prior period reporting. The total amount of interest and penalties accrued, but excluded from the table below for the years ending 2012, 2011 and 2010 were $1.0 million, $0.9 million and $1.0 million, respectively. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

	2012			2011			2010
	(in thousands)
Beginning Balance	$	1,181		$	1,279		$	1,359
Additions based on tax positions related to the current year	163			173			133
Additions for tax positions of prior years	—			—			—
Reduction for tax positions of prior years	(87		)	(271		)	(213		)
Settlements	—			—			—
Ending Balance	$	1,257		$	1,181		$	1,279

The Company conducts business globally and, as a result, one or more of its subsidiaries files income tax returns in the U.S. federal, various state, local and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities in countries in which it operates. With few exceptions, the Company is no longer subject to state and local, or non-U.S. income tax examinations by tax authorities for the years before 2008.

The Company’s continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. As of June 30, 2012, the Company had approximately $1.0 million accrued for interest and penalties, of which $0.1 million was a current period expense.

The Company's effective tax rate differs from the federal statutory rate of 35% primarily as a result the mix of income in lower tax rate jurisdictions and state taxes.

XML

Segment Information (Narrative) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012 segment	Jun. 30, 2011	Jun. 30, 2010
Segment Reporting Information [Line Items]
Number of reportable segments	2
Assets	$ 1,201,806	$ 1,182,188	$ 859,750
Operating income (loss)	113,516	113,109	75,776
North American Distribution [Member]
Segment Reporting Information [Line Items]
Assets	813,889	785,057	670,467
Operating income (loss)	104,044	94,932	64,342
Number of customers	14,500
International Distribution [Member]
Segment Reporting Information [Line Items]
Assets	387,917	397,131	189,283
Operating income (loss)	9,472	18,177	11,434
Number of customers	15,500
Restatement Adjustment [Member] | North American Distribution [Member]
Segment Reporting Information [Line Items]
Assets		173,700	114,100
Operating income (loss)		4,500
Restatement Adjustment [Member] | International Distribution [Member]
Segment Reporting Information [Line Items]
Assets		173,700	114,100
Operating income (loss)		4,500
Scenario, Previously Reported [Member] | North American Distribution [Member]
Segment Reporting Information [Line Items]
Assets		958,800	784,600
Operating income (loss)		90,400
Scenario, Previously Reported [Member] | International Distribution [Member]
Segment Reporting Information [Line Items]
Assets		223,400	75,200
Operating income (loss)		$ 22,700
Customer Concentration Risk [Member] | Maximum [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	6.00%	6.00%	6.00%
Customer Concentration Risk [Member] | Maximum [Member] | North American Distribution [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	6.00%	6.00%	6.00%
Customer Concentration Risk [Member] | Maximum [Member] | International Distribution [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	1.00%	1.00%	1.00%

XML

Consolidated Income Statements (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Income Statement [Abstract]
Net sales	$ 3,015,296	$ 2,666,531	$ 2,114,979
Cost of goods sold	2,713,272	2,392,224	1,896,052
Gross profit	302,024	274,307	218,927
Selling, general and administrative expenses	188,388	161,326	143,151
Change in fair value of contingent consideration	120	(128)	0
Operating income	113,516	113,109	75,776
Interest expense	1,639	1,723	1,472
Interest income	(2,886)	(1,212)	(1,387)
Other expense (income), net	3,552	712	(50)
Income before income taxes	111,211	111,886	75,741
Provision for income taxes	36,923	38,363	26,929
Net income	$ 74,288	$ 73,523	$ 48,812
Per share data:
Net income per common share, basic	$ 2.72	$ 2.74	$ 1.83
Weighted-average shares outstanding, basic	27,362	26,872	26,605
Net income per common share, diluted	$ 2.68	$ 2.70	$ 1.82
Weighted-average shares outstanding, diluted	27,751	27,246	26,869

XML

Goodwill and Other Identifiable Intangible Assets

12 Months Ended

Jun. 30, 2012

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Identifiable Intangible Assets

Goodwill and Other Identifiable Intangible Assets

In accordance with ASC 350, Intangibles - Goodwill and Other, the Company performs its annual goodwill impairment test at the end of each fiscal year, or whenever indicators of impairment are present. This testing includes the determination of each reporting unit's fair value using a discounted cash flows model compared to each reporting unit's carrying value. The reporting units utilized for goodwill impairment tests are North America segment and, in our International segment, various components that are a level below.

During fiscal years 2012, 2011 and 2010, no impairment charges related to goodwill were recorded. However, as of the latest annual goodwill impairment test, the estimated fair value of the Company's Brazilian goodwill reporting unit exceeded its carrying value by a smaller margin than the Company's other goodwill reporting units. The Brazilian operations were only recently acquired, resulting in a carrying value that approximates its fair value.

The carrying value of the Brazilian goodwill asset as of June 30, 2012 was $19.8 million. The estimated fair value of the Brazilian goodwill reporting unit exceeded its carrying value by 7% in the most recent annual impairment test. The increase in sensitivity to the Brazilian goodwill reporting unit is driven largely by the general macroeconomic environment and lower expectations for future results in this unit. Key assumptions used in determining fair value include projected growth and operating margin, working capital requirements and discount rates. While the Company does not believe that this goodwill reporting unit is impaired at this time, if the Company is not able to achieve its projected operating margins within the expected working capital requirements and/or there are unfavorable changes to the discount rate, a future impairment of goodwill is at least reasonably possible.

Changes in the carrying amount of goodwill for the years ended June 30, 2012 and 2011, by reporting segment, are as follows:

	North American Distribution Segment		International Distribution Segment			Total
	(in thousands)
Balance as of June 30, 2010	$	20,081	$	13,704		$	33,785
Goodwill acquired during 2011	—		24,643			24,643
Fluctuations in foreign currencies	—		662			662
Balance as of June 30, 2011	20,081		39,009			59,090
CDC measurement period adjustments	—		914			914
Fluctuations in foreign currencies	—		(6,119		)	(6,119		)
Balance as of June 30, 2012	$	20,081	$	33,804		$	53,885

During the fiscal year ended June 30, 2012 , the Company's goodwill balances increased due to the finalization of purchase accounting for CDC from measurement period adjustments. For further information regarding CDC purchase accounting adjustments, please see Note 4, Acquisitions. The remaining change in the goodwill balance is due to foreign currency translation.

During the fiscal year ended June 30, 2011, the Company’s goodwill balances increased due to the acquisition of CDC in April, 2011. The goodwill recognized in conjunction with the CDC acquisition is attributable to the depth and breadth of services that it can provide to Latin America’s largest economy, its vast geographical reach beyond that of other distributors in Brazil and its large, specialty product mix that is atypical for the region. The Company expects all of the goodwill acquired with CDC to be deductible for Brazilian tax purposes.

The following table shows the Company’s identifiable intangible assets as of June 30, 2012 and 2011, respectively. These balances are included on the consolidated balance sheet within other assets:

	June 30, 2012						June 30, 2011
	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
	(in thousands)
Amortized intangible assets:
Customer relationships	$	34,483	$	10,864	$	23,619	$	34,515	$	6,989	$	27,526
Debt issue costs	2,499		967		1,532		1,139		625		514
Trade names	2,127		1,285		842		2,743		286		2,457
Non-compete agreements	938		379		559		2,310		1,085		1,225
Distributor agreements	610		105		505		705		74		631
Total	$	40,657	$	13,600	$	27,057	$	41,412	$	9,059	$	32,353

In fiscal 2012, the Company incurred 1.4 million in debt issuance costs related to the negotiation and execution of the new credit facility (see note 6). In addition, during the re-measurement period for the valuation of CDC Brasil, the Company determined that the economic life for customer relationships should be reduced from 7 years to 6 years. The Company cumulatively adjusted all amortization so that the asset reflects the accumulated amortization of a 6 year life from the date of purchase in the first quarter of fiscal 2012. Upon receipt of the final valuation of identifiable intangible assets, the value of CDC's customer relationships were increased by $4.3 million in the third quarter of fiscal 2012. Amortization expense was cumulatively adjusted to reflect the appropriate balances. For further information regarding CDC purchase accounting adjustments, please see Note 4, Acquisitions.

In fiscal 2012, the Company wrote off the gross carrying amount and corresponding accumulated amortization for fully amortized non-compete agreements in the amount of $0.9 million. In fiscal 2011, the Company wrote off the gross carrying amount and corresponding accumulated amortization for fully amortized customer lists, non-compete agreements and trade names in the amounts of $0.3 million, $1.8 million and $1.0 million, respectively.

The weighted average amortization period for all intangible assets for the years ended June 30, 2012, 2011 and 2010 was approximately 10 years, 10 years, and 12 years, respectively. Amortization expense for the years ended June 30, 2012, 2011 and 2010 was $6.4 million, $3.0 million and $2.0 million, respectively. Estimated future amortization expense is as follows:

	Amortization Expense
	(in thousands)
Year Ended June 30,
2013	$	5,217
2014	4,342
2015	4,341
2016	4,312
2017	3,437
Thereafter	5,408
Total	$	27,057

XML

Acquisitions

12 Months Ended

Jun. 30, 2012

Business Combinations [Abstract]

Acquisitions

Acquisitions

Algol Europe,GmbH

On November 30, 2009, the Company acquired substantially all of the assets and certain liabilities of Algol Europe, GmbH (“Algol”). Algol, now a part of ScanSource Communications in the international distribution segment, is a value-added distributor of specialty technologies, including voice, data, and video communication products located in Cologne, Germany. This acquisition significantly expanded the footprint of the ScanSource Communications sales unit outside of the United Kingdom and is part of the Company’s strategy to become a pan-European distributor of communication products. The purchase price of this acquisition was allocated to the assets acquired and the liabilities assumed based on their estimated fair values on the transaction date, resulting in goodwill and identifiable intangible assets related to non-compete agreements, distributor agreements and customer relationships as of November 30, 2009. These amounts were recorded in the international segment. All professional fees and other costs associated with the acquisition of Algol’s assets were expensed as incurred. The purchase price, identified intangibles and goodwill as of the acquisition date were as follows:

	Purchase Price		Goodwill		Identifiable Intangible Assets
	(in thousands)
Algol Europe, GmbH	$	9,965	$	712	$	2,287

CDC Brasil S.A.

On April 15, 2011, the Company completed its acquisition of 100% of the shares of CDC, formerly known as CDC Brasil Distribuidora LTDA, Brazil’s leading distributor of AIDC and POS solutions. This acquisition gives the Company an established presence in Latin America’s largest specialty technology market and allows the Company to more easily scale its Latin American operations.

Under the Share Purchase and Sale Agreement, the Company structured the purchase transaction as an all cash share purchase with an initial payment of $36.2 million, net of cash acquired, and assumed working capital payables and debt at closing. The remaining purchase price will be paid in annual cash installments based upon the financial performance of CDC for the twelve month periods ended on June 30 from 2011 through 2015. As of June 30, 2012, there are four remaining earnout payments to be made to the former shareholders. Please see Note 8, Fair Value of Financial Instruments for further information regarding the fair value accounting for this contingent consideration.

In fiscal 2012 and 2011, the Company incurred $0.3 million and $1.1 million, respectively, of acquisition-related costs, primarily for professional fees incurred for due diligence, legal advice and tax planning. These costs are included in selling, general and administrative expenses in the Company's consolidated income statement.

During the third quarter of this fiscal year, the Company finalized the purchase accounting for the CDC acquisition. The Company has elected to record all purchase accounting adjustments in the current year as opposed to the retrospective application set forth in ASC 805. Management has determined that retrospective application is immaterial to the users of the Company's financial statements. The adjustments made during the year pertain to the finalization of the purchase price allocation to the fair value of customer relationships, pre-acquisition contingency liabilities and corresponding indemnification assets and deferred income taxes. These adjustments are summarized in the following table:

	As of April 15, 2011
	Preliminary Purchase Allocation			Purchase Accounting Adjustments			Revised Purchase Allocation
Consideration	(in thousands)
Initial cash payment, net of cash acquired	$	36,228		$	—		$	36,228
Fair value of earnout obligation	23,952			—			23,952
Total consideration	60,180			—			60,180
Recognized amounts of identifiable assets acquired and liabilities assumed
Accounts receivable, net of allowance	21,378			—			21,378
Inventories	30,560			—			30,560
Prepaid expenses and other assets	3,575			—			3,575
Current deferred income taxes, net	1,409			(3,225		)	(1,816		)
Property and equipment, net	1,741			—			1,741
Intangible assets	18,327			4,278			22,605
Escrowed pre-acquisition contingencies receivable	16,013			7,977			23,990
Short-term borrowings	(1,277		)	—			(1,277		)
Accounts payable	(34,006		)	—			(34,006		)
Accrued expenses and other liabilities	(3,896		)	—			(3,896		)
Income taxes payable	(2,097		)	1,174			(923		)
Escrowed pre-acquisition contingencies payable	(16,013		)	(7,977		)	(23,990		)
Long-term deferred income taxes, net	—			(3,141		)	(3,141		)
Other long-term liabilities	(177		)	—			(177		)
Total identifiable net assets	35,537			(914		)	34,623
Goodwill	$	24,643		$	914		$	25,557

All measurement period adjustments are presented as of the acquisition date. The Company used a combination of the market, cost and income approaches to estimate the fair values of the CDC’s assets acquired and liabilities assumed.

The revised purchase price allocated to the fair value of identified intangible assets associated with the acquisition of CDC after the finalization of purchase accounting is as follows:

	Amount
Identified intangible assets	(in thousands)
Trade names (2 year useful life)	$	2,746
Customer relationships (6 year useful life)	18,965
Non-compete agreements (5 year useful life)	894
Total identified intangible assets	$	22,605

In the current year, the Company recorded incremental amortization expense to catch up accumulated amortization for the additional purchase price allocated to customer relationships as of March 31, 2012, when purchase accounting was finalized. The weighted average amortization period for these identified intangible assets after purchase accounting adjustments, other than goodwill, is 5 years. Additionally, the Company adjusted the useful life for CDC customer relationships from 7 years to 6 years. The impact of the incremental amortization and related income tax effect recorded in the third quarter of this fiscal year is summarized in the following table:

	June 30, 2012
	(in thousands)
Consolidated income statement
Amortization expense	$	441
Provision for income taxes	$	(150	)

During the Company's due diligence for the CDC acquisition, several pre-acquisition contingencies were identified regarding various Brazilian federal and state tax exposures. The Company is able to record indemnification receivables that are reported gross of the pre-acquisition contingency liabilities as they were escrowed in the Share Purchase and Sale Agreement. As part of the initial payment, the sellers placed $25.5 million into a special and exclusive bank account to be released according to the specifications of the Share Purchase and Sale Agreement to provide for potential indemnification liabilities. However, indemnity claims can be made up to the entire purchase price, which includes the initial payment and all future earnout payments. During fiscal 2012, the Company and former shareholders released $5.3 million from the escrow account for the settlement of a pre-acquisition contingency and $2.5 million was released to the sellers, leaving $12.9 million, after the impact of foreign currency translation, available for future pre-acquisition contingency settlements or to be released to the sellers. The table below summarizes the balances and line item presentation of these pre-acquisition contingencies and corresponding indemnification receivables in the Company's consolidated balance sheet:

	June 30, 2012		June 30, 2011		April 15, 2011
	(in thousands)
Assets
Prepaid expenses and other assets (current)	$	3,886	$	—	$	—
Other assets (noncurrent)	$	5,112	$	16,250	$	16,013
Liabilities
Other current liabilities	$	3,886	$	—	$	—
Other long-term liabilities	$	5,112	$	16,250	$	16,013

The change in classification and amounts of the pre-acquisition contingencies is due to the finalization of purchase accounting in the third quarter of the current fiscal year, foreign currency translation on a weaker Brazilian real against the U.S. dollar and the expiration of the statute of limitations for one of the identified pre-acquisition contingencies. The Company finalized its quantitative assessments for various state and federal tax exposures and identified the statute of limitations for these exposures in determining the appropriate classification. The amount of reasonably possible undiscounted pre-acquisition contingencies as of June 30, 2012 is estimated to range as high as $12.4 million at this time, of which all exposures are indemnifiable under the Share Purchase and Sale Agreement.

In fiscal year 2011, CDC contributed net sales of approximately $29.6 million and net income of $0.7 million for the period of April 15, 2011 to June 30, 2011. CDC net income for the period included approximately $0.1 million of acquisition-related costs as well as $0.7 million of incremental amortization expense related to identified intangible assets.

The following unaudited pro forma summary presents consolidated information of the Company as if the business combination had occurred on July 1, 2009, based on the final purchase price allocation as adjusted in fiscal 2012 for the additional purchase price allocated to CDC's customer relationships:

	June 30,
	2011		2010
Unaudited, Supplemental Pro Forma Information	(in thousand, except per share information)
Net sales	$	2,786,905	$	2,247,721
Net income	$	75,328	$	52,450
Diluted earnings per share	$	2.76	$	1.95

These pro forma amounts have been calculated after applying the Company’s accounting policies and adjusting CDC’s results to reflect the additional amortization that would have been recorded assuming the fair value of the identified intangibles had been recorded as of July 1, 2009, adjusted for purchase accounting adjustments made during the measurement period. Also, the pro forma amounts reflect the acquisition-related costs incurred by the Company of approximately $0.3 million and $1.1 million in fiscal years 2012 and 2011, respectively, as if incurred in fiscal year 2010.

XML

Subsequent Events

12 Months Ended

Jun. 30, 2012

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

In accordance with ASC 855 – Subsequent Events, the Company evaluated events occurring from the end of the most recent fiscal year through the date the financial statements were filed with the SEC.

XML

Commitments and Contingencies

12 Months Ended

Jun. 30, 2012

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Leases

The Company leases office and warehouse space under non-cancelable operating leases that expire through November 2020. Lease expense and future minimum lease payments under operating leases are as follows:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Lease expense	$	5,025	$	4,989	$	4,430

	Payments
	(in thousands)
Fiscal Year Ended June 30,
2013	$	4,671
2014	3,999
2015	3,295
2016	3,125
2017	2,605
Thereafter	2,018
Total future minimum lease payments	$	19,713

On April 27, 2007, the Company entered into an agreement to lease approximately 600,000 square feet for distribution, warehousing and storage purposes in a building located in Southaven, Mississippi. The lease also provides for a right of first refusal on an additional 147,000 square feet of expansion space. The term of the lease is 120 months with 2 consecutive 5-year extension options.

Commitments and Contingencies

A majority of the Company’s net revenues in 2012, 2011 and 2010 were received from the sale of products purchased from the Company’s ten largest vendors. The Company has entered into written distribution agreements with substantially all of its major vendors. While the Company’s agreements with most of its vendors contain standard provisions for periodic renewals, these agreements generally permit termination by either party without cause upon 30 to 120 days notice.

The Company or its subsidiaries are, from time to time, parties to lawsuits arising out of operations. Although there can be no assurance, based upon information known to the Company, the Company believes that any liability resulting from an adverse determination of such lawsuits would not have a material adverse effect on the Company’s financial condition or results of operations.

The Company is in the process of designing and developing a new ERP system. The Company has spent approximately $33.5 million on the project from inception through June 30, 2012. Of the total amount spent, $26.8 million has been in the form of capital expenditures. The Company received a project assessment from a third party service provider, which indicates that the project will take longer to implement and exceed previously disclosed cost estimates, which at the high end was $38.5 million. The Company has revised its projections for the project and believes the total spend could range from $58 million to $72 million and will extend past fiscal year 2013. Capital expenditures for fiscal 2013 could range from $9 million to $15 million for a total capital expenditure of up to $42 million.

XML

Related Party Transactions (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Former Minority Shareholder of Netpoint [Member]
Affiliated sales	$ 4.2	$ 5.1	$ 3.7
Affiliated accounts receivable	0.5	1.2
Former Shareholder of CDC in Brazil [Member]
Affiliated sales	0.2	0.2
Affiliated accounts receivable	0.1	0.1
Former CEO and Current Member on the Board of Directors [Member]
Affiliated purchases	0.3	0.4
Affiliated accounts payable		$ 0.1

XML

Fair Value of Financial Instruments

12 Months Ended

Jun. 30, 2012

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, the Company is required to classify certain assets and liabilities based on the fair value hierarchy, which groups fair value-measured assets and liabilities based upon the following levels of inputs:

• Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

• Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability;

• Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

The assets and liabilities maintained by the Company that are required to be measured at fair value on a recurring basis include the Company's various debt instruments, deferred compensation plan investments, outstanding foreign exchange forward contracts and contingent consideration owed to the previous owners of CDC. The carrying value of debt listed in Note 6 is considered to approximate fair value, as the Company's debt instruments are indexed to LIBOR or the prime rate using the market approach (Level 2 criteria). The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2012:

	Total		Quoted prices  in active markets (Level  1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
	(in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion	$	11,635	$	11,635	$	—	$	—
Forward foreign currency exchange contracts	21		—		21		—
Total assets at fair value	$	11,656	$	11,635	$	21	$	—
Liabilities:
Deferred compensation plan investments, current and non-current portion	$	11,635	$	11,635	$	—	$	—
Forward foreign currency exchange contracts	110		—		110		$	—
Liability for contingent consideration, current and non-current	16,653		—		—		16,653
Total liabilities at fair value	$	28,398	$	11,635	$	110	$	16,653

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2011:

	Total		Quoted prices  in active markets (Level  1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
	(in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion	$	12,926	$	12,926	$	—	$	—
Forward foreign currency exchange contracts	165		—		165		—
Total assets at fair value	$	13,091	$	12,926	$	165	$	—
Liabilities:
Deferred compensation plan investments, current and non-current portion	$	12,926	$	12,926	$	—	$	—
Forward foreign currency exchange contracts	236		—		236		—
Interest rate swap	215		—		215		—
Liability for contingent consideration, current and non-current	23,794		—		—		23,794
Total liabilities at fair value	$	37,171	$	12,926	$	451	$	23,794

The investments in the deferred compensation plan are held in a rabbi trust and include mutual funds and cash equivalents for payment of non-qualified benefits for certain retired, terminated or active employees. These investments are recorded to prepaid and other assets (current) or other assets (non-current) depending on their corresponding, anticipated distributions to recipients, which are reported in accrued expenses and other liabilities (current) or other long-term liabilities (non-current), respectively.

Foreign currency forward contracts are measured using the market approach on a recurring basis considering foreign currency spot rates and forward rates quoted by banks or foreign currency dealers (Level 2). See Note 7, “Derivatives and Hedging Activities.” Foreign currency contracts are classified in the consolidated balance sheet in prepaid expenses and other assets or accrued expenses and other liabilities, depending on the respective contracts' favorable or unfavorable positions.

The Company recorded a contingent consideration liability at the acquisition date of CDC representing the amounts payable to former CDC shareholders, as outlined under the terms of the Share Purchase and Sale Agreement, based upon the achievement of projected earnings, net of specific pro forma adjustments. The current and non-current portions of this obligation are reported separately on the condensed consolidated balance sheet. The fair value of contingent consideration (Level 3) is determined using a discounted cash flow model. Subsequent changes in the fair value of the contingent consideration liability are recorded to the change in fair value of contingent consideration line item in the consolidated income statement. Fluctuations due to foreign currency translation are captured in other comprehensive income through the changes in foreign currency translation adjustments line item as seen in Note 14, "Accumulated Other Comprehensive Income."

The table below provides a summary of the changes in fair value of the Company’s only financial asset or liability, the contingent consideration for the CDC earnout that is measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the year ended June 30, 2012 and 2011:

	Contingent Consideration for the Year Ended  June 30, 2012			Contingent Consideration for the Year Ended  June 30, 2011
	(in thousands)
Fair value at beginning of period	$	23,794		$	—
Issuance of contingent consideration	—			23,952
Payments	(2,000		)	—
Change in fair value	120			(128		)
Fluctuation due to foreign currency exchange	(5,261		)	(30		)
Fair value at end of period	$	16,653		$	23,794

The fair value of the liability for the contingent consideration recognized at June 30, 2012 was $16.7 million, of which $5.0 million is classified as current. As of June 30, 2011, the fair value of the contingent consideration was $23.8 million, of which $2.4 million was classified as current. The fair values of amounts owed are recorded in “current portion of contingent consideration” and “long-term portion of contingent consideration” in the Company's consolidated balance sheet. The U.S. dollar amounts of actual disbursements made in conjunction with future earnout payments are subject to change as the liability is denominated in Brazilian reais and subject to foreign exchange fluctuation risk. Also, in accordance with ASC 805, the Company will revalue the contingent consideration liability at each reporting date through the last payment, with changes in the fair value of the contingent consideration reflected in the “change in fair value of contingent consideration” line item on the Company's consolidated income statement that is included in the calculation of operating income. The fair value of the contingent consideration liability associated with future earnout payments is based on several factors, including:

• estimated future results, net of pro forma adjustments set forth in the Share Purchase and Sale Agreement;

• the probability of achieving these results; and

• a discount rate reflective of the Company's creditworthiness and market risk premium associated with the Brazilian market.

A change in any of these unobservable inputs can significantly change the fair value of the contingent consideration. The change in fair value of the contingent consideration recognized in the consolidated income statement contributed a loss of $0.1 million for the year ended June 30, 2012. Generally, the change in fair value of the contingent consideration will generate a loss as the earnout period lapses. In the current fiscal year, the loss was partially offset by a change in the estimated future results from a weaker Brazilian economic outlook from the time of acquisition. In addition, volatility in the foreign exchange between the Brazilian real and the U.S. dollar has driven significant changes in the translation of the real-denominated liability. Although there is no contractual limit, total future undiscounted contingent consideration payments are estimated to be $24.0 million, based on the Company's best estimate as the earnout is based on a multiple of adjusted earnings.

XML

Fair Value of Financial Instruments (Short-term Investments and Financial Instruments at Fair Value) (Details) (USD $)	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Assets: Deferred compensation plan investments, current and non-current portion	$ 11,635,000	$ 12,926,000
Assets: Forward foreign currency exchange contracts	21,000	165,000
Total asset at fair value	11,656,000	13,091,000
Liabilities: Deferred compensation plan investments, current and non-current portion	11,635,000	12,926,000
Liability for contingent consideration, current and non-current	16,653,000	23,794,000	0
Total liabilities at fair value	28,398,000	37,171,000
Quoted Prices in Active Markets (Level 1) [Member]
Assets: Deferred compensation plan investments, current and non-current portion	11,635,000	12,926,000
Assets: Forward foreign currency exchange contracts	0	0
Total asset at fair value	11,635,000	12,926,000
Liabilities: Deferred compensation plan investments, current and non-current portion	11,635,000	12,926,000
Liability for contingent consideration, current and non-current	0	0
Total liabilities at fair value	11,635,000	12,926,000
Significant Other Observable Inputs (Level 2) [Member]
Assets: Deferred compensation plan investments, current and non-current portion	0	0
Assets: Forward foreign currency exchange contracts	21,000	165,000
Total asset at fair value	21,000	165,000
Liabilities: Deferred compensation plan investments, current and non-current portion	0	0
Liability for contingent consideration, current and non-current	0	0
Total liabilities at fair value	110,000	451,000
Significant Unobservable Inputs (Level 3) [Member]
Assets: Deferred compensation plan investments, current and non-current portion	0	0
Assets: Forward foreign currency exchange contracts	0	0
Total asset at fair value	0	0
Liabilities: Deferred compensation plan investments, current and non-current portion	0	0
Liability for contingent consideration, current and non-current	16,653,000	23,794,000
Total liabilities at fair value	16,653,000	23,794,000
Forward Foreign Currency Exchange Contracts [Member]
Liabilities: Forward foreign currency exchange contracts	110,000	236,000
Forward Foreign Currency Exchange Contracts [Member] | Quoted Prices in Active Markets (Level 1) [Member]
Liabilities: Forward foreign currency exchange contracts	0	0
Forward Foreign Currency Exchange Contracts [Member] | Significant Other Observable Inputs (Level 2) [Member]
Liabilities: Forward foreign currency exchange contracts	110,000	236,000
Forward Foreign Currency Exchange Contracts [Member] | Significant Unobservable Inputs (Level 3) [Member]
Liabilities: Forward foreign currency exchange contracts	0	0
Interest Rate Swap Agreement [Member]
Liabilities: Interest rate swap		215,000
Interest Rate Swap Agreement [Member] | Quoted Prices in Active Markets (Level 1) [Member]
Liabilities: Interest rate swap		0
Interest Rate Swap Agreement [Member] | Significant Other Observable Inputs (Level 2) [Member]
Liabilities: Interest rate swap		215,000
Interest Rate Swap Agreement [Member] | Significant Unobservable Inputs (Level 3) [Member]
Liabilities: Interest rate swap		$ 0

XML

Short-Term Borrowings and Long-Term Debt

12 Months Ended

Jun. 30, 2012

Debt Disclosure [Abstract]

Short Term Borrowings and Long Term Debt

Short-Term Borrowings and Long-Term Debt

Short-Term Borrowings

A subsidiary of the Company has a €6.0 million line of credit, which is secured by the assets of our European operations and is guaranteed by ScanSource, Inc. The subsidiary line of credit bears interest at the 30-day Euro Interbank Offered Rate (“EURIBOR”) plus a spread ranging from 1.25% to 2.00% per annum. The spread in effect as of June 30, 2012 was 1.25%. Additionally, the Company is assessed commitment fees ranging from 0.10% to 0.275% on non-utilized borrowing availability if outstanding balances are below €3.0 million. The interest rate and commitment fee spreads are based on the Company's Leverage Ratio for its revolving credit facility, as defined below. The outstanding balances at June 30, 2012 and 2011 are as follows:

	June 30, 2012		June 30, 2011
	(in thousands)
Short-term borrowings	$	4,268	$	3,164

Revolving Credit Facility

On October 11, 2011, the Company amended and restated its $250 million multi-currency revolving credit facility with a syndicate of banks that was scheduled to mature on September 28, 2012. The Company entered into a five-year, $300 million multi-currency senior secured revolving credit facility pursuant to the terms of an Amended and Restated Credit Agreement (the “New Credit Agreement”) with JPMorgan Chase Bank, N.A., as administrative agent and a syndicate of lenders named therein. The New Credit Agreement allows for the issuance of up to $50 million for letters of credit and has a $150 million accordion feature that allows the Company to increase the availability to $450 million subject to obtaining commitments for the incremental capacity from existing or new lenders. The Company incurred $1.4 million in debt issuance costs that were capitalized to other assets, including identifiable intangible assets, on the consolidated balance sheet and are being amortized on a straight-line basis through October 11, 2016, the maturity date of the New Credit Agreement.

At the Company's option, loans denominated in U.S. dollars under the New Credit Agreement, other than swingline loans, bear interest at a rate equal to a spread over the London Interbank Offered Rate (“LIBOR”) or prime rate depending upon the Company's ratio of total debt (excluding accounts payable and accrued liabilities), measured as of the end of the most recent quarter, to adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the most recently completed four quarters (the “Leverage Ratio”). The Leverage Ratio calculation excludes the Company's subsidiary in Brazil. This spread ranges from 1.00% to 2.25% for LIBOR-based loans and 0.00% to 1.25% for prime rate-based loans. The spread in effect as of June 30, 2012 was 1.00% for LIBOR-based loans and 0.00% for prime rate-based loans. Additionally, the Company is assessed commitment fees ranging from 0.175% to 0.40%, depending upon the Leverage Ratio, on non-utilized borrowing availability, excluding swingline loans. Borrowings under the New Credit Agreement are guaranteed by substantially all of the domestic assets of the Company as well as certain foreign subsidiaries determined to be material under the New Credit Agreement and a pledge of up to 65% of capital stock or other equity interest in each Guarantor as defined in the New Credit Agreement. The Company was in compliance with all covenants under the credit facility as of June 30, 2012. The outstanding balances at June 30, 2012 and June 30, 2011 are as follows:

	June 30, 2012		June 30, 2011
	(in thousands)
Revolving credit facility	$	—	$	26,513

Throughout the year ended June 30, 2012, the Company borrowed $1,408.5 million on the revolving credit facility. The Company repaid $1,433.2 million in addition to the $1.4 million paid for debt issuance costs previously described. The average daily balance on the revolving credit facility was $78.6 million for the year ended June 30, 2012. There was $300.0 million available for additional borrowings as of June 30, 2012, and there were no letters of credit issued.

For the year ended June 30, 2011, the Company borrowed $769.5 million on the revolving credit facility. The Company repaid $743.9 million. The average daily balance on the revolving credit facility was $14.2 million for the year ended June 30, 2011. There was $223.5 million available for additional borrowings as of June 30, 2011, and there were no letters of credit issued.

Long-Term Debt

On January 2, 2008, the Company entered into a $25.0 million promissory note with a third party lender. This note payable accrued interest on the unpaid balance at a rate per annum equal to the 30-day LIBOR plus 0.65% and was scheduled to mature on September 28, 2012. On October 11, 2011, the note was fully repaid using funds obtained through the New Credit Agreement.

On August 1, 2007, the Company entered into an agreement with the State of Mississippi in order to provide financing for the acquisition and installation of certain equipment to be utilized at the Company’s current Southaven, Mississippi distribution facility, through the issuance of an industrial development revenue bond. The bond matures on September 1, 2032 and accrues interest at the 30-day LIBOR rate plus a spread of 0.85%. The terms of the bond allow for payment of interest only for the first 10 years of the agreement, and then, starting on September 1, 2018 through 2032, principal and interest payments are due until the maturity date or the redemption of the bond. As of June 30, 2012, the Company was in compliance with all covenants under this bond.

The balances on the bond and promissory note as of June 30, 2012 and 2011 are as follows:

	June 30, 2012		June 30, 2011
	(in thousands)
Industrial Development Revenue Bond, monthly payments of interest only, 1.09% variable interest rate at June 30, 2012 and maturing on September 1, 2032	$	5,429	$	5,429
Unsecured note payable to a bank, monthly payments of interest only and maturing in fiscal 2013	—		25,000
	5,429		30,429
Less current portion	—		—
Long-term portion	$	5,429	$	30,429

The book value of debt listed above is considered to approximate fair value, as our debt instruments are indexed to LIBOR or the prime rate using the market approach.

Scheduled maturities of the Company’s revolving credit facility and long-term debt at June 30, 2012 are as follows:

	Future Debt Payments
	(in thousands)
Fiscal year:
2013	$	—
2014	—
2015	—
2016	—
2017	—
Thereafter	5,429
Total principal payments	$	5,429

XML

Derivatives and Hedging Activities

12 Months Ended

Jun. 30, 2012

General Discussion of Derivative Instruments and Hedging Activities [Abstract]

Derivatives and Hedging Activities

Derivatives and Hedging Activities

The Company’s results of operations could be materially impacted by significant changes in foreign currency exchange rates and interest rates. These risks and the management of these risks are discussed in greater detail below. In an effort to manage the exposure to these risks, the Company periodically enters into various derivative instruments. The Company’s accounting policies for these instruments are based on whether the instruments are designated as hedge or non-hedge instruments in accordance with U.S. GAAP. The Company records all derivatives on the balance sheet at fair value. Derivatives that are not designated as hedging instruments or the ineffective portions of cash flow hedges are adjusted to fair value through earnings in other income and expense.

Foreign Currency – The Company conducts a portion of its business internationally in a variety of foreign currencies. The exposure to market risk for changes in foreign currency exchange rates arises from foreign currency denominated assets and liabilities, and transactions arising from non-functional currency financing or trading activities. The Company’s objective is to preserve the economic value of non-functional currency denominated cash flows. The Company attempts to hedge transaction exposures with natural offsets to the fullest extent possible and, once these opportunities have been exhausted, through forward contracts or other hedging instruments with third parties. These contracts will periodically hedge the exchange of various currencies, including the U.S. dollar, euro, British pound, Canadian dollar, Mexican peso and Brazilian real. While the Company utilizes foreign exchange contracts to hedge foreign currency exposure, the Company's foreign exchange policy prohibits the use of financial instruments for speculative purposes.

At June 30, 2012, the Company had contracts outstanding with notional amounts of $62.3 million to exchange foreign currencies. To date, the Company has chosen not to designate these derivatives as hedging instruments, and accordingly, these instruments are adjusted to fair value through earnings in other income and expense. Summarized financial information related to these derivative contracts and changes in the underlying value of the foreign currency exposures are as follows:

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
Net foreign exchange derivative contract gain (loss)	$	(1,480	)	$	(2,706	)	$	(1,065	)
Net foreign currency transactional and re-measurement gain (loss)	$	(2,286	)	$	1,741		$	826
Net foreign currency gain (loss)	$	(3,766	)	$	(965	)	$	(239	)

Net foreign exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign currency exchange contract gains and losses. Foreign exchange losses and gains are generated as the result of fluctuations in the value of the British pound versus the euro, the U.S. dollar versus the euro, U.S. dollar versus the Brazilian real and other currencies versus the U.S. dollar.

In fiscal year 2012, the majority of losses were associated with exposures between the U.S. dollar and Brazilian real. In September 2011, the Company incurred a $2.5 million non-recurring loss in conjunction with an unfavorable forward exchange contract to purchase Brazilian reais. In mid-August, the Company decided to pre-fund a portion of the estimated earnout payments associated with the CDC acquisition. This contract was designed to preserve the currency exchange for the few weeks required to transfer the cash to Brazil. From the time the Company entered into the contract through settlement, the Brazilian real devalued from the contractual rate by 11.8%, ultimately resulting in a $2.5 million loss. Further contributing to the fiscal year 2012 foreign exchange loss, the Brazilian business incurred significant losses on U.S. dollar denominated exposures in the first quarter that were not hedged at the time. Subsequently, the Company has been including these exposures in its daily hedging activities.

Interest Rates – The Company’s earnings are also affected by changes in interest rates due to the impact those changes have on interest expense from floating rate debt instruments. To manage the exposure to interest rates, the Company may enter into interest rate swap agreements. In January 2008, the Company entered into an interest rate swap agreement to hedge the variability in future cash flows of interest payments related to the $25.0 million promissory note payable discussed in Note 6. Interest rate differentials paid or received under the swap agreement are recognized as adjustments to interest expense. To the extent the swap is effective in offsetting the variability of the hedged cash flows, changes in the fair value of the swap are not included in current earnings but are reported as other comprehensive income (loss). The swap expired on September 28, 2011. From the inception of the swap through expiration, there was no ineffectiveness associated with the instrument. Currently, there are no other swap agreements outstanding.

During fiscal years 2012 and 2011, the Company's sole cash flow hedge pertained to the interest rate swap discussed above. The components of the cash flow hedge included in accumulated other comprehensive income (loss), net of income taxes, in the consolidated statements of shareholders’ equity, are as follows:

	Fiscal Year Ended June 30,
	2012			2011
	(in thousands)
Net interest expense recognized as a result of interest rate swap	$	216		$	859
Unrealized gain (loss) in fair value of interest swap rates	(1		)	(119		)
Net increase (decrease) in accumulated other comprehensive income (loss)	$	215		$	740
Income tax effect	(76		)	(272		)
Net increase (decrease) in accumulated other comprehensive income (loss), net of tax	$	139		$	468

The Company has the following derivative instruments located on the Consolidated Balance Sheets and Income Statements, utilized for the risk management purposes detailed above:

	As of June 30, 2012
	Fair Value of  Derivatives Designated as Hedge Instruments		Fair Value of  Derivatives Not Designated as Hedge Instruments
	(in thousands)
Derivative assets:(a)
Foreign exchange contracts	$	—	$	21
Derivative liabilities:(b)
Foreign exchange contracts	$	—	$	110

(a) All derivative assets are recorded as prepaid expense and other assets in the Consolidated Balance Sheets.

(b) All derivative liabilities are recorded as accrued expenses and other liabilities in the Consolidated Balance Sheets.

XML

Share-Based Compensation

12 Months Ended

Jun. 30, 2012

Share-based Compensation [Abstract]

Share-Based Compensation

Share-Based Compensation

Share-Based Compensation Plans

The Company has awards outstanding from four share-based compensation plans (the 1993 Incentive Stock Option Plan, the 1997 Stock Incentive Plan, the 2002 Long-Term Incentive Plan, and the 2003 Director Plan), two of which (the 2002 Long-Term Incentive Plan and the 2003 Director Plan) are available for future grants. As of June 30, 2012, there were 1,888,923 and 88,100 shares available for future grant under the 2002 Long-Term Incentive Plan and the 2003 Director Plan, respectively. All of the Company’s share-based compensation plans are shareholder approved, and it is the Company’s belief that such awards better align the interests of its employees and directors with those of its shareholders. Under the plans, the Company is authorized to award officers, employees, consultants and non-employee members of the Board of Directors various share-based payment awards, including options to purchase common stock and restricted stock. Restricted stock can be in the form of a restricted stock award (“RSA”) or a restricted stock unit (“RSU”). An RSA is common stock that is subject to risk of forfeiture or other restrictions that lapse upon satisfaction of specified conditions. An RSU represents the right to receive shares of common stock in the future with the right to future delivery of the shares subject to risk of forfeiture or other restrictions that lapse upon satisfaction of specified conditions.

The Company accounts for its share-based compensation awards in accordance with ASC 718 – Stock Compensation, which requires all share-based compensation to be recognized in the income statement based on fair value and applies to all awards granted, modified, canceled, or repurchased after the effective date. Total share-based compensation included as a component of selling, general, and administrative expense in our Consolidated Income Statements was as follows:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Share-based compensation related to:
Equity classified stock options	$	2,875	$	3,106	$	4,698
Equity classified restricted stock	3,965		1,771		1,367
Total share-based compensation	$	6,840	$	4,877	$	6,065

Stock Options

During the fiscal year ended June 30, 2012, the Company granted 85,578 stock options to certain employees. These options vest annually over 3 years and have a 10-year contractual life. In accordance with the requirements of the Company’s Equity Award Grant Policy, the options issued during the fiscal year were granted with an exercise price that is no less than 100% of the fair market value of those shares on the date of the grant.

The fair value of each option (for purposes of calculation of share-based compensation) was estimated on the date of grant using the Black-Scholes-Merton option pricing formula that uses assumptions determined at the date of grant. Use of this option pricing model requires the input of subjective assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before exercising them (“expected term”), the estimated volatility of our common stock price over the expected term (“expected volatility”) and the number of options that will ultimately not complete their vesting requirements (“forfeitures”). Changes in the subjective assumptions can materially affect the estimate of the fair value of share-based compensation and, consequently, the related amount recognized in the Consolidated Income Statements.

The Company used the following weighted average assumptions for the options granted during the following fiscal years:

	Fiscal Year Ended June 30,
	2012			2011			2010
Expected term	6.77 years			6.88 years			6.82 years
Expected volatility	41.33		%	42.92		%	46.27		%
Risk-free interest rate	1.42		%	2.56		%	2.89		%
Dividend yield	0.00		%	0.00		%	0.00		%
Weighted average fair value per option	$	14.94		$	17.21		$	12.43

The weighted average expected term of the options represents the period of time the options are expected to be outstanding based on historical trends and behaviors of certain groups and individuals receiving these awards. The expected volatility is predominately based on the historical volatility of our common stock for a period approximating the expected life. The risk-free interest rate reflects the interest rate at grant date on zero-coupon U.S. governmental bonds that have a remaining life similar to the expected option term. The dividend yield assumption was based on our dividend payment history and expectations of future dividend payments.

A summary of our stock option plans is presented below:

	Fiscal Year Ended June 30, 2012
	Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life	Aggregate Intrinsic Value
Outstanding, beginning of year	1,969,477		$	27.47
Granted during the period	85,578		34.23
Exercised during the period	(415,959	)	21.67
Canceled, forfeited, or expired during the period	(9,137	)	34.42
Outstanding, end of year	1,629,959		29.27		5.67	$	5,970,110
Vested and expected to vest at June 30, 2012	1,629,870		29.27		5.67	$	5,970,070
Exercisable, end of year	1,385,371		$	28.60	5.12	$	5,652,620

The aggregate intrinsic value was calculated using the market price of our stock on June 30, 2012 and the exercise price for only those options that have an exercise price that is less than the market price of our stock. This amount will change as the market price per share changes. The aggregate intrinsic value of options exercised during the fiscal years ended June 30, 2012, 2011, and 2010 was $5.8 million, $5.2 million, and $1.6 million, respectively.

A summary of the status of the Company’s shares subject to unvested options is presented below:

	Fiscal Year Ended June 30, 2012
	Options		Weighted      Average Exercise Price		Weighted Average Grant     Date Fair-     Value
Unvested, beginning of year	445,010		$	26.29	$	12.25
Granted	85,578		34.23		14.94
Vested	(280,703	)	22.71		10.28
Canceled or forfeited	(5,297	)	33.30		10.42
Unvested, end of year	244,588		$	33.02	$	15.49

As of June 30, 2012, there was approximately $2.3 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the plans in the form of stock options. This cost is expected to be recognized over a weighted-average period of 1.09 years. The total fair value of options vested during the fiscal years ended June 30, 2012, 2011, and 2010 is $2.9 million, $3.5 million and $4.3 million, respectively. The following table summarizes information about stock options outstanding and exercisable as of June 30, 2012:

	Options Outstanding				Options Exercisable
Range of Exercise Prices	Shares   Outstanding	Weighted Average Remaining   Contractual   Life	Weighted     Average Exercise Price		Number   Exercisable	Weighted     Average Exercise Price
$11.01 - $14.68	20,602	0.51	$	13.67	20,602	$	13.67
$14.68 - $18.35	314,396	6.20	18.12		314,396	18.12
$18.35 - $22.01	18,800	1.43	21.58		18,800	21.58
$22.01 - $25.68	189,725	6.41	24.55		137,915	24.56
$25.68 - $29.35	81,500	3.52	27.48		81,500	27.48
$29.35 - $33.02	364,120	4.62	31.46		359,120	31.45
$33.02 - $36.69	640,816	6.34	35.84		453,038	36.03
	1,629,959	5.67	$	29.27	1,385,371	$	28.60

The Company issues shares to satisfy the exercise of options.

Restricted Stock

Grants of Restricted Shares

During the fiscal year ended June 30, 2012, the Company elected to grant 173,246 shares of restricted stock to employees and non-employee directors, of which 159,746 of these shares were issued in the form of RSUs:

	Fiscal Year Ended June 30, 2012
	Shares granted	Date granted	Grant date fair value		Vesting period
Employees
Certain employees based on promotions	5,000	January 31, 2012	$	37.56	Annually over 3 years
Certain employees based on promotions	4,500	May 1, 2012	32.61		Annually over 3 years
Certain employees	1,000	June 18, 2012	31.33		Annually over 3 years
Certain employees	1,500	November 1, 2012	32.94		Annually over 3 years
Certain employees	147,683	December 2, 2011	34.35		Annually over 3 years
Executive officers, vesting based on certain service and performance conditions	1,563	May 14, 2012	32.01		Annually over 2 years
Non-Employee Directors(1)	12,000	December 2, 2011	$	34.35	6 months

(1) Per the Amended and Restated Director’s Equity Compensation Plan, non-employee directors will receive annual awards of restricted stock, as opposed to stock options. The number of shares of restricted stock to be granted will be established from time to time by the Board of Directors. Currently, the number of shares of restricted stock awarded to each non-employee director will be determined by dividing $80,000 by the fair market value of the common stock on the date of grant. These awards will generally vest in full on the day that is six months after the date of grant or upon the earlier occurrence of (i) the director’s termination of service as a director by reason of death, disability or retirement, or (ii) a change in control by the Company. The compensation expense associated with these awards will be recognized on a pro-rata basis over this period.

A summary of the status of the Company’s outstanding restricted stock is presented below:

	Fiscal Year Ended June 30, 2012
	Shares		Weighted Average Grant Date Fair Value
Outstanding, beginning of year	241,085		$	29.15
Granted during the period	173,246		34.34
Vested during the period	(122,071	)	28.12
Cancelled, forfeited, or expired during the period	(25,002	)	32.00
Outstanding, end of year	267,258		$	32.43

As of June 30, 2012, there was approximately $6.4 million of unrecognized compensation cost related to unvested restricted stock awards granted, which is expected to be recognized over a weighted average period of 1.88 years. The Company withheld 43,122 shares for income taxes during the fiscal year ended June 30, 2012.

XML

Share-Based Compensation (Weighted Average Assumptions for Options Granted) (Details) (USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Share-based Compensation [Abstract]
Expected term (years)	6 years 9 months 7 days	6 years 10 months 17 days	6 years 9 months 26 days
Expected volatility	41.33%	42.92%	46.27%
Risk-free interest rate	1.42%	2.56%	2.89%
Dividend yield	0.00%	0.00%	0.00%
Weighted average fair value per option	$ 14.94	$ 17.21	$ 12.43

XML

Valuation And Qualifying Accounts (Schedule Of Valuation and Qualifying Accounts) (Details) (USD $)	12 Months Ended
	Jun. 30, 2012		Jun. 30, 2011		Jun. 30, 2010
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of period	$ 26,562,000		$ 21,907,000		$ 16,883,000
Amounts Charged to Expense	7,134,000		7,488,000		10,854,000
Reductions	(7,249,000)	[1]	(11,098,000)	[1]	(7,097,000)	[1]
Other	902,000	[2]	8,265,000	[2]	1,267,000	[2]
Balance at End of Period	27,349,000		26,562,000		21,907,000
Trade And Current Note Receivable Allowance [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at End of Period	27,349,000		26,562,000		21,907,000
Long-Term Note Allowance [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at End of Period	0		0		0
Recoveries [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Valuation allowances and reserves, recoveries			3,900,000
CDC Brasil S A [Member] | Accounts Receivable Reserve [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Valuation allowances and reserves, reserves of businesses acquired, accounts receivable			$ 3,100,000

[1] “Reductions” amounts represent write-offs for the years indicated.

[2] “Other” amounts include recoveries and the effect of foreign currency fluctuations. The amount in 2011 includes $3.9 million of recoveries and $3.1 million of accounts receivable reserves acquired with CDC Brasil, S.A., on April 15, 2011.

XML

Share-Based Compensation (Stock Options Outstanding) (Details) (USD $)	12 Months Ended
	Jun. 30, 2012
Options outstanding, shares outstanding	1,629,959
Options outstanding, weighted average remaining contractual life (in years)	5 years 8 months 1 day
Options outstanding, weighted average exercise price	$ 29.27
Options exercisable, shares exercisable	1,385,371
Options exercisable, weighted average exercise price	$ 28.60
$11.01 - $14.68 [Member]
Options outstanding, shares outstanding	20,602
Options outstanding, weighted average remaining contractual life (in years)	6 months 4 days
Options outstanding, weighted average exercise price	$ 13.67
Options exercisable, shares exercisable	20,602
Options exercisable, weighted average exercise price	$ 13.67
Range of exercise prices, lower limit	$ 11.01
Range of exercise prices, upper limit	$ 14.68
$14.68 - $18.35 [Member]
Options outstanding, shares outstanding	314,396
Options outstanding, weighted average remaining contractual life (in years)	6 years 2 months 12 days
Options outstanding, weighted average exercise price	$ 18.12
Options exercisable, shares exercisable	314,396
Options exercisable, weighted average exercise price	$ 18.12
Range of exercise prices, lower limit	$ 14.68
Range of exercise prices, upper limit	$ 18.35
$18.35 - $22.01 [Member]
Options outstanding, shares outstanding	18,800
Options outstanding, weighted average remaining contractual life (in years)	1 year 5 months 5 days
Options outstanding, weighted average exercise price	$ 21.58
Options exercisable, shares exercisable	18,800
Options exercisable, weighted average exercise price	$ 21.58
Range of exercise prices, lower limit	$ 18.35
Range of exercise prices, upper limit	$ 22.01
$22.01 - $25.68 [Member]
Options outstanding, shares outstanding	189,725
Options outstanding, weighted average remaining contractual life (in years)	6 years 4 months 28 days
Options outstanding, weighted average exercise price	$ 24.55
Options exercisable, shares exercisable	137,915
Options exercisable, weighted average exercise price	$ 24.56
Range of exercise prices, lower limit	$ 22.01
Range of exercise prices, upper limit	$ 25.68
$25.68 - $29.35 [Member]
Options outstanding, shares outstanding	81,500
Options outstanding, weighted average remaining contractual life (in years)	3 years 6 months 7 days
Options outstanding, weighted average exercise price	$ 27.48
Options exercisable, shares exercisable	81,500
Options exercisable, weighted average exercise price	$ 27.48
Range of exercise prices, lower limit	$ 25.68
Range of exercise prices, upper limit	$ 29.35
$29.35 - $33.02 [Member]
Options outstanding, shares outstanding	364,120
Options outstanding, weighted average remaining contractual life (in years)	4 years 7 months 13 days
Options outstanding, weighted average exercise price	$ 31.46
Options exercisable, shares exercisable	359,120
Options exercisable, weighted average exercise price	$ 31.45
Range of exercise prices, lower limit	$ 29.35
Range of exercise prices, upper limit	$ 33.02
$33.02 - $36.69 [Member]
Options outstanding, shares outstanding	640,816
Options outstanding, weighted average remaining contractual life (in years)	6 years 4 months 2 days
Options outstanding, weighted average exercise price	$ 35.84
Options exercisable, shares exercisable	453,038
Options exercisable, weighted average exercise price	$ 36.03
Range of exercise prices, lower limit	$ 33.02
Range of exercise prices, upper limit	$ 36.69

XML

Share-Based Compensation (Schedule of Share-Based Compensation) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Share-based Compensation [Abstract]
Equity classified stock options	$ 2,875	$ 3,106	$ 4,698
Equity classified restricted stock	3,965	1,771	1,367
Total share-based compensation	$ 6,840	$ 4,877	$ 6,065

XML

Employee Benefit Plans (Tables)

12 Months Ended

Jun. 30, 2012

Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]

Employer Contributions

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Matching contributions	$	473	$	419	$	395
Discretionary contributions	5,066		5,952		3,200
Total contributions	$	5,539	$	6,371	$	3,595

XML

Goodwill and Other Identifiable Intangible Assets (Estimated Future Amortization Expense) (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012
Goodwill and Intangible Assets Disclosure [Abstract]
2013	$ 5,217
2014	4,342
2015	4,341
2016	4,312
2017	3,437
Thereafter	5,408
Total	$ 27,057

XML

Accumulated Other Comprehensive Income

12 Months Ended

Jun. 30, 2012

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

The components of accumulated other comprehensive income, net of tax, are as follows:

	2012			2011			2010
	(in thousands)
Currency translation adjustment	$	(21,691	)	$	3,768		$	(11,127	)
Unrealized gain (loss) on fair value of interest rate swap	—			(139		)	(607		)
Accumulated other comprehensive income (loss)	$	(21,691	)	$	3,629		$	(11,734	)

XML

Earnings per Share (Tables)

12 Months Ended

Jun. 30, 2012

Earnings Per Share [Abstract]

Schedule of Earnings per Share

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands, except per share data)
Fiscal Year Ended June 30, 2012:
Net income	$	74,288	$	73,523	$	48,812
Denominator:
Weighted-average shares, basic	27,362		26,872		26,605
Dilutive effect of share-based payments	389		374		264
Weighted-average shares, diluted	27,751		27,246		26,869
Net income per common share, basic	$	2.72	$	2.74	$	1.83
Net income per common share, diluted	$	2.68	$	2.70	$	1.82

XML

Goodwill and Other Identifiable Intangible Assets (Changes in the Carrying Amount of Goodwill) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 59,090	$ 33,785
Goodwill acquired during period	914	24,643
Fluctuations in foreign currencies	(6,119)	662
Goodwill, ending balance	53,885	59,090
North American Distribution [Member]
Goodwill [Roll Forward]
Goodwill, beginning balance	20,081	20,081
Goodwill acquired during period	0	0
Fluctuations in foreign currencies	0	0
Goodwill, ending balance	20,081	20,081
International Distribution [Member]
Goodwill [Roll Forward]
Goodwill, beginning balance	39,009	13,704
Goodwill acquired during period	914	24,643
Fluctuations in foreign currencies	(6,119)	662
Goodwill, ending balance	$ 33,804	$ 39,009

XML

Property and Equipment (Narrative) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 3.5	$ 3.7	$ 4.1

XML

Consolidated Statements of Shareholders' Equity (USD $) In Thousands, except Share data, unless otherwise specified	Total	Common Stock [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Balance, Amount at Jun. 30, 2009	$ 445,446	$ 104,461	$ 337,822	$ 3,163
Balance, Shares at Jun. 30, 2009		26,565,870
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Net income	48,812		48,812
Unrealized gain on hedged transaction, net of tax	148			148
Foreign currency translation adjustment	(15,045)			(15,045)
Total comprehensive income	33,915
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes, Shares		137,168
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes, Amount	1,095	1,095
Share based compensation	6,168	6,168
Tax benefit of deductible compensation arising from exercise or vesting of share based payment arrangements	227	227
Balance, Amount at Jun. 30, 2010	486,851	111,951	386,634	(11,734)
Balance, Shares at Jun. 30, 2010		26,703,038
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Net income	73,523		73,523
Unrealized gain on hedged transaction, net of tax	468			468
Foreign currency translation adjustment	14,895			14,895
Total comprehensive income	88,886
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes, Shares		406,894
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes, Amount	6,373	6,373
Share based compensation	5,081	5,081
Tax benefit of deductible compensation arising from exercise or vesting of share based payment arrangements	203	203
Balance, Amount at Jun. 30, 2011	587,394	123,608	460,157	3,629
Balance, Shares at Jun. 30, 2011	27,109,932	27,109,932
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Net income	74,288		74,288
Unrealized gain on hedged transaction, net of tax	139			139
Foreign currency translation adjustment	(25,459)			(25,459)
Total comprehensive income	48,968
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes, Shares		494,908
Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes, Amount	7,642	7,642
Share based compensation	7,004	7,004
Tax benefit of deductible compensation arising from exercise or vesting of share based payment arrangements	1,303	1,303
Balance, Amount at Jun. 30, 2012	$ 652,311	$ 139,557	$ 534,445	$ (21,691)
Balance, Shares at Jun. 30, 2012	27,604,840	27,604,840

XML

Property and Equipment

12 Months Ended

Jun. 30, 2012

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and Equipment

Property and equipment is comprised of the following:

	June 30,
	2012			2011
	(in thousands)
Land	$	3,009		$	3,009
Buildings and leasehold improvements	18,231			16,029
Computer software and equipment	13,829			14,270
Furniture, fixtures and equipment	14,739			15,847
Construction in Progress	29,045			18,738
	78,853			67,893
Less accumulated depreciation	(30,068		)	(31,074		)
	$	48,785		$	36,819

During the fiscal year ended June 30, 2012, the increase in gross fixed assets from the prior year is largely related to capital expenditures for a new global ERP system that is currently under development. In addition, the Company acquired fixed assets related to various office renovations and new leasehold improvements.

Depreciation expense was $3.5 million, $3.7 million, and $4.1 million, respectively, for the fiscal years ended 2012, 2011, and 2010.

XML

Derivatives and Hedging Activities (Components of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (loss)) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
General Discussion of Derivative Instruments and Hedging Activities [Abstract]
Net interest expense recognized as a result of interest rate swap	$ 216	$ 859
Unrealized gain (loss) in fair value of interest swap rates	(1)	(119)
Net increase (decrease) in accumulated other comprehensive income (loss)	215	740
Income tax effect	(76)	(272)
Net increase (decrease) in accumulated other comprehensive income (loss), net of tax	$ 139	$ 468

XML

Segment Information (Financial Information by Product Category) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Sales by Product Category	$ 3,015,296	$ 2,666,531	$ 2,114,979
POS, Barcoding and Security Products [Member]
Sales by Product Category	1,837,307	1,615,461	1,300,525
Communication Products [Member]
Sales by Product Category	$ 1,177,989	$ 1,051,070	$ 814,454

XML

Employee Benefit Plans (Narrative) (Details) (USD $)	12 Months Ended
	Jun. 30, 2012	Mar. 31, 2011 Supplemental Executive Retirement Plan [Member]
Employer matching contribution, percent of participant's contribution	50.00%
Employer contribution per participant	$ 800
Defined benefit plan, employer contributions, vesting period (in years)	5 years
Deferred compensation plan, employer contributions, vesting period (in years)	5 years
Employer contributions		$ 2,400,000

XML

Property and Equipment (Tables)

12 Months Ended

Jun. 30, 2012

Property, Plant and Equipment [Abstract]

Components of Property and Equipment

Property and equipment is comprised of the following:

	June 30,
	2012			2011
	(in thousands)
Land	$	3,009		$	3,009
Buildings and leasehold improvements	18,231			16,029
Computer software and equipment	13,829			14,270
Furniture, fixtures and equipment	14,739			15,847
Construction in Progress	29,045			18,738
	78,853			67,893
Less accumulated depreciation	(30,068		)	(31,074		)
	$	48,785		$	36,819

XML

Income Taxes (Deferred Tax Assets and Liabilities) (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Jun. 30, 2011
Income Tax Expense (Benefit) [Abstract]
Allowance for accounts receivable	$ 6,456	$ 2,857
Inventories	7,336	11,310
Nondeductible accrued expenses	512	2,204
Net operating loss carryforwards	2,931	452
Tax credits	583	241
Deferred compensation	4,331	4,822
Stock compensation	5,631	2,868
Timing of depreciation and other deductions for building and equipment	98	0
Total deferred tax assets	27,878	24,754
Valuation allowance	(541)	(517)
Total deferred tax assets	27,337	24,237
Timing of amortization deduction from intangible assets	(5,840)	(2,717)
Timing of depreciation and other deductions for building and equipment	0	(238)
Total deferred tax liabilities	(5,840)	(2,955)
Net deferred tax assets	$ 21,497	$ 21,282

XML

Accumulated Other Comprehensive Income (Tables)

12 Months Ended

Jun. 30, 2012

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Components Of Accumulated Other Comprehensive Income, Net Of Tax

The components of accumulated other comprehensive income, net of tax, are as follows:

	2012			2011			2010
	(in thousands)
Currency translation adjustment	$	(21,691	)	$	3,768		$	(11,127	)
Unrealized gain (loss) on fair value of interest rate swap	—			(139		)	(607		)
Accumulated other comprehensive income (loss)	$	(21,691	)	$	3,629		$	(11,734	)

XML

Segment Information

12 Months Ended

Jun. 30, 2012

Segment Reporting, Measurement Disclosures [Abstract]

Segment Information

Segment Information

The Company is a leading distributor of specialty technology products, providing value-added distribution sales to resellers in the specialty technology markets. The Company has two reporting segments, based on geographic location.

North American Distribution

The North American distribution segment offers products for sale in four primary categories: (i) AIDC and POS equipment sold by the ScanSource POS and Barcoding sales unit, (ii) voice, data and converged communications equipment sold by the Catalyst Telecom sales unit, (iii) video conferencing, telephony, and communications products sold by the ScanSource Communications unit, and (iv) electronic security products and wireless infrastructure products sold by the ScanSource Security sales unit. These products are sold to more than 14,500 resellers and integrators of technology products that are geographically dispersed over the United States and Canada in a pattern that mirrors population concentration. No single account represented more than 6% of the Company’s consolidated net sales for the fiscal years ended June 30, 2012, 2011, and 2010, respectively.

International Distribution

The international distribution segment sells to two geographic areas, Latin America aggregated with Europe, offers AIDC and POS equipment as well as communications products to more than 15,500 resellers and integrators of technology products. Additionally, the Company offers security products in Latin America. Of this segment’s customers, no single account represented more than 1% of the Company’s consolidated net sales during the fiscal years ended June 30, 2012, 2011, and 2010, respectively.

Inter-segment sales consist primarily of sales by the North American distribution segment to the international distribution segment. All inter-segment revenues and profits have been eliminated in the accompanying Consolidated Financial Statements.

Selected financial information for each business segment is presented below:

	Fiscal Year Ended June 30,
	2012			2011			2010
	(in thousands)
Sales:
North American distribution	$	2,285,342		$	2,048,767		$	1,688,663
International distribution	778,837			643,863			448,967
Less intersegment sales	(48,883		)	(26,099		)	(22,651		)
	$	3,015,296		$	2,666,531		$	2,114,979
Depreciation and amortization:
North American distribution	$	3,960		$	4,246		$	4,730
International distribution	5,962			2,416			1,334
	$	9,922		$	6,662		$	6,064
Operating income:
North American distribution	$	104,044		$	94,932		$	64,342
International distribution	9,472			18,177			11,434
	$	113,516		$	113,109		$	75,776
Assets:
North American distribution	$	813,889		$	785,057		$	670,467
International distribution	387,917			397,131			189,283
	$	1,201,806		$	1,182,188		$	859,750
Capital expenditures:
North American distribution	$	9,789		$	14,366		$	5,344
International distribution	3,001			503			262
	$	12,790		$	14,869		$	5,606

In prior periods, the Company inappropriately included its intercompany investment and funding arrangements related to foreign subsidiaries in its North American segment assets with the offsetting liabilities and elimination entries included as a reduction to the international segment's assets. This resulted in the understatement of international segment assets and an overstatement of North American segment assets. During the current period, the Company corrected its disclosure of assets by segment by eliminating intercompany investments and funding arrangements from both segments. Management concluded that the correction of prior periods is immaterial and, accordingly, previous filings have not been revised. However, segment assets related to prior periods presented herein have been adjusted to remove intercompany investment and funding arrangements.

The effect of the segment asset adjustments listed above as of June 30, 2011 was to reduce North American segment assets by $173.7 million, from $958.8 million as previously disclosed to $785.1 million and to increase international segment assets by $173.7 million, from $223.4 million as previously disclosed to $397.1 million. The effect of this adjustment on segment assets listed above as of June 30, 2010 was to reduce North American segment assets by $114.1 million from $784.6 million as previously disclosed to $670.5 million and to increase international segment assets by $114.1 million from $75.2 million as previously disclosed to $189.3 million.

Also in the prior fiscal year, the Company inappropriately excluded shared operating expense allocations from the international distribution segment. This resulted in the overstatement of the international segment's operating income and an understatement of the North American segment's operating income. Management concluded that the correction of the prior period is immaterial and, accordingly, previous filings have not been revised. However, segment operating income related to the prior period presented herein has been adjusted to allocate shared operating expenses to the international distribution segment. The effect of this adjustment on segment operating income listed above for the year ended June 30, 2011 was to increase North American segment operating income by $4.5 million from $90.4 million as previously disclosed to $94.9 million and to decrease international segment operating income by $4.5 million from $22.7 million to $18.2 million.

Selected financial information by product category is presented below:

	Fiscal Year Ended June 30,
	2012		2011		2010
	(in thousands)
Sales by Product Category:
POS, barcoding and security products	$	1,837,307	$	1,615,461	$	1,300,525
Communication products	1,177,989		1,051,070		814,454
	$	3,015,296	$	2,666,531	$	2,114,979